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SUMMARY
Mammalian reoviruses are ds RNA viruses that are not associated 
with any specific disease process in man. They can cause disease in mice 
where the type I (Tl) and type 3 (T3) viruses exhibit markedly different 
tissue tropism and virulence properties. The different disease patterns of 
these serotypes are due in large part to the viral cell-attachment protein, o l, 
specifically targetting the virus to either neuronal cells (T3) or ependy mal 
cells (T l). The main aim of this project was to locate the cell-binding 
domain of protein a l in order to further characterise the virus-cell 
attachment process.
The Tl and T3 a l  proteins were expressed in vitro from cloned 
DNA copies of the respective SI genes. In vitro translations were carried 
out in a rabbit reticulocyte lysate system optimised with respect to salt and 
si RNA concentration to maximise the efficiency of translation. The si 
mRNAs were poorly translated in the lysate (in agreement with in vivo and 
in vitro studies of other groups). Two different methods were therefore 
employed to effect an increase in the synthesis of the respective a l 
proteins: (i) Oligonucleotide directed mutagenesis of the cloned Sl-1 gene 
was utilized to simultaneously improve the weak sequence context of the 
o l initiation codon and reduce the length of the 5' untranslated (leader) 
region. The resulting "mutant" transcripts possessed a leader sequence of 
the same length as those synthesized in vivo, (ii) The inclusion of 2- 
aminopurine in the in vitro translation reactions improved the efficiency 
with which a  I of both serotypes was synthesized. This was due, 
presumably, to an inhibition of the RNA dependent protein kinase, PI/elF- 
2a, which is involved in the control of protein synthesis.
A cell-binding assay was developed in which oligomerization of 
type 3 a  I was found to be critical for its ability to bind to monolayers of L- 
cells. It was found that the formation of oligomeric species required an in 
vitro translation temperature of 37°C instead of the standard 30°C.
Protein a l- l  was neither able to oligomerize or bind to cells. Specific, 
saturable binding of a l-3  was demonstrated. These studies also revealed 
that the Tl and T3 virus probably bind to different receptors on L-cells.
Deletion mutants of a l-3  were created by oligonucleotide directed 
mutagenesis as a means of locating the cell-binding domain of this protein. 
None of the mutant proteins were found to be capable of binding to L- 
cells. However, a conformational effect could not be discounted as the 
primary reason for their inability to bind, as opposed to the removal of a 
critical binding domain.
XI

1.1 G enera l  Characteris tics  of Reovirus
1.1.1 Reovirus Classification
Mammalian reoviruses belong to the Orthoreovirus genus of the 
Reoviridae family. They were originally members of the ECHO 10 group of 
viruses but Sabin (1959) proposed that they be reclassified into a new 
group as they had several anomalous characteristics compared to other 
known enteroviruses: they were larger, produced cytoplasmic inclusions in 
monkey kidney cells, were pathogenic in newborn but not adult mice and 
caused haemagglutination in human type O erythrocytes. The name 
reovirus is an acronym for respiratory, enteric, orphan viruses as they were 
(and are) not associated with any known disease in humans. The 
prototypic type 1 reovirus is the Lang strain and was first isolated by 
Ramos-Alvarez and Sabin (1954) from a healthy child. Two other viral 
isolates from the stools of children with diarrhoea subsequently became 
the prototypic strains for the other serotypes of reovirus and are the type 2 
Jones (or D5) and the type 3 Dearing viruses (Sabin, 1959). Another viral 
isolate, Abney, also became a prototype for reovirus type 3 (Rosen, 1960 
and Rosen et al., 1960).
The three serotypes can be distinguished on the basis of 
haemagglutination-inhibition and neutralization assays (Rosen, 1960; 
Rosen, 1962 and Sabin, 1959).
1.1.2 The Structure and Morphology of Reovirus
Reovirions are non-enveloped particles, 75-80nm in diameter and 
consist of two concentric layers, the inner and outer capsids, both of which 
are icosahedral in shape (Jordan and Mayor, 1962; Luftig et al., 1972 and
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Harvey et al., 1981). An electron micrograph of a reovirus type 3 particle is 
shown in Figure 1.1.1 (reproduced from Schiff and Fields. 1990). The inner 
core is 50-60nm in diameter and encloses the double-stranded (ds) RNA 
genome (Luftig et al., 1972 and Harvey et al., 1981) which is tightly 
packed into a spherical structure organized such that the adjacent 
stretches of helix are parallel to each other (Harvey et al., 1981). This was 
the first natural example of ds RNA and was identified when mammalian 
cells infected with reovirus stained orthochromatically to give a pale green 
colour when treated with acridine orange, instead of the intense red colour 
associated with single-stranded (ss) nucleic acids (Gomatos et al., 1962). 
The genome consists of ten discrete segments of ds RNA (Shatkin et al., 
1968) which can be divided into three size classes. L (large), M (medium) 
and S (small) (Bellamy et al., 1967 and Watanabe and Graham, 1967).
Reoviral proteins can also be divided into three size classes - X, p 
and a  - and comprise both structural and non-structural species (Smith et 
al., 1969; Zweerink et al., 1971; Both et al., 1975 and McCrae and Joklik, 
1978; Table 1). The outer capsid consists of the major proteins a3 and pic 
and the minor protein a l  (Smith et al., 1969) whilst the core is composed 
of the major polypeptide species A.1, A.2 and a2 and the minor protein X3 
and possibly p2 (Smith et al., 1969). Polypeptide X2 forms a pentameric 
spike structure (Ralph et al.. 1980) which is located at the vertices of the 
core icosahedron. Antibodies directed against X2 were found to react with 
intact virions, suggesting that X2 is exposed on the surface of the virus 
particle (Hayes et al., 1981). Protein a l  is thought to be located close to X2 
since X2 specific antibodies prevent anti-al antibodies from binding 
virions, an effect not observed with antibodies directed against the other 
outer capsid proteins (Lee et al., 1981b).
3
Figure 1.1.1 Electron Micrograph of a Reovirus Type 3 Particle
Reproduced from Schiff and Fields (1990).
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dsRNA Gene Size 
(Kb)
Protein Protein RMM 
(kDa)
Location of 
Protein
L1 3 85 ^3 135 Core
L2 3.91 K2 140 Core Spike
L3 3 89 X1 155 Core
M1 2.3 M2 70 Core
M2 2.2 m1/h1C 80/72 Outer Capsid
M3 2.24 MNS 75 Non-
structural
S1 1.42 a1 49 Outer Capsid
0.36 a l s 14 Non-
structural
S2 1 33 o2 38 Core
S3 1.2 oNS 36 Non-
structural
S4 1.2 o3 34 Outer Capsid
Table 1 Properties of the Genes and Proteins of Reovirus
Adapted from Schiff and Fields (1990).
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1.1.3 Coding Assignments of the Genome RNAs
Two different approaches to the problem of assigning the protein 
coding potential of each gene were pursued in independent laboratories 
and both gave similar answers. A direct methodology, where the individual 
ds RNA segments were isolated, denatured and then translated in vitro 
resulted in the identification of the polypeptide encoded by each gene 
(McCrae and Joklik, 1978; Figure 1.1.2); it also formally demonstrated that 
the plus strand of the genome RNA could act as mRNA. At the same time, 
Mustoe et al. (1978) used a genetic approach. It was known that the ds 
RNA and protein profiles of each serotype were different when examined 
by polyacrylamide gel electrophoresis (PAGE). Recombinant viruses were 
derived from pairwise crosses of different serotypes and their genome and 
protein profiles examined; comparisons between the recombinants and 
parental viruses enabled unambiguous coding assignments for the M and S 
sized genes. (This could not be achieved for the L genes as the X protein 
profiles of the three serotypes could not be sufficiently resolved).
Cleavage of p.1 to jj. 1 c (Smith et al., 1969 and Zweerink and Joklik, 
1970) by the removal of a small amino-terminal fragment (Jayasuriya et al.,
1988) accounted for the initial identification of eleven protein products 
from ten genes. However, a series of investigations led to the discovery of 
a third non-structural protein, a ls , found to be encoded by the SI gene. 
Two unique 80S ribosome protected fragments were isolated from si 
mRNA (Kozak, 1982a). The si message was also shown to direct the 
synthesis of two formylmethionine dipeptides in vitro (Cenatiempo et al.,
1984). Sequencing of SI cDNA clones from all three serotypes revealed 
the existence of a second open reading frame (ORF) initiating about 70 
nucleotides downstream and out of frame with
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Figure 1.1.2 Gene - Protein Coding Assignments for Reovirus
Adapted from McCrae and Joklik (1978).
the start codon for al(Nagata et al., 1984; Bassel-Duby et al., 1985; 
Cashdollar et al., 1985 and Munemitsu et al., 1986). The second ORF was 
predicted to form a small highly basic protein of approximately 14 
kilodaltons (kDa). This has been expressed from si mRNA in vitro (Ernst 
and Shatkin, 1985; Jacobs et al., 1985 and Jacobs and Samuel, 1985) and 
has been identified in the cytoplasm of reovirus infected cells but is not 
associated with virus particles (Ernst and Shatkin, 1985; Jacobs and 
Samuel, 1985 and Ceruzzi et al., 1986). Expression in Escherichia coli (£. 
coli) has also been achieved (Ceruzzi et al., 1986 and Pelletier et al., 
1987). The SI gene, unlike the others, is therefore functionally dicistronic, 
but the functional significance of e ls  protein is unknown.
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1.2 An O verview  of the Reovirus Replicative Cycle
1.2.1 Adsorption/Penetration
Reoviruses attach to specific receptors on the cell surface by means 
of the outer capsid protein a l  (Lee et al., 1981b). Once adsorbed, the virus 
particles are taken up into phagocytic vesicles which then fuse with 
lysosomes. This appears to be a fairly rapid process as virus particles have 
been observed in these endocytic vesicles as early as 15 minutes post­
adsorption (Silverstein and Dales 1968; Sturzenbecker et al., 1987 and 
Georgi et al., 1990).
Evidence that viral entry is a receptor mediated endocytotic event, 
was obtained recently by Georgi et al. (1990) who followed the initial 
events in reovirus infection by means of individually labelled fluorescent 
virions. Virus particles initially attached over the entire surface of the cell, 
were internalized as small clusters of virions which then migrated to a 
perinuclear localization. At this point the label became dispersed, probably 
owing to fusion of the vesicles containing the internalized clusters of 
virions with lysosomes. This strongly resembles the characteristic sequence 
of events involved in the receptor mediated endocytosis of various cellular 
ligands (Goldstein et al., 1985).
1.2.2 Uncoating
Chymotrypsin digestion of reovirus particles in vitro produces viral 
cores that are biochemically and morphologically similar to those produced 
in vivo. Digestion in vitro in low salt buffer yields viral cores lacking all 
outer shell proteins (Smith et al., 1969 and Joklik, 1972) whilst digestion in 
high salt conditions gives a structure that more closely resembles the
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subviral particle (SVP) formed in vivo as it contains polypeptide 5, one of 
the digestion products of polypeptide |ilc  (Joklik, 1972; Shatkin and 
LaFiandra, 1972; Silverstein et a i, 1972 and Borsa et a i, 1973).
Uncoating appears to be an essential step in the reovirus life cycle 
since lysosomotropic agents, which raise the pH of acidic vesicles, prevent 
degradation of the outer coat and inhibit the replicative cycle (Canning et 
ai, 1983).
1.2.3 Transcription
Digestion of the virus outer capsid proteins with chymotrypsin was 
shown to activate the transcriptase of reovirus (Shatkin and Sipe, 1968; 
Skehel and Joklik, 1969 and Banerjee and Shatkin, 1970). Specifically, 
cleavage of p ic  appears to be the step responsible for activation of the 
viral transcriptase since removal of c3 (the other major outer capsid 
polypeptide) is not concomitant with the onset of transcription (Joklik, 
1972 and Drayna and Fields, 1982). However, Borsa et al. (1973 and 
1974) reported that transcriptional activity was not manifest unless the 
digested particles were in the presence of monovalent cations. (These 
cations were not removed in the viral purification procedure of the other 
authors mentioned above).
Virus specific mRNA can be isolated from cytoplasmic extracts of 
infected cells (Bellamy and Joklik, 1967 and Shatkin and Rada, 1967) and 
separated into three size classes (1, m and s) corresponding to the genome 
segments from which they are derived (Bellamy and Joklik, 1967; 
Watanabe and Graham, 1967 and Watanabe el a i, 1967). All ten segments 
of ds RNA are transcribed and only one strand of the ds RNA template is 
copied (Skehel and Joklik, 1969; Levin et a i, 1970 and Banerjee and 
Shatkin, 1970).
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Transcripts produced in vitro were shown to be identical in nature 
to their in vivo counterparts (Hay and Joklik, 1971). Both in vivo and in 
vitro messages were described as full length copies of their respective 
genomic segments. This resulted from hybridization experiments in which 
they had appeared to form perfect hybrids with denatured ds RNA (Skehel 
and Joklik 1969; Levin et al., 1970 and Hay and Joklik 1971). This 
postulation was confirmed later from sequencing data, in which the 3' 
termini of all ten species of mRNAs and plus strand RNAs were shown to 
possess a short consensus sequence (McCrae, 1981 and Antczak et al., 
1982). Translation in vitro confirmed that these molecules were messenger 
RNAs (McDowell et al., 1972 and Graziadei et al., 1973). Sequencing 
experiments of McCrae (1981) and Antczak et al. (1982) revealed that the 
minus strands also shared a common 3' terminal sequence, which was 
different to that of the plus strands.
The transcriptase reaction is fully non-conservative in that the 
genomic ds RNA remains within the viral core and is never detected 
amongst the transcription products (Skehel and Joklik, 1969; Banerjee and 
Shatkin, 1970; Silverstein et al., 1970 and Schonberg et al., 1971).
Early transcription occurs in parental SVPs (uncoated, infectious 
virions) and yields capped mRNA (Desrosiers et al., 1976; Furuichi et al., 
1975; Galster and Lengyel, 1976 and Skup et al., 1981). The 5 'terminal 
cap has the structure: ^mG(5')ppp(5')G(m)pCp (Furuichi et al., 1975; Faust 
et al., 1975 and Skup et al., 1981). The plus strand of the genome RNA 
also has the same cap structure as early mRNA and mRNA produced from 
viral cores via in vitro reactions (Furuichi et al., 1975)
Late transcripts, however, are produced from progeny virion 
particles and have been reported by one group to have uncapped 5' ends - 
pGpC....- owing to latent activity of the capping enzymes in these particles 
(Skup and Millward, 1980b; Zarbl et al., 1980 and Skup ef al., 1981).
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The early transcripts are thought to act as templates for minus 
strand synthesis, but it has been suggested that some late transcripts may 
also perform a similar role (Morgan and Zweerink, 1977).
The transcriptional activity of the progeny virions is abrogated by 
assembly of the the outer shell to form whole virions (Astell et al., 1972) 
with a3 implicated as the protein responsible for the inactivation. This was 
taken to mean that the transcriptase and capping enzymes were latent in 
whole virions. However, Stolzfus et al. (1974) demonstrated an 
oligoadenylate activity in whole virions. Yamakawa ct al. (1982) also 
showed that intact virions do have transcriptase and capping activities but 
that only short oligonucleotides are produced, probably owing to abortive 
initiation. This correlates well with earlier observations that reovirions 
contain single stranded (ss) as well as ds RNA. The ss RNA is present as 
short oligoadenylate molecules and truncated 5'-G- terminated molecules 
(Bellamy and Joklik, 1967; Bellamy et al., 1972; Nichols et al., 1972 and 
Stolzfus and Banerjee, 1972).
Physical constraints imposed by the outer capsid proteins of the 
maturing virion have been proposed to convert the transcriptase to an 
oligoadenylate synthetase (Silverstein et al., 1976). The G- terminated 
molecules appear to be products of abortive initiation (Bellamy et al., 1972 
and Yamakawa et al., 1982) since they contain the consensus sequence 
-GCUA- found at the 5' end of reovirus mRNAs (Nichols et al., 1972) and 
genes (McCrae, 1981 and Antczak et al., 1982).
Recently, biochemical evidence has been obtained to suggest that 
\2  is the reovirus guanylyltransferase as it is the only protein able to bind 
radiolabelled GTP (forming a A.2-GMP complex) and catalyse the transfer 
of the guanylyl group to short reovirus oligonucleotides (Cleveland et al., 
1986). Sequencing of the L2 gene (which encodes \2 ) and subsequent
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analysis of the data has also revealed some homology to the consensus 
sequence of GTP binding proteins (Seliger et al., 1987).
1.2.4 Replication to Double-Stranded RNA
The capped message sense transcripts produced early in infection 
serve as templates for minus strand synthesis in nascent, progeny SVPs 
(Acs et al., 1971; Schonberg el al., 1971 and Sakuma and Watanabe,
1971). Replication is fully conservative as the parental ds RNA remains 
within the SVP throughout the infectious cycle (Silverstein et al., 1970; 
Acs et al., 1971 and Schonberg et al., 1971). The replication step is also 
thought to proceed asynchronously in that plus sense RNA is synthesized 
before the minus strand (Acs et al., 1971 and Schonberg et al., 1971), but 
some evidence exists to suggest that late mRNA (i.e. that synthesized late 
in the infectious cycle) may also act as minus strand template (Morgan and 
Zweerink, 1977). Whichever is correct, only a single round of replicase 
activity apparently occurs (Zweerink, 1974).
1.2.5 Translation
Newly synthesized viral proteins can be detected two hours post­
infection and by 10 hours most of the proteins synthesized in infected cells 
are viral (Zweerink and Joklik, 1970). This is in accordance with earlier 
observations that following reovirus infection, a gradual decrease in host 
cell protein synthesis is observed with a concomitant increase in viral 
polypeptide synthesis (Gomatos and Tamm, 1963 and Ensminger and 
Tamm, 1969).
The underlying mechanism causing the switch to viral protein 
synthesis and hence a preference for the translation of uncapped RNA is
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as yet unknown. Several theories have been proposed to account for this 
phenomenon and only a brief description of these will be given.
ai) Modification of the cap dependent host cell translation system.
Skup and Millward (1980a) and Skup el al. (1981) have proposed 
that the cap dependence of the host cell translation apparatus undergoes a 
modification to allow the translation of capped mRNA early in infection 
and uncapped message at later stages. They demonstrated that early 
mRNA was capped and could be translated efficiently only in extracts 
from uninfected cells, whilst late mRNA was uncapped and could only be 
translated in extracts prepared from infected cells.
aii) A variation on the above theme has been forwarded by 
Lemieux et al. (1984) in which the host translation machinery is not 
modified per se but instead a factor present in infected cells aids the 
translation of uncapped mRNA. Two other studies have even proposed 
that a3 may function in just this manner, Lemay and Millward (1986) and 
Lemieux et al. (1987).
b) Inactivation of a host cell cap binding protein.
Zarbl and Millward (1983) suggest that a host cell cap binding 
protein necessary for the translation of capped RNA is inactivated and 
thus allows translation of uncapped mRNAs.
c) Competition of viral mRNA for a message discriminating factor.
A completely different mechanism to those suggested by the
authors in (a) and (b) has been proposed in which the ability of viral and 
cellular mRNAs to compete for a message discriminatory factor determines 
the efficiency with which a message is translated (Walden et al.. 1981). In 
this model the discriminatory factor must bind to the message before 
complexing with 40S ribosomal subunits. In vitro studies by Brendler et 
al. (1981 a;b) determined that under a particular set of magnesium and 
potassium ion concentrations, the hierarchy of translation efficiencies
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owing to competition faithfully reproduced that of the in vivo experiments 
of Walden et al. (1981). Also, no difference in this order was noted for 
uncapped compared to capped reovirus messages. Further work by Detjen 
et al. (1982) disputed the takeover of the host translation system by 
uncapped viral message as it was seen that: infected and uninfected cell 
extracts translated capped globin mRNA equally well, there was no visible 
increase in decapped globin mRNA translation in reovirus infected cells 
and translation of cellular and viral messages were sensitive to inhibition 
by the cap analogue 7-methyl guanosine triphosphate. Also, elF 4A and 
the cap binding protein complex have been proposed by Ray et al. (1983) 
to be candidates for these message discriminatory factors .
1.2.6 Regulation of Translation
Viral protein synthesis is a highly regulated process in reovirus with 
control exerted at both transcriptional and translational levels.
I.2.6.1 Transcriptional Control
Viral mRNA synthesis is regulated not only with respect to the 
frequency of transcription but also in a qualitative manner with a set of so- 
called "early mRNAs" preferentially transcribed at early times in infection. 
Between 0-2 hours post-infection, only 4 mRNAs are produced, namely. II, 
m3, s3 and s4 (Watanabe et al., 1968; Nonoyama et al., 1974 and Lau et 
al., 1975).
Nonoyama et al. (1974) showed that if protein synthesis is inhibited 
at the time of infection by the addition of cycloheximide, then only the 4 
early viral mRNAs are produced. By performing the block at various times 
post-infection a gradual increase in the number of gene segments
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transcribed was observed with all 10 ds RNAs being transcribed by 4-6 
hours post-infection. Similarly, Shatkin and LaFiandra (1972) showed that 
viral cores produced by chymotrypsin digestion can synthesize all ten 
species of mRNA in vitro but are restricted to the early pattern when used 
to infect cycloheximide treated cells.
Skehel and Joklik (1969) and Banerjee and Shatkin (1970) 
demonstrated that the rate of transcription in vitro was inversely 
proportional to the size of the ds RNA segment being transcribed, i.e. 2x 
and 4x as many s sized transcripts are formed as m and I respectively in 
accordance with their gene sizes. This situation differs in vivo. Zweerink 
and Joklik (1970) found that although the relative rates of transcription 
were broadly similar between size classes there were differences among 
some of the individual class members. However, it was reported in a later 
study by Nonoyama et al. (1974) that early in the infectious cycle there 
were some differences in the transcription rates of individual messages 
within a size class but this changed late in infection to each message 
having a similar transcription frequency. It is possible that the differences 
in the methods of analysis contribute to some of the discrepancies between 
the latter two studies. A list of transcription frequencies is given in Table 
1.2.1.
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Gene Transcription
Frequency
Translation
Frequency
Translation
Transcription
Frequency
L1 0.05 0.03 0 6
L2 0.05 0.15 3
L3 0.05 0.1 2
M1 0.15 0.03 0.2
M2 0.3 1.0 3.3
M3 0.5 0.5 1
S1 0 5 0 05 0.1
S2 0.5 0.2 0 4
S3 1.0 0.3 0.3
S4 1.0 0.7 0.7
Table 1.2.1 Approximate Relative Transcription and 
Translation Frequencies of the Reovirus Genes 
Taken from Joklik (1981).
17
1.2.6.2 C ontro l of T ranslation  Frequencies
The ten species of reovirus mRNA are translated with widely 
varying efficiencies (Table 1.2.1), a phenomenon first reported by 
Zweerink and Joklik (1970). These differences remain constant throughout 
the infectious cycle (Zweerink and Joklik, 1970; Joklik, 1981 and Gaillard 
and Joklik, 1985) despite capping of the early messages and non-capping 
of the late transcripts. The relative translation efficiencies are 
approximately equivalent for each serotype (Gaillard and Joklik, 1985). 
Different turnover rates of the various mRNAs do not account for the 
varying translation efficiencies as each message appears to be equally 
stable (Skehel and Joklik, 1969 and Zweerink and Joklik, 1970) and the 
different abundancies of individual viral transcripts only partially accounts 
for this effect. The S4 gene is transcribed twice as frequently as the SI 
gene but translated fourteen times as frequently. The s4 message is 
therefore translated seven times more efficiently.
Remarkably similar results to the in vivo studies have been 
produced in vitro (Levin and Samuel, 1980). For example. Levin and 
Samuel (1980) found that the s4 mRNA was translated about 8x as 
efficiently as the si mRNA in vitro in a wheat germ system correlating with 
a sevenfold difference between them in vivo (Gaillard and Joklik, 1985 and 
Atwater el at., 1987). The polypeptides synthesized in vitro migrate to the 
same relative positions as native reovirus proteins on sodium dodecyl 
sulphate (SDS) polyacrylamide gels (Graziadei and Lengyel, 1972; 
McDowell et al„ 1972; Levin and Samuel, 1977 and Skup and Millward, 
1977) and would therefore appear to be authentic products.
Altogether, this data suggested that control of translation frequency 
is probably directed by an inherent property of each message; i.e. resides 
within sequence information. To this end, the 5' terminal sequences of the
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reovirus mRNAs and genes were determined (Kozak, 1977; Kozak and 
Shatkin, 1977a,b; Kozak, 1982b; McCrae, 1981 and Antczak etal., 1982) 
and analysed for features that may be important in regulating the 
translational efficiencies of the reovirus messages. No obvious feature, 
such as leader length or sequence symmetry was found that correlated 
with the ability of a message to be well or poorly translated. The only 
feature apparently associated with efficiently translated messages is an AG 
rich area upstream of and surrounding the initiation codon, the significance 
of which is unknown (Antczak el al., 1982).
Kozak (1981; 1983 and 1984) proposed the "-3 +4" rule for 
translation, based on comparisons between numerous eukaryotic mRNA 
sequences in which initiation of translation is efficient if the -3 nucleotide 
(with respect to the initiating AUG codon) is a purine - usually an "A"- and 
the +4 a "G". This is generally obeyed in reovirus with the exception of the 
the ml message; here the start codon is in a favourable context 
£UCAUG£L but the message is translated poorly (Antczak et al., 1982).
1.2.7 Morphogenesis and Release
Free ds RNA has never been found in the cytoplasm of reovirus 
infected cells. Minus sense RNA is formed from a plus sense template with 
which it remains associated in a progeny particle and so is not found free 
in the cytoplasm either (Acs et al., 1971). Assembly of reovirus RNA is 
therefore purported to be at the level of single stranded, plus sense RNA 
and the earliest particles detected contain ss RNA associated into a protein 
complex that is RNase sensitive (Acs et al., 1971; Morgan and Zweerink, 
1974; 1975 and Zweerink et al., 1976). Replication of the ss RNA then 
ocurs to give particles containing ds RNA, that are RNase resistant and 
manifest transcriptional activity (Acs et al., 1971; Sakuma and Watanabe.
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1971 and Morgan and Zweerink, 1975); these are the progeny 
transcriptase particles. It was suggested by Acs et a i  (1971) and Sakuma 
and Watanabe (1971) that the RNase resistance of these particles was the 
result of a conformational change (in the replicase particles) that 
accompanied the replication step. They further suggested that the 
transcriptase may be an alternative form of the replicase enzyme but no 
direct evidence was reported.
Although replicase and progeny transcriptase particles could be 
isolated from infected cells, pure populations of these two species were 
never obtained (Zweerink et a i, 1972; Zweerink, 1974; Morgan and 
Zweerink, 1975 and Zweerink et al., 1976). However, the progeny 
transcriptase particles were shown to be morphologically different from the 
SVPs formed when infectious virions are uncoated (Morgan and Zweerink, 
1975 and Zweerink et al., 1976). In the literature to date, there appears to 
have been little further elaboration on either the nature of the replicase and 
transcriptase particles or their respective enzyme activities. Hence, it is still 
unknown if the viral replicase and transcriptase are two different enzymes 
or alternative activities of the same protein (or protein complex).
One of the last steps in reovirus morphogenesis appears to be the 
formation of the short oligonucleotides present in mature virus particles 
(Zweerink et a i, 1976), previously described in section 1.2.3.
A characteristic of reovirus infected cells is that they develop dense 
granular particles in the cytoplasm known as inclusion bodies or factories 
(Gomatos et a i, 1962). During the infection, they coalesce and form a 
collar around the nucleus. Viral factories have been shown to contain ds 
RNA (Gomatos et a i, 1962 and Silverstein and Schur, 1970) and mature 
and incomplete virions (Gomatos et a i, 1962 and Dales and Gomatos, 
1965). Isolation of the cytoplasmic fraction containing viral factories 
demonstrated that it contained ss RNA and ds RNA synthesis activity in
2 0
vitro (Acs et a i, 1971) and that all ten ds RNA segments can be 
synthesized from it (Watanabe et al., 1968). No ribosomes are found 
within the factories; this necessitates the export of RNA to the cytoplasm 
for translation and import of proteins for virion assembly. Taken together, 
the above studies suggest that the viral factories are the sites of virus 
replication and assembly.
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1.3 Reovirus as a Pathogen
1.3.1 The Mouse Model of Reovirus Pathogenesis
Reoviruses are widely distributed in nature, being found in both 
vertebrates and invertebrates. Approximately 80% of the human 
population is estimated to be seropositive for reovirus but there is little 
evidence of association with disease or illness (Sharpe and Fields, 1985). 
The same is true for most animals with the important exception of mice. 
Reovirus T3 causes a spontaneous infection in the mouse, characterized by 
jaundice, oily hair, diarrhoea and growth retardation, symptoms also seen in 
systemically infected newborn mice (Walters et al., 1963 and Stanley el al., 
1964). Infection of the central nervous system (CNS) is also possible with 
reovirus serotypes 1 and 3, when they are inoculated intracerebrally; this 
mode of infection also reveals highly specific differences in the pattern of 
disease and neurotropism exhibited by these two serotypes. Type 1 infects 
ependymal cells (which line the ventricles of the brain) causing a non-fatal 
hydrocephalus from which the mice recover (Kilham and Margolis, 1969; 
Margolis and Kilham, 1969 and Weiner et al., 1977); type 3 however, 
attacks the neurones and invariably leads to a fatal encephalitis (Walters et 
al., 1963; Margolis et al., 1971; Gonatas et al., 1971; Raine and Fields,
1973 and Weiner et al., 1977). In each case the brain cell/tissue type 
attacked is specific to the respective serotype; type 1 does not infect 
neurones and type 3 does not invade the ependymal cells.
There are also striking differences in the virulence of these two 
serotypes when inoculated in this manner. The type 3 virus can have a 
lethal dose 50 (LD50) of only 10 pfu whereas doses of up to 106 pfu of 
type 1 are non-lethal; correspondingly, the yield of virus from the brains of 
such mice is 102-103 -fold greater for type 3 than for type 1 (Raine and
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Fields, 1973; Weiner et al., 1977; Weiner et al., 1980b and Hrdy et al., 
1982).
Inoculation of newborn mice by the oral route does not lead to 
clinical symptoms of these characteristic disease patterns with either T1 
(Walters et al., 1965) or T3 virus (Rubin and Fields, 1980) although the 
former is more virulent than the latter in this case, as shown by an increase 
in viral titre in the stomach for type 1 and a decrease for type 3 (Rubin and 
Fields, 1980). This is discussed more fully in section ii.
After oral inoculation, reovirus initially concentrates in intestinal M 
(microfold) cells, specialized cells that overlie Peyer's patches and then the 
Peyer's patches themselves (Wolf et al., 1981; Wolf et al., 1983 and 
Kauffman et al., 1983b). Transport through the cells of Peyer's patches 
allows access to the underlying tissue, from which the virus can spread to 
more peripheral organs. Reovirus type 3 has a limited capacity to spread, 
reaching only the Peyer's patches in adult mice and the mesenteric lymph 
nodes in suckling mice. Type 1 can spread to the mesenteric lymph nodes 
and spleen in both adult and suckling mice (Kauffman et al., 1983b).
1.3.2 The Use of Reassortants in the Genetic Analysis of
Reovirus Pathogenesis
The nature of the genetic material of reovirus, i.e. discrete segments 
of ds RNA, has greatly aided the study of many aspects of reovirus biology 
as it confers upon the virus the ability to form reassortants. During 
replication each gene segment segregates independently of the others. 
Therefore, mixed infections, that is infection of the same cell with two 
different serotypes, results in a high proportion of the progeny virions 
having some genome segments derived from each parental serotype; these 
are the reassortant viruses (Fields and Joklik, 1969; Fields, 1971; Sharpe et
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al., 1978 and Ramig et al., 1978). Some of these réassortants contain a 
genome where only one gene segment has been replaced and are called 
monoreassortants, (Figure 1.3.1). Investigations could therefore be carried 
out to ascertain the biologic effects of individual genes.
1.3.2.1 The Role of the SI Gene
As reovirus types 1 and 3 exhibit such distinct patterns of tissue 
tropism and neurovirulence, reassortants were made between these two 
serotypes and their virulence properties examined by intracranial 
inoculation of suckling mice. The results suggested that the specific 
virulence properties correlated with the presence of the appropriate type 
SI gene (Weiner et al., 1977). In a further study, a recombinant clone 
containing the SI gene of reovirus type 3 and nine genes from type 1 - 
clone 1.HA3 - was shown to cause a necrotizing encephalitis and killed the 
mice (as did the type 3 virus). Infection with the reciprocal clone - 3.HA1 - 
(containing 9 genes from type 3 and the SI of type 1) was not fatal to any 
of the mice and showed the same pattern of tropism as type 1 virus, i.e. 
damage to ependymal cells, not the neurones (Weiner et al, 1980b). Thus 
both tissue tropism and virulence are determined by the SI gene (Weiner et 
al., 1977 and Weiner et al., 1980b). It was thought that the a l  protein 
(encoded by the SI gene) was probably responsible for targetting the virus 
to the different cell types and hence producing the separate patterns of 
tropism and virulence. This was shown to be the case in two separate 
studies, one by Tardieu and Weiner (1982) and the other by Dichter and 
Weiner (1984). Respective binding studies in vitro demonstrated the 
absolute specificity of type 1 and clone 3.HA1 attachment to ependymal 
cells and of type 3 and clonel.HA3 to neural cells. Similar studies in vivo.
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Figure 1.3.1 Schematic Representation of Reassortant Formation
Here, a genetic cross between type I and type 3 reovirus is shown, 
resulting in a monoreassortant where the SI gene of type I has 
replaced that of type 3.
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on sections of infected mouse brains showed type 1 viral antigen on 
ependymal cells and type 3 on neuronal cells (Weiner et al., 1980b).
i) SI and Attenuation
Studies on antigenic variants of reovirus further revealed the 
involvement of the SI gene in the virulence process. Spriggs and Fields 
(1982) generated reovirus type 3 antigenic variants by growing stock type 
3 virus in the presence of a neutralizing, anti-haemagglutinin (anti-HA) 
monoclonal antibody (Mab). The virulence properties of these variants 
were subsequently investigated. In each case the variants were found to 
be far less virulent than the parental type 3 Dearing strain (requiring an 
LD50 dose at least 10,000 times higher) and had a greatly reduced ability to 
replicate in the brains of the mice into which they were injected (Spriggs 
and Fields, 1982). Subsequent investigations (Spriggs et al., 1983a; Kaye 
et al., 1986 and Bassel-Duby et al., 1986) revealed that the variants could 
only infect a subset of neurones and were completely impaired in their 
ability to spread to the brain after peripheral inoculation.
Genes from a selection of these and other similarly generated 
variants were sequenced and found to contain only a single amino acid 
substitution in the carboxy-terminal half of the a l protein, where the cell­
binding domain has been postulated as being located (Bassel-Duby et al., 
1986). A reassortant virus containing the SI gene from one of the variants 
clearly showed the single amino acid substitution in a l  to be responsible 
for the attenuated virulence and growth characteristics of these variants 
(Kaye et al., 1986).
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Reovirus T1 and T3 also use distinct pathways of spread once they 
have invaded the host, a property again related to the origin of the SI 
gene. Type 1 virus spreads to the CNS via lymphatic and haematogenous 
routes, whereas type 3 disseminates via neural pathways and in particular 
appears to utilize the system of fast axonal transport (Tyler et al., 1986). 
Studies on reassortant viruses demonstrated that this was specifically 
owing to the parental origin of the SI gene. Similarly, the degree to which 
reovirus will spread to other organs after intragastric inoculation is also 
influenced by the nature of the SI segment (Kauffman et al., 1983b).
1.3.2.2 The Role of the M2 Gene
The M2 gene encodes the viral protein (il whose cleavage product 
[lie is a major component of the viral outer capsid. Studies involving 
various type 3 field isolates and reassortant clones have illustrated the 
marked effect on virulence that the M2 gene can have. Reovirus type 1 
and 3 differ greatly in their sensitivity to chymotrypsin (and other 
proteases including those found in gastric fluids) and in the subsequent 
effect it has on their ability to replicate. Type 1 is relatively insensitive to 
protease action and can replicate as ably as intact virions but type 3 is 
extremely sensitive and loses this ability (Rubin and Fields, 1980). This 
characteristic was found to map to the M2 RNA segment and resulted in 
T1 virus being able to replicate in the intestine of perorally infected mice 
whilst T3 was rapidly cleared from this site. However, recombinant viruses 
containing a type 1 M2 gene and a type 3 SI gene were lethal when 
inoculated by the same route (Rubin and Fields, 1980).
Recently, evidence has been obtained that questions this particular 
function of the M2 gene. Bodkin and Fields (1989) noted that in the study
SI and Viral Spread in the Host
27
of Rubin and Fields (1980), the reassortant viruses utilized to assign the 
protease sensitivity of the virus to the M2 gene were generated by 
crossing mutagenized, temperature sensitive type 3 virus with wild type 
stocks of type 1 virus. It was also noted that the amount of virus excreted 
from the intestines of infected mice and the ability to be transmitted 
amongst littermates of newborn mice mapped to the L2 gene (Keroack and 
Fields, 1986); furthermore, the reassortant viruses utilized in this study 
were derived from non-mutagenized parental stocks. Bodkin and Fields 
(1989) therefore employed similar reassortant viruses created from crossing 
wild type stocks of T1 and T3 and found that the growth and survival 
properties of reovirus in the intestinal environment of mice were 
determined by the L2 and SI genes. Thus, reassortants containing the T1 
L2 and SI genes behaved as type 1 reovirus and grew well in the intestinal 
environment whereas the converse was true for type 3 virus and 
reassortants with a type 3 L2/S1 pairing. Furthermore, there was no 
correlation of these growth and survival properties with the presence of 
the M2 RNA segment.
Apart from its posssible role in conferring protease sensitivity, the 
M2 gene affects reovirus virulence in a less well understood manner. Hrdy 
et al. (1982) examined various field isolates of reovirus type 3 and found a 
highly attenuated clone - T3(H/Ta). The greatly reduced virulence of this 
isolate mapped to the M2 gene but it retained a chymotrypsin sensitivity 
comparable to the T3 Dearing laboratory strain and displayed a pattern of 
tissue tropism that was similar to all of the other T3 isolates. Thus, it was 
suggested that the M2 segment may affect the virus' growth properties 
(Hrdy etal., 1982).
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1 .4 The a l  P rotein o f Reovirus
The previous sections have shown that a l  plays a crucial role in the 
replication of reovirus and in determining the tropism and virulence 
properties of the virus. The following sections describe the structure and 
other functions of this protein.
1.4.1 The Physical and Morphological Properties of a l
The SI gene of reovirus, which encodes the a l  protein (Weiner et 
al., 1978) has been cloned and sequenced by several groups (Nagata et al., 
1984; Bassel-Duby et al., 1985; Cashdollar et al., 1985 and Munemitsu et 
al., 1986). The gene is approximately 1.4 Kb long and encodes a a l  
protein of approximately 450 amino acids, 49 kDa in molecular mass.
The predicted T3 a l  protein sequence was analysed and predicted 
to form two structurally distinct regions (Bassel-Duby et al., 1985). The 
amino-terminal third of the protein (aa 28-158) was seen to consist of a 
heptapeptide repeat pattern (a-b-c-d-e-f-g) in which the amino acids 
occupying positions a and d are primarily hydrophobic. Proline and 
aromatic residues are absent in the repeat which led to the suggestion that 
this region would form an a-helical coiled-coil. By analogy with other 
coiled-coil protein structures the hydrophobic residues at positions a and d 
would form the interface between adjacent helices and provide the major 
stabilising force for this region of a l  through hydrogen bonding (Bassel- 
Duby et al., 1985).
The carboxy-terminal half of the protein was predicted to have no 
regular structure. It was therefore proposed to have a globular 
configuration composed of short a-helices and P-sheets with many turns.
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Sequence determination of all three SI genes and computer analysis 
of the predicted amino acid residues coupled with computer processed 
electron micrographs of virion released type 2 a l  proteins have refined this 
model, resulting in a predicted structure that can be divided into several 
morphological domains [Ti, Tii, Tiii, Tiv and H] (Nibert et al., 1990 and 
Fraser et al., 1990), which are shown schematically in Figure 1.4.1. The 
amino-terminal twenty or so aa (Ti) are proposed to form a short 
hydrophobic tail and a hinge that joins this region to the a-helical coiled- 
coil (Tii). Immediately carboxy-terminal to the coiled-coil, an area of cross-p 
sheet is proposed (Tiii) and this is joined to the C-terminal globular head 
(H) by means of a flexible neck (Tiv). The latter is thought to consist of an 
area of P-sheet separating two short coiled-coils. Fraser et al. (1990) and 
Nibert et al. (1990) have suggested that the neck provides flexibility, 
which may be important in the attachment process and could also 
contribute to the formation of the extended and retracted states of a l  seen 
in the electron micrographs of Furlong et al. (1988), (described below). A 
slight anomaly was also cleared by the complementary studies of Fraser et 
al. (1990) and Nibert et al. (1990) in that the region of coiled-coil 
identified by Bassel-Duby et al. (1985) did not fully account for the length 
of the fibrous portion of a l  particles seen in electron micrographs (Furlong 
et al., 1988). However, the region of heptad repeats was extended and the 
cross-P sheet of domain Tiii was proposed to form a rod-like structure 
(Nibert et al., 1990) thus reconciling the predicted length of the fibrous 
section to that observed.
Experiments using Mabs directed against various reovirus proteins 
(Lee et al., 1981b) and a separate study with a particular reovirus 
temperature sensitive (Ts) mutant (McPhillips and Ramig, 1984) have 
suggested that a l is closely associated with the XI spike. Bassel-Duby
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et al. (1985) have further proposed that the coiled-coil of a l may extend 
into the channel of the spike formed by X2.
Smith et al. (1969) originally proposed that a l  existed in virions as 
a dimer. Evidence has recently been presented that suggests it may exist as 
a tetrameric structure (Bassel-Duby et al., 1987 and Banerjea et al., 1988) 
and can exist in an extended or retracted state (Furlong et al., 1988). 
Polypeptide a l expressed in E.coli, isolated from reovirus infected cells or 
when released from intact virions formed an approximately 200,000 kDa 
band when subjected to SDS-PAGE under non-reducing conditions 
(Bassel-Duby et al., 1987). Similarly, SDS-PAGE analysis of a l expressed 
from a vaccinia virus recombinant gave a band of the same size (Banerjea 
etal., 1988).
A dimeric or tetrameric structure has also been proposed by Yeung 
et al. (1987) on the basis of chemical crosslinking experiments of a l  
purified from virions, whilst Fraser et al. (1990) have suggested a tetramer 
on the basis of their computer enhanced electron micrographs. Electron 
microscopy studies have also visualized a l  both attached to and in 
isolation from virus particles. They have confirmed the lollipop nature 
predicted for this protein in that it can be seen as a fibre or rod topped with 
a globular head (Banerjea et al., 1988; Furlong et al., 1988 and Fraser et 
al., 1990). However, the proposed extended/retracted forms of a l  (Furlong 
et al., 1988) were only noted for virion associated protein; free a l  was 
only seen in an extended state. The physiological importance of these two 
states (if any) has yet to be determined although Furlong et al. (1988) 
have suggested that it may be the extended form that is involved in the 
attachment to host cells. In this state, the likelihood of a l  binding to a 
receptor molecule(s) is probably increased.
1.4.2 The Functions of a l
Although a l  constitutes only 1-2% of the total viral protein (Smith 
et al., 1969; Lee et al., 1981b and Bassel-Duby et al., 1987) it performs a 
wide variety of functions (Table 1.4.1), many of which can be related to the 
fact that it is the host cell attachment protein (Lee et al., 1981b). It can also 
interact with the host cell in a less direct manner, an example of which is to 
alter certain aspects of host macromolecular synthesis (see below). A 
further property of a l  is that it is the viral haemagglutinin (Weiner et al., 
1978) where glycophorin has been shown to be the moiety to which it 
binds (Paul and Lee, 1987).
Weiner and Fields (1977) demonstrated that a l  is responsible for 
eliciting virus serotype specific neutralizing antibodies and must therefore 
contain type-specific antigenic determinants. Further evidence for the 
type-specificty of this protein is that antibodies directed against a l 
generally: precipitate only homologous type a l  molecules (Gaillard and 
Joklik, 1980 and Lee et al., 1981a), neutralize only homologous type virus 
(Hayes et al., 1981) and will only inhibit the haemagglutination properties 
of the corresponding virus serotype (Hayes et al., 1981). The type- 
specificity is not absolute however, as of four Mabs generated against a l-  
3, three neutralized the homologous type virus, but the fourth 
demonstrated high activity against type 3 and type 1 virus (Hayes et al., 
1981). Also, whereas antiserum against type 3 virus was able to precipitate 
only homologous type a l ,  anti-type 2 virus antiserum precipitated type 1 
as well as type 2 a l ,  albeit less efficiently (Gaillard and Joklik, 1980).
These observations are consistent both with ds RNA hybridisation 
studies (Gaillard and Joklik, 1982) which demonstrated that SI has 
diverged the most out of the ten gene segments and with sequence 
comparison data (Cashdollar et al., 1985) which show there to be very
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Table 1.4.1 Functions of the ctI Protein o f  Reovirus
FUNCTION REFERENCES
Cell attachment 
Haemagglutinin
Tissue tropism and neurovirulence
Pathways of spread in the host 
Role in viral growth in the intestine
Antigen responsible for type-specific 
neutralizing antibody production
Cytotoxic T-cel I generation
Suppressor T-cell generation
T-cell dependent delayed-type 
hypersensivity
Interaction with host cell 
microtubules
Inhibition of host cell DNA 
replication
Lee et al. 1981b
Weiner et al. ( 1978)
Weiner et al. (1977) and Weiner et 
al. (1980b)
Tyler el al. (1986)
Bodkin and Fields (1989)
Weiner and Fields (1977)
Finberg et al. (1979; 1982)
Fontana and Weiner (1980)
Weiner et al. (1980a)
Babiss et al. (1979) and Sharpe et al. 
(1982)
Sharpe and Fields 1981
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little homology between the SI genes of the three virus serotypes. A 
curious point emerging from these studies is that although T1 and T3 
reoviruses exhibit the greatest overall genome homology, in the case of SI 
and hence a l ,  the highest homology is between T1 and T2.
Cell-mediated immune responses are also induced by a l ,  with 
cytotoxic T-cell responses (Finberg et al., 1979;1982), suppressor T-cell 
generation (Fontana and Weiner, 1980) and delayed hypersensitivity 
reactions (Weiner et al., 1980a) all elicited against this protein. A further 
important feature of this protein is that it determines tissue tropism and 
virulence patterns (as previously described in section 1.3.2.1) (Weiner et 
al., 1977 and Weiner et al., 1980b).
Two other properties of a l  are (a) that it is proposed to be 
responsible for the inhibition of host cell DNA synthesis (Sharpe and 
Fields, 1981) with T3 a l  being a more potent inhibitor than that of T1 and 
(b) it is also thought to control the association of virus particles with 
microtubules (Babiss et al., 1979 and Sharpe et al., 1982). A recent study 
has elaborated on the inhibition of cellular DNA synthesis associated with 
the SI gene segment (Fajardo and Shatkin, 1990). It was found that the 
inhibition exhibited by T1 reovirus was accelerated when it was used to 
infect cells co-expressing the T3 a l and a ls  proteins but not a l by itself. 
Inhibition was not effected merely by the expression of a l or a l  and a ls  
together. The initial conclusion drawn by Sharpe and Fields (1981) was 
made before the discovery of the second ORF in the SI gene encoding the 
a ls  product.
Domains on the Protein
Reassortant viruses (see section 1.3.2) have proved to be an 
extremely useful tool in the study of reoviruses and in the assignment of 
many functions to protein a l .  Antibody mapping has demonstrated that at 
least some of these functions exist as distinct domains on the a l  protein. 
Monoclonal antibodies were raised against the T3 a l  protein and found to 
have either: neutralizing activity, haemmagglutination inhibition (HI) 
activity, weak neutralizing and HI activity or neither of these properties 
(Burstin et a i, 1982). From this work, it was deduced that there were at 
least three antigenically distinct sites on a l .  Further evidence for distinct 
domains on a l  was provided by Spriggs et al. (1983b) in 
radioimmunoassay competition experiments where those Mabs showing 
strong neutralizing activity did not compete with those exhibiting HI 
activity in binding assays with a l .
1.4.3 Localisation of the V arious Functions of a l  to Distinct
3 6
1.5 Examples of Virus - Receptor Systems
It is possible that viruses bind to host cells either specifically or in a 
non-specific manner. The former case would imply that the initial 
interaction is through a specific set of receptor molecules, whose cell- 
surface expression would be a major factor in determining the cell types 
permissive for productive infection. Non-specific binding would intimate 
that permissiveness is determined at the level of virus entry or at some 
stage in replication. (These factors also apply when viruses interact with a 
specific receptor moiety). It has become clear that specific binding does 
occur in a number of virus systems. In the following sections some virus- 
receptor interactions will be described, from which it can be seen that a 
broad spectrum of approaches have been employed to identify specific 
viral receptors. This has shed further light on the various ways in which 
tissue tropism and viral virulence is governed in the host.
1.5.1 Non-Enveloped RNA Viruses
Two viruses from the Picomaviridae family - poliovirus and 
rhinovirus - will be used as examples of the interaction of non-enveloped 
viruses with host cells.
13.1.1 Poliovirus
Poliovirus, the causative agent of poliomyelitis, belongs to the 
enterovirus genus of the family Picomaviridae. It is 30 nm in diameter, 
icosahedrally shaped and posseses a single stranded, positive sense RNA 
genome of approximately 7.4 Kb. The virion capsid is composed of 60
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copies of proteins VP1, VP2, VP3 and VP4 which are derived by proteolytic 
cleavage of a large (- 220 kDa) polyprotein (reviewed by Rueckert, 1985).
Cell surface expression of the poliovirus receptor (PVR) was 
thought to be a major determinant in confining poliovirus replication to a 
limited number of sites in its human or primate hosts. This view arose from 
the observation that transfection of the viral RNA into non-susceptible 
cells relieved the inhibition of viral replication, suggesting that the block to 
infection was at the binding, entry or uncoating stage (Holland et al., 
1959). More recently, further supporting evidence was obtained by 
Mendelsohn et al. (1986) who rendered non-permissive L-cells susceptible 
to poliovirus infection by transforming them with human DNA leading to 
the expression of the PVR at the cell surface.
A 100 kDa protein was identified in HeLa cells that was proposed 
to be involved in poliovirus attachment (Shepley et al., 1988).
Mendelsohn et al. (1989) used a molecular cloning and expression 
approach to identify and isolate the PVR gene. Sequencing of the cDNA 
lead to a predicted size for the PVR of 45 kDa. Comparative analysis of the 
predicted amino acid sequence showed the PVR to be a new member of 
the immunoglobulin superfamily, having a three domain Ig-like 
extracellular stucture, a transmembrane region and a short cytoplasmic tail. 
In fact, two cDNA clones were obtained which diverged at their COOH 
termini; one possessed a longer tail than the other leading to predicted 45 
kDa and 43 kDa forms that could arise from alternative splicing or 
polyadenylation events (Mendelsohn et al.. 1989).
Koike et al. (1990) have also cloned the PVR and found that it 
exists as four different mRNA isoforms generated by alternative splicing 
pathways giving rise to four different PVR molecules. Two of the four are 
membrane bound and two are soluble as they lack the transmembrane 
domain. The two membrane bound forms were identical to those cloned by
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Mendelsohn et al. (1989). Transformants expressing the soluble forms of 
the PVR were hardly permissive for poliovirus infection whereas those 
with the membrane bound form were fully permissive.
The relevance of these different forms in vivo is unknown as three 
of the mRNA isoforms can be detected in many human tissues including 
those that do not normally support poliovirus infection. All four isoforms 
were not detected as the means of assay was by the polymerase chain 
reaction and the primers utilised in the reactions did not enable selection of 
the fourth isoform (Koike et a i, 1990). Mendelsohn et al. (1989) also 
detected PVR mRNA in many tissues not all of which sustain virus 
replication in vivo. It has therefore been suggested that certain cell types 
may still specifically regulate the production of one particular mRNA (by 
splicing for example) or that some form of translational regulation may limit 
PVR expression at the cell surface. Alternatively, post-translational 
modification could produce tissue specific expression (Mendelsohn et al.,
1989). A monoclonal antibody against the PVR only stained a subset of 
cells when used to histochemically stain human brainstem (Shepley, 1988), 
implying that only a limited number of cells express the PVR protein.
Recently, the PVR gene was used to create a mouse transgenic for 
PVR (Ren et al., 1990). Inoculation of these mice with poliovirus type 1 
Mahoney (Pl/Mahoney) by the intracerebral, intravenous or 
intraperitoneal route leads to the expected paralysis in nearly all of the 
cases. Inoculation with the live attenuated Sabin type 1 vaccine strain did 
not result in clinical disease. Pl/Mahoney was not pathogenic when 
inoculated orally . The cloning of the PVR has therefore led to the 
development of a potential mouse model of a clinically important human 
disease (Ren et al., 1990).
Once bound, poliovirus is thought to gain entry to the cell by the 
process of receptor mediated endocytosis whereby its genome is liberated
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to the genome from acidic vesicles (Madshus et al., 1984 and Zeichhardt 
et al., 1985). Increasing the pH of the intracellular acidic vesicles prior to 
or at the time of infection prevented viral replication by inhibiting the virus 
uncoating step as neither attachment, penetration or the infectivity of the 
virus was shown to be affected by the weak bases used to raise the pH.
1.5.1.2 Rhinovirus
Rhinovirus also belongs to the Picomaviridae family but is a 
member of the rhinovirus genus. It therefore possesses the same general 
physical and chemical characteristics as poliovirus, i.e. icosahedral shape, 
single strand of positive sense RNA, etc.
There are however, over 100 different serotypes of human 
rhinoviruses which can be split into two main groups according to the 
cellular receptor they bind. These groups were assigned according to cross 
competition assays between the viral serotypes and cell protection assays 
with a monoclonal anti-receptor antibody. Approximately 80 of the 100 
serotypes have been classified into a "major rhinovirus receptor group" 
and bind to a single receptor entity. The remaining serotypes belong to the 
"minor rhinovirus receptor group" and bind to one or more receptors 
(Abraham and Colonno, 1984 and Colonno et al., 1986).
The major human rhinovirus receptor (HRR) was initially identified 
as a 90 kDa glycoprotein with a broad tissue distribution (Tomassini and 
Colonno, 1986 and Colonno et al., 1986). Two distinct approaches were 
used in the identification of intercellular adhesion molecule-1 (ICAM-1) as 
the major HRR. One group followed the same strategy to that employed in 
the cloning of the PVR. HeLa cell genomic DNA was used to transform 
non-permissive cells rendering them susceptible to rhinovirus binding after 
transformation. The HRR protein was purified from these transformed cells
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and partially sequenced enabling it to be identified as 1CAM-1 by 
sequence comparison. This identification was confirmed by cDNA cloning 
and sequencing (Greve et al., 1989). The second group noticed that 
ICAM-1 and the proposed major HRR had a similar tissue distribution. 
Binding assays to purified ICAM-1 and ICAM-1 transfected non- 
permissive cells with two major rhinovirus serotypes, HRV 14 and HRV 3, 
confirmed ICAM-1 as the HRR (Staunton et al., 1989).
ICAM-1 is a 90 kDa glycoprotein with an amino-terminal structure 
composed of five Ig-like domains, a single transmembrane segment and a 
short cytoplasmic tail (Simmons et al., 1988 and Staunton et al.. 1988). It is 
therefore a member of the Ig superfamily. Lymphocytes bind to a variety of 
cell types, including epithelial cells, via the interaction of LFA-1 
(lymphocyte function associated molecule-1) with ICAM-1 (reviewed by 
Dustin et al., 1988). ICAM-1 is strongly induced by lymphokines and 
cytokines in inflammatory responses (Dustin et al., 1988). Rhinoviruses 
infect the nasal epithelium in vivo; rhinovirus infection may therefore lead 
to the increased expression of its receptor (Staunton et al., 1989).
The three dimensional stuctures of HRV 14, PI /Mahoney and the 
attenuated P3/Sabin strain have all been determined (Rossmann et al., 
1985; Hogle et al., 1985 and Filman et al., 1989). A cleft or canyon was 
noticed to encircle each of the five fold axes of the viral icosahedral 
structure which separates a peak from a plateau structure (Figure 1.5.1); 
various prominent loops were found to lie in close proximity to the 
canyons. Rossmann et al. (1985) proposed the canyon to be the site of 
attachment for the host cell receptor. Its deepest residues would be 
inaccessible to an antibody whose Fab fragment ( -  35A) would be too 
large to penetrate into the canyon (25A). Consequently, they would be 
free from immune pressure and enable the virus to maintain an unchanging 
receptor binding site.
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Figure 1.5.1 The Rhinovirus Canyon
Shown above is a schematic diagram of the position of the canyon 
structure in a picomavirion, reproduced from Rossmann (1989). The 
canyon is formed roughly at the junction of the clustered VP1 subunits and 
the surrounding VP3 proteins. PolypeptideVP4 is not evident as it is buried 
beneath VP1 and VP2. VP1 contributes the majority of the residues lining 
the canyon and VP3 most of the remainder; VP2 is barely associated with 
this structure (Rossmann el al., 1985).
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Neutralizing Mabs have been generated against both poliovivirus 
and rhinovirus (Sherry and Rueckert, 1985; Sherry et al., 1986; Minor et 
al., 1983;1985 and Diamond et al., 1985) and used to generate 
neutralizing escape mutants. When analyzed, the mutations could be 
grouped geographically into four distinct clusters which mapped to the 
most exposed sites surrounding the canyon (Hogle et al., 1985 and 
Rossmann et al., 1985) but not in the canyon itself.
A comparison of picomavirus sequences revealed that the canyon 
contains highly conserved amino acid residues (Rossmann and 
Palmenberg, 1988) and mutation of residues in the canyon floor abrogated 
efficient binding of HRV 14 to its host cell (Colonno et al., 1988). Taken 
together, these observations provide strong evidence for the canyon being 
the receptor site.
1.5.2 Enveloped RNA Viruses
Influenza virus and human immunodeficiency virus-1 will be the 
main examples discussed in the following sections as the means of 
attachment and entry to the host cell are very different to the 
aforementioned viruses.
1.5.2.1 Influenza Virus
Influenza viruses belong to the Orthomyxoviridae family and are 
characterized by a lipid envelope which surrounds a helical nucleocapsid. 
The genome is comprised of 8 (influenza A and B) or 7 (influenza C) 
segments of negative sense, single-stranded RNA. Two types of spike 
glycoprotein are found in the the lipid envelope, the haemagglutinin (HA)
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and neuraminidase (NA) (Kilboume, 1987). These viruses are a major cause 
of upper respiratory tract infections in man and some animals.
i) Structure of the HA
The HA is formed by proteolytic cleavage of a precursor molecule 
called HAo (Lazarowitz and Choppin, 1975 and Klenk el al., 1975) which 
divides it into two disulphide linked chains, HAi and HA2 by the removal 
of one (or more) residues (Verhoeyen et al., 1980 and Wilson et al., 1981; 
Figure 1.5.2). This proteolytic cleavage was also found to be a prerequisite 
for viral infectivity. Virions carrying HAo could attach to, but not 
efficiently infect cells without prior protease digestion, the effect of which 
was to cleave the precursor (Lazarowitz and Choppin, 1975 and Klenk et 
al., 1975).
The three dimensional structure of bromelain released HA has been 
determined (Wilson et al., 1981) to 3A resolution and the HA ascertained 
to be composed of a long a-helical stem on top of which sits a globular 
head. Bromelain cleaves the HA close to the viral membrane leaving only 
the small COOH terminal fragment of HA2 associated with the membrane. 
Three HA molecules associate to form a trimeric structure with the HA2 
chains coming together as an a-helical coiled-coil and the HA] chains 
forming the globular heads, but with far fewer inter-subunit interactions 
(Wilson et al., 1981). A diagram of the trimeric HA structure is shown in 
Figure 1.5.2.
A cellular protein, BiP (Binding Protein) appears to interact with the 
influenza HA during the subunit folding process and/or during assembly of 
the subunits to form the trimeric structure. Gething et al. (1986) found that 
two different, incorrectly folded, mutant forms of the HA were retained in
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Figurel.5.2 Schematic Diagram of the 1968 Hong Kong Influenza 
Virus Haemagglutinin
(A) Linear map of the haemagglutinin. Shown here is the external domain 
(which extends to aa 184 of HA2), the membrane anchor (aa 185-211) and 
the cytoplasmic domain (aa 212-221). Also shown are the various 
processing sites and location of the fusion peptide; the only disulphide 
bond shown is that linking HA1 and HA2; those within HA1 and HA2 are 
not marked.
(B) Trimeric structure of the haemagglutinin showing the receptor binding 
sites.
The diagrams opposite are adapted from Wilson et al. (1981)
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the endoplasmic reticulum (ER) whilst wild-type (correctly folded) HA 
forms were transported from the ER to the Golgi and cell-surface as 
normal. In the ER, the mutant forms were associated with BiP. It was thus 
suggested that BiP bound to misfolded molecules to prevent their 
intracellular transport and were possibly transiently associated with wild- 
type chains to ensure correct folding (Gething et al., 1986). These 
functions of BiP (and BiP related) proteins were also suggested by Munro 
and Pelham (1986) as a general concept in the intracellular folding and 
association of many cellular proteins.
ii) Influenza Virus Entry and Membrane Fusion
The HA functions as both the cell attachment (Rogers, et al., 1983 
and Wiley and Skehel, 1987) and membrane fusion protein (White et al., 
1982a) of influenza virus. Sialic acid is the receptor moiety to which 
influenza binds (Paulson et al., 1979) and different strains of influenza 
virus exhibit preferences for specific sialic acid configurations. Binding is 
mediated by a surface pocket on the globular head of the HA molecule 
into which the sialic acid residue fits exactly (Weis et al., 1988). Single 
amino acid substitutions in the binding pocket alter the specificity for 
different sialyloligosaccharide structures (Rogers et al., 1983) and later 
studies by Weis et al. (1988) have shown that this is likely to be a 
conformational effect, rather than via a direct interaction with the altered 
residue.
Influenza viruses enter the host cell by the process of receptor 
mediated endocytosis and so are delivered to acidic vesicles ( Matlin et al.,
1981) where the viral membrane fuses with that of the vesicle, thus 
delivering the nucleocapsid to the cytosol. Membrane fusion is strictly 
dependent upon an acidic pH (White et al., 1981; Huang et al., 1981 and
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Matlin et a i, 1981). The acidic environment is thought to induce a 
conformational change in the viral HA, causing the N-terminal 
hydrophobic portion of HA2 to become exposed and mediate the fusion 
event (Skehel et ai, 1982; White and Wilson, 1987 and Weis et a i, 1988). 
Experiments involving expression of a cloned cDNA copy of the HA and 
the use of reassortant viruses have demonstrated that the HA is the only 
viral gene product necessary for fusion and that it confers the pH 
dependence property of the fusion event (White et a i, 1982b and Lenard 
et a i, 1982).
1.5.2.2 Comparison of Influenza with the Paramyxoviruses
Paramyxoviruses are similar in structure to the influenza viruses in 
that they consist of a lipid envelope which encloses a helical nucleocapsid 
whose genetic material is negative sense, single stranded RNA (reviewed 
by Galinski and Wechsler, 1991). However, the genome comprises a single 
molecule of RNA and the cell attachment and fusion functions are 
associated with different spike glycoproteins. The HN protein is the viral 
haemagglutinin and neuraminidase and the F-protein mediates membrane 
fusion (Galinski and Wechsler, 1991). These viruses also probably use sialic 
acid bearing structures as receptors (Landsberger et a i, 1981 and Oku et 
ai, 1982).
Homma and Ohuchi (1973) and Scheid and Choppin (1974) found 
that virus grown in certain cell lines was non-fusogenic and non-infectious 
unless treated with trypsin, a property that mapped to the F-protein. 
Trypsin cleaved the protein into its two subunits, Fi and F2, which are 
linked by a disulphide bond, and restored the fusogenic property and 
infectivity of the virus.
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The F2 fragment corresponds to the N-terminal region and Fj to the 
C-terminus of Fo (the uncleaved precursor), with the Fi domain serving to 
anchor the spike to the viral membrane (Scheid and Choppin, 1977; Figure 
1.5.3). Sequencing of the N-terminus of Fi has revealed that it is highly 
hydrophobic (Gething et al., 1978). This terminus is created upon cleavage 
of Fo and is homologous to other paramyxovirus Fj proteins and to the 
HA2 of influenza virus (White et al., 1983). It was suggested that this 
region could play a role in membrane fusion (Gething et al., 1978), 
probably via a conformational effect exposing this hydrophobic area after 
cleavage of Fo. That the N-terminus of Fi is involved in membrane fusion is 
supported by the experiments of Richardson et al. (1980) and Richardson 
and Choppin (1983). Various synthetic peptides that were similar in 
sequence to this region of Fi, but which contained a carbobenzoxy-group 
at their N-termini, were found to inhibit virus infectivity at the level of 
penetration and virus-cell membrane fusion. (The exact effect of the 
carbobenzoxy group was not known but its presence greatly increased 
the inhibitory activity of the peptides). The site of peptide action was 
determined to be on the cell membrane not that of the virus, leading to the 
suggestion that the peptides competed with the Fi protein for receptor 
sites on the cell membrane, thus preventing fusion of the membranes 
(Richardson and Choppin, 1983).
Evidence for a conformational change in the F protein upon 
cleavage to the F1-F2 complex came principally from circular dichroism 
studies of the uncleaved and cleaved forms of the protein (Hsu et al., 1981 
and Kohama et al., 1981). The two forms gave different circular dichroism 
spectra indicating that each had a distinct conformation. Further evidence 
came from the observation that the cleaved form bound more anionic 
detergent than the uncleaved, probably owing to the exposure of 
previously hidden hydrophobic residues (Hsu et al., 1981). Also, cleaved
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Figure 1.5.3 Schematic Representation of the F Protein of 
the Paramyxovirus - Sendai Virus (Adapted from White et 
al.. 1983).
The disulphide linkage shown between F| and F2 is not an 
exact representation and only indicates that these two chains 
are linked in such a manner. The hydrophobic amino-terminus 
of F| exposed upon proteolytic cleavage of the F() protein is 
shown as a box.
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and uncleaved F protein exhibited different isoelectric points (pis). As the 
amino acid composition of each form is similar, a conformational change 
resulting in a rearrangement of the charged residues was suggested to 
account for the more acidic pi of the cleaved form (Kohama et at., 1981).
A major difference in the fusion event between paramyxoviruses 
and influenza is that for the former it is largely a pH independent process 
(Clavell and Bratt, 1972 and White et at., 1983). This means that fusion 
can occur at the cell surface and not in an acidic vesicle, leading to the 
direct release of the nucleocapsid into the cytosol after fusion (Fan and 
Sefton, 1978). It is still not clear however, if this type of fusion leads to a 
productive infection.
1.5.3 Human Immunodeficiency Virus and CD4
Human immumnodeficiency virus type 1 (HIV-1), belongs to the 
lentivirus genus of the Retroviridae family. It is generally accepted as the 
aetiologic agent of acquired immune deficiency syndrome (AIDS) (Barre- 
Sinousi et at., 1983; Gallo et at., 1984 and Popovic et at., 1984) which is 
characterised by a depletion of T cells. It had been noticed that the virus 
exhibits a selective tropism for T lymphocytes bearing the surface marker 
CD4 (Klatzmann et at., 1984a) suggesting that this glycoprotein may play 
a role in the entry of HIV-1 into the host cell. Dalgleish et at. (1984) and 
Klatzmann et at. (1984b) subsequently demonstrated that only CD4 
bearing T cells were susceptible to infection and that antibodies to CD4 
specifically inhibited this process. Confirmation that CD4 was in fact the 
receptor for HIV-1, came from genetic studies in which the CD4 gene was 
transfected into various CD4- cell lines, including epithelial and B-cells as 
well as T-cell lines. Expression of the CD4 protein rendered these 
transfected cells permissive for infection (Madddon et at., 1986). The
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block to productive viral infection apears to be at the step of virus 
binding/entry as transfection of HIV DNA clones into non-permissive cells 
overcomes this block (Levy et al., 1986 and Adachi et al., 1986).
HIV can infect other cell types including monocytes and 
macrophages (Gartner et al., 1986; Clapham et al., 1987 and Gendelmann 
et al., 1988) and brain tissue (Koenig et al., 1986; Wiley et al., 1986; 
Cheng-Mayer et al., 1987 and Chiodi et al., 1987).
The viral outer envelope glycoprotein gpl20 mediates binding to 
the host cell (McDougal et al., 1986) and is produced, together with gp41, 
by proteolytic cleavage of the precursor molecule gpl60 (Robey et al., 
1985 and McCune et al., 1988; Figure 1.5.4). The cleavage event is 
necessary for viral infectivity (McCune et al., 1988). The glycoproteins 
gpl20 and gp41 are associated non-covalently and gp41 serves as the 
membrane anchor for the complex whilst gpl20 is exposed on the 
membrane surface (Veronese et al., 1985 and Ozel et al., 1988).
Entry to the host cell is thought to occur by direct fusion of the 
viral and cellular membranes at the cell surface in a pH independent 
manner, analogous to that discussed above for paramyxoviruses (Stein et 
al., 1987; McClure et al., 1988 and Grewe et al., 1990). The fusion process 
and uncoating of the internalised virus is not dependent upon the 
cytoplasmic tail of CD4, thought to be required for CD4 internalization 
(Bedinger et al., 1988). Viral entry would not appear to be via receptor 
mediated endocytosis but Pauza and Price (1988) and Grewe et al. (1990) 
have provided some evidence it can occur.
Glycoprotein gpl20 can be divided into several conserved (C) and 
variable (V) regions (Willey et al., 1986), some of which have been 
assigned cell-binding or fusion functions. The carboxy-terminal half of 
gpl20 harbours the CD4 binding site; mutations in the second, third and 
fourth conserved regions affect CD4 binding without significantly altering
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Figure 1.5.4 Schematic Representation of the HIV env Glycoprotein
(A) Diagram of the gpI60 precursor molecule and its cleavage products 
gpl20 and gp41. Some of the functional regions of these proteins are 
marked by black boxes; S = signal sequence. Diagram adapted from 
Bumy et al. (1988).
(B) Representation of the conserved and variable regions of gpl20. The 
conserved regions are denoted by unshaded boxes and the variable 
regions by hatched boxes; asterisks denote domains in which residues 
have been reported to be important in CD4 binding. These residues were 
assigned in mutational analyses where the mutations did not appear to 
affect the conformation of gpl20; see text for details. The location of 
the conserved domains is based on gpl 20 maps in l.asky et al. (1987) 
and Olshevsky et al. (1990).
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the conformation of the viral protein (Kowalski et al., 1987; Cordonnier et 
al., 1989a;band Olshevsky et al., 1990; Figure 1.5.4). Similar studies 
delineated conserved regions Cl, C3, C4 and C5 as important for CD4 
interaction but the interpretation of these results is less clear as the 
mutational analysis was by the introduction of insertions or deletions 
within these areas and the overall effect on conformation was not 
determined (Kowalski et al., 1987; Lasky et al., 1987; Linsley et al., 1988 
and Cordonnier et al., 1989a;b). The gpl20 sequences important in CD4 
binding would therefore appear to be discontinuous.
The non-covalent association between gpl20 and gp41 is mediated 
by an amino-terminal domain of gpl20 whilst a hydrophobic region in the 
carboxy-terminus of gp41 acts to anchor the complex to the surface of the 
infected cell and virion (Kowalski et al., 1987). Another hydrophobic 
domain has been located in the amino terminal half of gp41 and proposed 
to be important in the fusion process owing to its homology with the 
fusion peptides of paramyxoviruses (Gallaher, 1987). Mutations 
introduced into this domain were found to inhibit fusion, demonstrating its 
importance (Kowalski et al., 1987). It has been proposed that a 
conformational change in the gpl20/gp41 complex on binding to the host 
cell could lead to exposure of the fusogenic peptide of gp41 and its 
insertion in the cell membrane, leading to virus-cell fusion (Bumy et al., 
1988). This is analogous to the fusion event observed during influenza 
infection. However, with influenza, the conformational change required for 
exposure of the fusion peptide is driven by the acid environment of the 
endosome (Skehel et al., 1982 and White and Wilson 1987). In contrast, 
virus-cell fusion occurs at the cell surface for HIV (Stein et al., 1987) and 
there is no direct evidence of a conformational change in the gp 120/41 
complex taking place upon binding to the host cell membrane.
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Regions within gpl20 may be important in the fusion event as 
shown by studies using antibodies raised against peptides derived from the 
V3 and C2 areas. Antibodies against the V3 region (which contains the V3 
loop, a major neutralizing antibody epitope) inhibit fusion induced by HIV- 
1 (Palker et al., 1988 and Skinner et al., 1988) but not binding to CD4.
The polyclonal sera directed against the C2 peptide was able to neutralize 
several HIV isolates but also did not affect binding, implying that C2 may 
be involved in fusion or another postbinding event (Ho et al., 1988).
A characteristic of cells infected in vitro with HIV-1 is the formation 
of multinucleate giant cells, or syncytia (Barre-Sinoussi et al., 1983; Gallo 
et al., 1984; Levy et al., 1984 and Popovic et al., 1984). Syncytia 
formation is also observed when infected, HIV-1 producing cells are mixed 
with uninfected CD4 bearing cells. This phenomenon is the result of the 
interaction of gpl20 exposed on the surface of infected cells with cell 
surface CD4 on uninfected cells; CD4‘ cells do not undergo fusion when 
similarly analysed (Lifson et al., 1986a;b; Sodroski et al., 1986 and 
Kowalski et al., 1987). Syncytia die soon after formation and so the 
involvement of uninfected CD4 bearing cells in syncytia formation may 
contribute to the characteristic depletion of T cells expressing this marker 
protein seen in AIDS patients (Lifson et al., 1986a;b).
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1.6 The Reovirus Receptor
1.6.1 The Nature of the Reovirus Receptor
Much effort has been expended in attempts to characterize and 
identify the reovirus receptor and although progress has been made, the 
precise receptor molecule has not been unequivocally defined.
Reovirus T1 and T3 bind to, and infect different cells in vivo; the 
former binds to ependymal cells (Kilham and Margolis, 1969 and Margolis 
and Kilham, 1969 ) and the latter to neuronal cells (Margolis et al., 1971; 
Gonatas et al., 1971 and Raine and Fields, 1973). Their ability to 
specifically bind to these respective cell types has also been demonstrated 
in vitro (Tardieu and Weiner, 1982 and Dichter and Weiner, 1984). 
However, in vitro, all three serotypes can bind to the same cell type -mouse 
L-cells - which are routinely used for the purification of reovirus.
Radiolabelled reovirus has been utilized in many cell-binding assays 
to ascertain the presence of saturable, high affinity receptors on the host 
cell. In many cases L-cells were used (Armstrong et al., 1984; Epstein et 
al., 1984; Gentsch and Hatfield, 1984 and Gentsch and Pacitti, 1985), 
although other cell types have been investigated, including rat pituitary 
cells (Maratos-Flier et al., 1983), murine splenic lymphocytes (Epstein et 
al., 1984), HeLa cells (Gentsch and Hatfield, 1984) and rat endothelial cells 
(Verdin et al., 1989). Roughly similar values have been obtained for the 
number of receptor sites/cell and the affinity of binding and these are 
approximately 80,000-100.000 binding sites and a dissociation constant 
(Kd) of approximately 0.8-3.0nM (Table 1.6.1).
It is not known if T1 and T3 reovirus utilize the same receptor on 
L-cells. Epstein et al. (1984) found that only homologous serotype virus 
could prevent binding in competition assays performed with whole virus.
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Lee et al. (1981b), however, were able to inhibit the attachment of c l  
protein using reovirus of homologous and heterologous serotypes; thus, 
Tl, T2 and T3 virus were all effective in competing the binding of c l  
derived from any of the three virus serotypes.
The precise role played by sugar residues in the virus-cell 
attachment process is also unclear. In two separate studies neuraminidase 
treatment of the target cells had no effect on the cellular binding capacity 
of Tl or T3 reovirus; neither did the presence of various sugars (Armstrong 
et al., 1984 and Epstein et al., 1984). However, in experiments by Gentsch 
and Hatfield (1984) and Gentsch and Pacitti (1985), neuraminidase 
digestion decreased reovirus binding by 50-70%; the residual binding was 
still saturable and specific. Whether neuraminidase affects the specificity of 
reovirus attachment is therefore unclear.
Sialic acid containing glycoproteins were found to inhibit reovirus 
attachment as were several sialyloligosaccharides (Gentsch and Pacitti,
1985) indicating that it is the sialic acid component that causes the 
inhibitory effect. Cell surface, sialic acid components were thus suggested 
to play a role (as yet undefined) in the interaction of reovirus with the host 
cell.
1.6.2 The Use of Anti-Idiotypic Antibodies as Probes for the
Reovirus Type 3 Receptor
An alternative approach to characterizing and identifying the 
reovirus receptor was to generate anti-reovirus T3 (anti-R3) antibodies 
which could subsequently be used as probes for the reovirus receptor.
Nepom et al. (1982b) used antibodies directed against the HA (a l) 
of reovirus T3 to generate a rabbit, xenogeneic, anti-idiotypic antiserum. A 
neutralizing, anti-al, monoclonal antibody, 9BG5, (Burstin et al.. 1982)
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was shown to specifically inhibit the binding of the xenogeneic antisera 
with the anti-HA antibodies, suggesting that an idiotypic, HA binding 
determinant had been identified. The generation of such anti-idiotypic 
antibodies is shown schematically in Figure 1.6.1. Other ctI Mabs did not 
have this effect and inhibition was shown to be type specific. The 
idiotypic HA T3 binding determinant was thus designated ld3 to signify its 
association with the binding of the type 3 HA (Nepom et al., 1982a;b).
The xenogeneic antisera was then used to probe for the presence of 
the Id3 determinant on a number of cell types and the resultant pattern of 
attachment corresponded with that shown by reovirus (Nepom et al., 
1982a;b). Rl.l cells (a Tcell thymoma cell line) and mouse neural cells 
(from explanted nervous tissue) specifically bound the rabbit antisera and 
reovirus T3 whereas ependymal (T1 virus specific cells) and YAC 
(lymphoma) cells did not.
Following this, an anti-idiotypic monoclonal antibody - 87.92.6 - 
was prepared against Id3 using the Id3 bearing 9BG5 hybridoma 
(Noseworthy et al., 1983). This antibody also mimicked the characteristic 
patterns of reovirus T3 binding but there were some exceptions; two cell 
lines P815 (mastocytoma) and EL-4 (lymphoma) can bind and are 
permissive for reovirus T3 yet do not bind and are not protected by
87.92.6 (Noseworthy et al., 1983 and Kauffman et al., 1983a) suggesting 
that there are two structurally distinct receptors, only one of which is 
recognized by the Id3 antigenic site on the viral HA.
Several other pieces of evidence indicated that the anti-idiotypic 
antibodies would be useful anti-R3 receptor antibodies. Monoclone
87.92.6 has comparable binding parameters to T3 virus in that there are 
79,000 binding sites for this antibody on Rl.l cells with a Kj of 
approximately 0.96 nM (Gaulton et al., 1985) which agrees very well with 
that determined by Epstein et al. (1984). Reovirus T3 blocks the
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Figure 1.6.1 Schematic Representation of the Anti-idiotypic Approach 
Identifying the Reovirus Receptor
attachment of 87.92.6 to Rl.l and rat B104 neuroblastoma cells (Gaulton 
et al., 1985 and Kauffman el al., 1983a) and conversely, 87.92.6 blocks 
the serotype specific binding of T3 reovirus to a thymoma line BW5147 
(Kauffman et al., 1983a). This anti-idiotypic antibody also prevents viral 
attachment and infection of neurones grown in cell culture (Dichter et al.,
1986).
1.6.3 Putative Identification o f the Reovirus Receptor
Analysis of Rl.l  thymoma and B104 neuroblastoma membrane 
extracts by immunoprécipitation and Western blotting techniques revealed 
that the xenogeneic rabbit antisera and reovirus T3 bound to a single 
glycoprotein of 67 kDa with a heterogeneous isoelectric point of 5.8-6.0. 
Various other murine B and T lymphoid cell lines as well as L 929 
fibroblasts also expressed this protein. This 67 kDa polypeptide was 
therefore proposed to be the reovirus T3 receptor (Co et al., 1985a).
The tissue distribution of P-adrenergic receptors was observed to be 
similar to that for reovirus binding and infection (Co et al., 1985b and 
Cohen et al., 1989 unpublished results). Purified p2-adrenergic receptor 
(p2AR) was specifically precipitated by the rabbit anti-idiotypic antibodies 
and had a similar Mr and pi as the reovirus receptor (67 kDa and 5.8-6.0 
respectively). Tryptic digests of the two receptors revealed an identical 
pattern and the reovirus T3 receptor was shown to specifically bind the P- 
antagonist IHYP (iodohydroxybenzyl-pindolol). Hence, the two receptors 
were deemed to be structurally and antigenically similar (Co et al., 1985b).
However, although similar, the two receptors are not identical as 
shown by the fact that the P-adrenergic ligand and reovirus binding sites 
are distinct entities. Anti-R3 antibodies and P-adrenergic ligands do not 
compete for the same binding sites on either purified reovirus T3 receptor
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or P2AR (Liu et al., 1988 and Sawutz et al., 1987. Further evidence came 
from Choi and Lee (1988) who used the human epidermoid carcinoma 
A431 cell line to investigate the relatedness of the two receptors. This cell 
line possesses a large number of functional p-adrenergic receptors and was 
susceptible to reovirus T3 infection. Four pieces of evidence pointed to the 
receptors being distinct moieties:-
a) reovirus did not stimulate adenylate cyclase activity whereas a P- 
agonist did. b) reovirus T3 did not inhibit the dose dependent stimulation 
of adenylate cyclase even at saturating concentrations and so was not 
acting as an antagonist, c) the binding of a P-adrenergic antagonist could 
not be competed by R3 and d) internalization of the p-adrenergic 
receptors did not affect Reovirus T3 binding and vice versa. The same 
results were seen for mouse L 929 fibroblasts which were also shown to 
possess few p-adrenergic receptors (Choi and Lee, 1988).
1.6.4 Structural and Functional Determinants Shared by a l
and the Anti-idiotypic Antibody 87.92.6
Bruck et al. (1986) determined the nucleic acid and predicted 
protein sequence of the the 87.92.6 antibody and then compared it to the 
already available a l  T3 predicted protein sequence. A significant area of 
homology was detected between aa 317-332 of a l  and the combined 
determinant of the complementarity determining region II (CDRII) of Mab 
87.92.6. Amino acids 45-51 of the antibody Vh (variable region of the 
heavy chain) exhibited high homology with 317-323 of a l ,  as did a 
second slightly larger area, comprising amino acids 47-54 of the antibody 
Vl (variable region of the light chain) and 324-331 of a l .
A series of synthetic peptides were built corresponding to these 
regions of homology in order to test their functional relevance. Peptide Vh
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corresponded to aa 43-56 of the Vh CDRII of Mab 87.92.6; peptide Vl 
corresponded to aa 39-55 of the Vl CDRII of Mab 87.92.6 and the reo 
peptide to aa 317-332 of a l  (Williams et al., 1988). The latter peptide was 
extremely hydrophobic and so was of limited use in most of the assays in 
which it was to be tested. A list of the properties of these peptides is given 
in Table 1.6.2 and are described below.
The neutralizing anti-HA3 Mab 9BG5 could bind Vl peptide, reo 
peptide and Vh+Vl peptide (i.e. peptides Vh and Vl linked by an amino 
terminal cysteine residue) but not to Vh. This same peptide reactivity 
pattern was evident when they were used in competition assays to inhibit 
the binding of reovirus T3 with 9BG5, suggesting that the area of 
sequence similarity between the Vl of Mab 87.92.6 and reo peptide (aa 
323 -332 of a l)  may be involved in the neutralizing epitope.
The effects of the peptides in binding assays between reovirus T3 
and L-cells and between 9BG5 and the anti-idiotypic antibody 87.92.6 
were also investigated. It was thus determined that Vl peptide and hence 
aa 323-332 of the HA were involved specifically in reovirus T3 receptor 
recognition but that Vh and Vl of Mab 87.92.6 were important in the 
interaction of the idiotypic and anti-idiotypic Mabs.
A reovirus neutralizing escape mutant, K, created by the growth of 
reovirus T3 in the presence of Mab 9BG5 was investigated to establish 
how it escapes neutralization. Peptide Vl prevented variant K (and 
reovirus T3) from binding to L-cells; K also had a greatly diminished 
capacity to bind to 9BG5. From this, it was concluded that variant K 
attaches to L-cells via the same residues as the parental virus but escapes 
neutralization by 9BG5 by diminishing the Mab's ability to interact with 
this site on the haemagglutinin. The only alteration in K was an amino acid 
change at position 419 of a l  (Bassel-Duby et al., 1986). From the above 
work it is possible that amino acid 419 is involved in 9BG5 recognition.
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1.6.5 Summary
1) Serotype-specific tissue tropism of reovirus T1 and T3 appears to be 
largely due to the cell attachment protein a l ,  targetting each virus 
serotype to a different cell-type.
2) The type 1 and type 3 virus both bind to L-cells, but it is unclear if 
they attach to the same receptor. Sialic acid may be involved in the 
receptor recognition process for the T3 virus.
3) An antiidiotypic monoclonal antibody (87.92.6) was generated in 
an attempt to identify the reovirus receptor. The (3-2 adrenergic receptor 
was subsequently proposed to be the receptor on L-cells but a later study 
proved this to be unlikely.
4) A combined determinant of Mab 87.92.6 shows sequence 
homology to aa 317-332 of protein cl-3. (a) Amino acids 317-332 of c l 
have been proposed to constitute a receptor binding site, (b) Amino acids 
323-332 of c l  have been identified as a putative neutralization epitope. 
Amino acid 419 was defined as a site of interaction with the neutralizing 
Mab. 9BG5.
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1.7 AIMS
1) Express the a l  protein of reovirus in vitro from cloned copies of the 
S1 type 1 and type 3 genes.
2) Develop a cell-binding assay utilizing the in vitro expressed a l  
proteins.
3) Map the cell-binding domain(s) of the a l  polypeptides by effecting 
a mutational analysis of the respective cloned genes.
The in vitro approach taken in this project was designed to further 
characterize the reovirus-receptor binding process by utilizing the virus 
cell-attachment protein a l .  It was hoped that this would clarify the 
controversial subject of the type 1 and type 3 viruses binding to the same 
or distinct receptors on mouse L-cells. Also, by attempting to map the 
binding domain of a l , some molecular detail of the binding process would 
be gained, which could have implications with regard to the serotypic 
differences in tissue tropism seen in the reovirus-mouse model.
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2.1 M ATERIALS
2.1.1 A list of the biochemicals, chemicals and radiochemicals
utilized in this study is given below:
Amersham International pic., Amersham, Buckinghamshire:
a 35S dATP (44TBq/mmol), Amplify, 5,6 3H-UTP (1.92 TBq/mmol), L-35S 
methionine (30TBq/mmol).
BDH Chemicals Ltd., Poole, Dorset:
Ammonium acetate, p-mercaptoethanol, Bromophenol blue, Caesium 
chloride, Calcium chloride, Crystal violet, EDTA, Glucose, Glycerol, Lithium 
chloride, Nonidet P40 (NP40), Phenol, PEG 6000, Potassium chloride. 
Sodium acetate. Sodium chloride. Sodium dihydrogen phosphate, Sodium 
dodecyl sulphate, Sodiun hydroxide, Sucrose, Tris-base.
Bethesda Research Laboratories UK Ltd., P.O. Box 145, Cambridge:
Restriction enzymes, T4 DNA Ligase, Urea.
Bio-Rad, Richmond, California:
Ammonium persulphate, N, N'-methylene-bis-acrylamide, TEMED.
Boehringer Mannheim UK Ltd., Lewes, East, Sussex:
Calf intestinal phosphatase, Mung bean nuclease.
Difco Laboratories, Basingstoke, Hampshire:
Bacto-agar, Bactotryptone, Yeast extract.
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Eastman Kodak Co., Rochester, New York:
LX 24 X-ray developer, FX 40 X-ray fixer.
FSA, Loughborough, Leicestershire:
Acids, Acrylamide, Formaldehyde, Formamide, Glycine, Magnesium 
chloride. Xylene cyanol.
Fuji Photo Film Co. Ltd., Japan:
RX X-ray film.
May and Baker Ltd., Dagenham:
Diethyl ether. Trichloroacetic acid.
Northumbria Biologicals Ltd., Cramlington, Northumberland:
Foetal calf serum, Tisue culture dishes.
Pharmacia Biotechnology, Uppsala, Sweden:
DNA polymerase I (Klenow fragment), 5' methyl cap (m7G5'ppp5'Gm), 5- 
methyl dCTP.
Polaroid UK Ltd., St Albans, Hertfordshire:
Type 665 (positive/negative) and 667 (positive) film.
Promega, Madison, Wisconsin, USA:
ImM amino acid mixture (minus methionine), BMV RNA, Rabbit 
reticulocyte lysate (nuclease treated), RNAsin, T3 RNA polymerase, T7 
RNA polymerase.
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Sigma Chemical Co. Ltd., Poole, Dorset:
Agarose medium EEO (type II), 2-aminopurine, Ampicillin, BSA, 
Chloramphenicol, Deoxynucleoside triphosphates, Dideoxynucleoside 
triphosphates, DTT, EtBr, IPTG, Lysozyme, Manganese chloride, MOPS, 
Ribonucleotide triphosphates. Rubidium chloride. Spermidine.
United States Biochemicals, Cleveland, Ohio, USA:
Sequenase version 2.0, Sequencing handbook.
Whatman International Ltd., Maidstone, Kent:
3MM Filter paper (No.l).
2.1.2 Media and Solutions
The following media and solutions were prepared by the media 
preparation staff in the Department of Biological Sciences, University of 
Warwick :
2x Agar, 2x GMEMS, 200mM Glutamine, 200mM Leucine, MEMS, 
NaHCÛ3 (5% w/v), Phosphate buffered saline (PBS; 8g NaCl, 0.2g KC1, 
1.15g Na2HP04,0.2g KH2PO4 per litre of sterile, distilled water), 
Penicillin/Streptomycin stock solution (100g and 100,000,000 units per 21 
sterile, distilled water respectively). Sterile distilled water. Trypsin solution 
(0.25% in versene), 200mM Valine, Versene.
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2.2 STORAGE OF BA CTERIAL STOCKS
The bacterial strains utilized in this study were maintained in the 
short term on minimal agar plates (see below for recipe) or in the long term 
by mixing an overnight culture of bacteria (grown as in section 2.7.1) with 
sterile glycerol in an 85:15 ratio and then freezing and storing in liquid 
nitrogen.
Minimal agar plates consisted of : lx  "A" salts (5x = 5.25g K2HPO4, 
2.25g KH2PO4, 0.5g (NH4)2 SO4,0.25g sodium citrate per 100ml of sterile, 
distilled water), 0.5ml of 1M MgS04, 0.25ml of 1% thiamine HC1, 10ml of 
20% glucose per 500ml sterile, distilled water, solidified with noble agar to 
a final concentration of 1.5%.
2.3 TISSUE CULTURE
2.3.1 Recovery of Cells from Liquid Nitrogen
An ampoule of L-cells was removed from liquid nitrogen and 
immediately thawed at 37°C. The cells were then diluted into 20ml. of 
MEMS1 media (MEMS + 5% FCS, 0.001% streptomycin, 100,000 units 
penicillin and 2mM glutamine ), centrifuged at 1.5K for 5 minutes (mins) 
and resuspended in 10ml media before being transferred to a 75 cm^ Flow 
bottle. Further media was added and the cells allowed to grow to 
confluency by incubation in a 37°C, 5% CO2 incubator.
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2.3.2 G row th and M aintenance of L-cells
2.3.2.1 In Monolayer Culture
L-cells were grown in 75cm2 Flow bottles or 1.5 litre roller bottles 
using MEMS1 medium. When confluent, the cells were passaged at a ratio 
of 1:4. Monolayers were rinsed twice with versene and detached with a 
small volume (3-5ml) of a trypsin/versene mixture. The trypsin was 
inactivated by the addition of approximately lOmls of media, the cells 
pipetted vigorously and reseeded. (Roller bottles were initially seeded with 
the contents of two Flow bottles).
2.3.2.2 In Suspension Culture
Cells from 6 confluent roller bottles were harvested,pooled and 
counted using a haemocytometer before being diluted into the appropriate 
volume of media to give a cell density o f8 x  105 - lxlO6 cells/ml. The 
culture was incubated in a flat bottomed, round flask, with stirring, at 
37°C. Incubation was continued for 6-8 hours before the cells were split 
1:2; thereafter the cells were split 1:2 every 24 hrs to maintain the cell 
density between 5 xlO5 - lxlO6 cells/ml.
2.4 VIRUS GROWTH AND PREPARATION
2.4.1 Preparation of Virus Inocula
Confluent Flow bottles of L-cells were inoculated with virus at a 
multiplicity of infection (moi) of 0.1 pfu/cell in 10ml. of MEMS1. One bottle 
was mock inoculated with MEMS1 as a control. Cells were incubated at
71
37°C for 3-4 days until the cytopathic effect (cpe) was clearly evident as 
compared to the control. The contents of each Flow were harvested, 
pooled and stored at -70°C. The stock was freeze-thawed 3x and 
sonicated before being titrated as described in 2.4.4.
2.4.2 Large Scale Growth of Virus
This was essentially peformed as described by McCrae (1985). Four 
or eight litre spinner cultures of L-cells (cell density lxlOtyml) were 
incubated at 34°C for 1-2 hrs before reovirus inoculum was added at a moi 
of 10 pfu/cell. (The culture temperature must be lowered as reovirus is 
cytotoxic to L-cells at 37°C). Incubation was continued at 34°C for 36-42 
hrs, after which time the culture was transferred to 4°C and the cells 
allowed to settle for 4 -8 days.
2.4.3 Virus Purification
This procedure was carried out as described by McCrae (1985). 
Briefly, most of the culture medium was removed by suction and the 
cellular material remaining concentrated by centrifugation at 2K, 4°C for 
20mins. Cells were resuspended in reovirus resuspension buffer, 
homogenized with Arcton (trifluoro-trichloroethane) and the phases 
separated by low speed centrifugation. The aqueous phase was decanted 
and the process repeated 3-4 times.The aqueous phases were pooled and 
back extracted with Arcton. Virus was concentrated from the aqueous 
phase by centrifugation at 20K, 4°C for 2hrs in a Beckman SW 28 rotor, 
the resulting pellet overlayed with 50mM Tris pH 8.0 and stored at 4°C 
overnight.
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After resuspension by sonication, virus was layered on a pre-formed, 
1.2-1.4 g/ml density, caesium chloride gradient and centrifuged at 20K, 4°C 
for 2hrs in a Beckman SW 28 rotor. The virus band (grey/blue colour) was 
harvested, diluted in 50mM Tris pH 8.0 and re-centrifuged as described 
above to concentrate the virus. The viral pellet was finally resuspended in 
a small volume of 50mM Tris pH 8.0 and stored at -70°C.
2.4.4 Plaque Assay of Virus
Monolayers of L-cells were plated out in 24-well tissue culture 
dishes (2 x 105 cells/well). Serial 10 fold dilutions of virus were made in 
PBS; monolayers were then washed once with PBS, lOOpl of the 
appropriate virus dilution added and the dishes incubated at 37°C for 
1 hour.
After incubation, the monolayers were gently overlayed with a 1 x 
GMEM/agar mix which was allowed to harden before the dishes were 
incubated in a 37°C/5% CO2 incubator in a humidified atmosphere. 
Reovirus type 1 plaque assays were incubated for 4-5 days and type 3 for 
3-4 days.
Monolayers were fixed with formal saline ( 30% formaldehyde in 
PBS [v/v] ), the agar overlay removed and monolayers stained with crystal 
violet (0.5% [w/v] crystal violet in 20% [v/v| ethanol) to visualize plaques.
2.4.5 Labelling of Infected Cell Polypeptides
Confluent L- cell monolayers in 12-well tissue culture dishes (5 x 
105 cells/well) were washed 1 x with PBS and inoculated with lOOpl virus 
at a moi of 10 pfu/cell. Virus adsorption was allowed to proceed at 37°C 
for 1 hr, after which the monolayers were overlayed with MEMS + 2%
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FCS and incubated at 37°C for 12-15 hrs. The media was then removed, 
the cells washed in methionine-free (met-free) GMEMS and starved of 
methionine by incubation in met-free GMEMS + 2% FCS for l-2hrs. (Met- 
free GMEMS = 500ml 2x GMEMS minus leucine, valine, methionine and 
NaHCC>3, supplemented with 10ml 200mM leucine, 10ml 200mM valine, 
10ml 200mM glutamine, 20ml NaHCC>3 [5% w/v], 1ml penicilin/ 
streptomycin stock solution, and made up to a volume of 1 litre with sterile 
distilled water ). 100p.l of 35S-methionine (500pCi/ml in PBS) was used to 
replace the media and the cells returned to 37°C for 20mins. Monolayers 
were scraped into 250pl 50mM Tris-HCl pH 8.5, divided into 50|il aliquots 
and stored at -70C.
The trichloroacetic acid (TCA) precipitable radioactivity of the 
samples was measured (essentially as described in 2.11.2) before analysis 
on SDS-polyacrylamide gels.
2.5 ROUTINE PURIFICATION OF NUCLEIC ACIDS
2.5.1 Phenol/Chloroform Extraction
An equal volume of phenol/chloroform was added to the DNA 
sample and inverted several times to ensure thorough mixing. The sample 
was then briefly spun in an Anderman microfuge to separate the phases 
and the upper, aqueous layer removed without disturbing the interface, to 
a fresh tube. If necessary, successive extractions were performed until the 
interface was clear. The sample was then extracted once with chloroform 
and the DNA precipitated as described below.
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2.5.2 Precipitation of DNA
DNA was precipitated from aqueous solutions in the following 
manner. The sample was made 0.15M with respect to lithium chloride and 
2-2.5 volumes ethanol (-20°C) added followed by incubation on ice or at 
-20°C for 15 minutes. DNA was pelleted by centrifugation, washed with 
80% ethanol and dried under vacuum. Finally, the nucleic acid pellet was 
resuspended in sterile, distilled water or TE (lOmM Tris-HCl pH 8.0, ImM 
EDTA).
2.6 DNA RESTRICTION AND MODIFICATION
REACTIONS
2.6.1 Restriction Enzyme Digests
Restriction digests were carried out according to the manufacturers 
instructions. Buffers used were those supplied with the enzymes (as a lOx 
concentrate) or were made as lOx stocks as detailed in the suppliers 
instructions.
Typically, DNA was digested in a 20p.l reaction volume containing 
buffer at lx concentration. Enzyme was added to no more than 10% of the 
final volume and the sample incubated at the appropriate temperature, 
usually 37°C.
Following digestion, the DNA was analysed by agarose gel 
electrophoresis or phenol/chloroform extracted and ethanol precipitated 
before use in further enzyme modification reactions.
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2.6.1.1 Partial Digests
These were performed during subcloning procedures when it was 
necessary to use a restriction enzyme whose recognition sequence was 
present more than once in the DNA being manipulated.
A preliminary reaction was set up to determine the conditions 
necessary to create the correct extent of digestion. The DNA to be 
digested was diluted to lmg/ml (in TE) and the enzyme concerned diluted 
to 1 unit/|i.l in the appropriate lx reaction buffer and stored on ice. A 
reaction mix was set up where lpg DNA was pre-warmed in 9p.l of lx 
reaction buffer at 37°C; 1 unit of enzyme was added to the pre-warmed 
mix and lpl aliquots taken at various time points, typically O', 3', 5', 7', 10', 
and 15' mintes. The aliquots were added to lp.1 of 0.5M EDTA pH 8.0 and 
analysed on a mini-gel, as described below. The optimum time point was 
taken to be the one that gave the greatest amount of linearised product.
A larger reaction was then carried out by increasing the scale of the 
digestion and incubating for the previously determined length of time. For 
example, instead of l|ig DNA with lunit of enzyme for 5 minutes, 5pg 
would be digested with 5 units of enzyme for 5 minutes. The linearised 
fragment would then be isolated from a mini-agarose gel (section 2.9.1).
2.6.2 End-Filling Reactions
The Klenow fragment of E. coli DNA polymerase 1 was used to fill 
5' overhanging ends of DNA. The reaction mixture shown overleaf was 
incubated at 37°C for 15 minutes then at 65°C for 5 minutes to inactivate 
the enzyme before precipitation of the DNA as described in section 2.5.2.
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End-filling reaction mix
DNA: up to 5p.g 
3|i.l lOx Pol. 1 buffer
(lOx Pol.l buffer = 0.5M Tris-HCl pH 8.0, 
0.1 mM MgCl2)
3|oJ lOmM DTT
1 p.1 20mM dNTPs
2 units Klenow polymerase 1 
H2O to 30p.l
2.6.3 Removal of Overhanging Ends
3' overhanging ends were removed by digestion with mung bean 
nuclease (MBN). The reaction mix used was as follows :
DNA up to 5p.g 
5|il lOx MBN buffer 
(300mM NaAc pH 5.0, 500mM NaCl, 
lOmM ZnCh, 50% glycerol)
10 units mung bean nuclease 
H2O to 50(0.1
The mix was incubated at 37°C for 30 minutes and then at 70°C for 
10 minutes. This was followed by phenol/chloroform extraction and 
ethanol precipitation.
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2.6.4 Phosphatase Treatm ent
The 5’ phosphates of restriction endonuclease digested vector DNA 
were removed by treatment with calf intestinal phosphatase (CIP) to 
prevent re-ligation. CIP buffer (10 x buffer = 0.5M Tris-HCl pH 9.0, lOmM 
MgCb, lOmM ZnCh, lOmM spermidine) was added to a final 
concentration of lx and lunit of CIP added. Incubation followed at 37°C 
for 30 minutes for 5' overhanging ends or for 15 minutes at 37°C, followed 
by the addition of a further unit of CIP then 55°C for 45 minutes for blunt- 
ended or recessed 5' ends.
The CIP was inactivated by heating at 70°C for 10 minutes 
followed by phenol/chloroform extraction and the DNA ethanol 
precipitated and resuspended in H2O.
2.6.5 Ligations
Ligation reactions were perfomed in a volume of 15|xl containing 
100-200ng of vector DNA and sufficient insert DNA such that there was a 
5-10:1 ratio of molecules of the latter to the former. 1.5p.l of lOx ligation 
buffer (660mM Tris-HCl pH 7.5, 50mM MgCl2, 50mM DTT and lOmM 
ATP*) and 3 units of T4 DNA ligase were added to the DNA and the 
remaining volume made up with sterile, distilled water. The ligation mix 
was incubated at 15°C for 16 hours or room temperature for 4 hours. Half 
of the mix was then transformed into E. co li.
* For blunt ended ligations, the ligation buffer contained 5mM ATP 
(BRL Focus newsletter, 1988).
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2.7 TRANSFORM ATION AND PREPARATION OF
PLASMID DNA
Two methods were used for bacterial transformation:
2.7.1 Transformation with calcium chloride prepared cells
lml of an overnight culture of E. coli JM103 (grown from a single 
colony in minimal media , stock solutions of which comprised : 20ml 5x A 
salts, 0.1ml of 1M MgS04, 0.05ml of 1% thiamine HC1 and 2ml of 20% 
sterile glucose solution, made up to a 100ml final volume with sterile, 
distilled H2O and filter sterilised before use) was diluted 1:100 in L-broth 
(lOg bactotryptone, 5g yeast extract, 5g sodium chloride per litre of sterile, 
distilled H2O) and incubated at 37°C, 200 rpm, until the A590 reached 0.4- 
0.6. The cells were then pelleted, resuspended in 0.5 volumes of ice cold 
0 .1M MgCl2 and immediately re-centrifuged. The pellet of cells was then 
gently resuspended in lml of 0.1 M CaCh and incubated on ice for 30 
minutes.
The DNA sample to be transformed was made 0.1M with respect to 
CaCh in a volume of lOOpl, added to a 200|J.l aliquot of the competent 
cells and incubated on ice for 20-30 minutes. The mix was then heat 
shocked at 42°C for 2 minutes and returned to ice for 30 minutes. Samples 
of 10, 100 and ~200pl were spread on dried Luria-Bertaini (LB) agar 
plates (lOg bactotryptone, 5g yeast extract, 5g NaCl, 15g bacto-agar per 
litre of sterile, distilled H2O). When antibiotic selection was necessary, 
ampicillin at a final concentration of lOOpg/ml was included in the agar 
plates. Blue/white colour selection was made possible by including 5- 
Bromo-4-Chloro-3-Indolyl-(3-D-Galactoside (X-Gal) at 0.002% and
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isopropyl-p-thiogalactopyranoside (IPTG) at 4pM in the plating medium. 
Plates were incubated overnight at 37°C.
2.7.2 The Hanahan Method (Hanahan, 1983)
E. coli JM103 cells were grown as described above (2.7.1), 
centrifuged, resuspended in 12.5ml of solution RF1 (Table 2.1) and 
incubated on ice for 15-30 minutes. Following incubation, the cells were 
re-centrifuged and resuspended in 2.4ml of solution RF2 (Table 2.1). They 
were then incubated for a further 15 minutes on ice before being aliquoted 
into 200(J.l amounts. Aliquots not used immediately were stored at -70°C. 
10|il samples of DNA were added directly to the competent cells, gently 
mixed and returned to ice for 30 minutes. Aliquots were plated out as 
described above (section 2.7.1).
Table 2.1 Composition of Transformation Buffers RF1 and RF2
RF1 RF2
1.2g RbCl 0.5M MOPS (3-[N-
Morpholinolpropanesulphonic acid)
0.99g MnCl2 0.06g RbCl
3.0ml KOAc 0.55g CaCl2
0.15g CaCl2 NaOH to pH 6.8
12ml glycerol H20  to 50ml
Acetic acid to pH 5.8
H20  to 100ml *
RF1 and RF2 were filter sterilized before use.
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2.7.3 Small Scale Isolation of Plasmid DNA (Mini-plasmid 
preparations)
This was based on the method of alkaline lysis as described in 
Sambrook et al. (1989)
Individual bacterial colonies were picked into 5ml of L-broth 
(containing ampicillin at a final concentration of 100p.g/ml) and grown for 
5-6 hours or overnight at 37°C, 200rpm. 1.5ml of culture were spun in an 
eppendorf centrifuge to pellet the cells. The pellets were each resuspended 
in lOOpl of GET solution (50mM glucose. lOmM EDTA, 25mM Tris-HCl 
pH 8.0), to which 200pl of 0.2M NaOH,l%SDS was added. After gentle 
mixing, 150pl of 3M sodium acetate pH 4.8 was added, the solutions mixed 
and then incubated on ice for 5 minutes. Samples were then centrifuged 
for 10 minutes and the pellets removed with a toothpick. 2 volumes of 
100% ethanol (~ 950 p.1) added and samples left for 5 minutes at room 
temperature. DNA was pelleted by centrifugation for 10 minutes.washed in 
80% ethanol and vacuum dried before being resuspended in 50(0.1 sterile 
distilled water or TE.
2.7.4 Large Scale Isolation of Plasmid DNA
An overnight culture (10ml) of the desired clone (grown in L-broth 
containing ampicillin at 100|Og/ml) was inoculated into 1 litre of L-broth / 
ampicillin(100p.g/ml) and incubated at 37°C with shaking for 6 hours. 
Chloramphenicol was then added to a final concentration of 150pg/ml and 
incubation continued overnight.
Bacterial cells were then pelleted by centrifugation at 2K, 4°C, for 
15 minutes, resuspended in 8.4ml of 25% sucrose, 50mM Tris-HCl pH 8.0 
and placed in a pre-cooled 500ml conical flask. 1,4ml of lysozyme
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(lOmg/ml in 50mM Tris-HCI pH 8.0) was added to the cells and the mix 
swirled on ice for 5 minutes. A volume of 4.6ml of 0.25M EDTA was then 
added, the mix swirled for a further 10 minutes on ice before 9.6ml of lysis 
solution (2% Triton, 62.5mM EDTA, 50mM Tris-HCI pH 8.0) was slowly 
added.
Lysed cells were centrifuged at 16K, 4°C for 1 hour in a Beckman 
JA 20 rotor to pellet the chromosomal DNA. The resulting supernatant was 
removed, adjusted to 25 ml with sterile water and 25g of CsCl plus 1.25ml 
of EtBr (lOmg/ml) added. This was then centrifuged at 25K, 23°C for 1 
hour in a Beckman SW 28 rotor and the floating debris removed. The 
samples were then transferred to Beckman 38ml quick seal tubes and 
centrifuged in a VTi 50 rotor at 45K, 23°C for 16-18 hours.
Plasmid DNA bands were recovered by side puncture of the tubes 
and either dialysed against three changes of 51 of TE or diluted into 5 
volumes of TE. The DNA was precipitated by making the sample 0.15M 
with respect to LiCl followed by the addition of 2 .5 volumes of ethanol 
(section 2.5.2).
After resuspending the pellet of DNA in 1ml of TE, a 
phenol/chloroform extraction was performed, the nucleic acid precipitated 
and resuspended in 0.5 ml of TE. To check the purity of the sample, optical 
density (O.D) measurements were made at 260 and 280 nm and the 
260/280 ratio calculated; a ratio of 1.8 or greater signified that the sample 
contained a negligible amount of contaminating protein. The DNA 
concentration was then estimated from the O.D reading obtained at 260nm 
(1 O.D unit was taken to be equivalent to 50pg/ml DNA).
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2.8 SITE DIRECTED MUTAGENESIS
2.8.1 Subcloning into M13
Type 1 and 3 reovirus SI genes (SI T1 and SI T3) were subcloned 
from their respective transcription clones into M13mpl9 in order to 
produce single-stranded (ss) DNA as template for oligonucleotide directed 
mutagenesis. Restriction enzyme digests, DNA modification reactions and 
ligations were performed as described in section 2.6.
2.8.2 Transformation into E. co li JM103
Competent cells to be used in the transformation of M13mpl9 
based ligation reactions were prepared as detailed in section 2.7.1. The 
plating procedure differed from that used for plasmid transformations in the 
following manner. After heat-shock treatment and incubation on ice, the 
ligation/competent cell mix was added to 3ml of molten (45°C ) H-Top 
media (5g bactotryptone, 4g NaCl per 500ml distilled H2O, solidified by the 
addition of 4g noble agar) and 200pl of exponentially growing JM103 
cells. This mixture was then poured onto dried LB agar plates, allowed to 
set and incubated overnight at 37°C. When blue/white colour selection 
was required, 30|ll of lOmM IPTG and 15pl of 2% X-Gal were added to the 
plating mix.
Plaques were picked and grown as described below (section 2.8.3) 
and the replicative form (RF) of the DNA from the mpl9 clones prepared 
by the method of alkaline lysis as for mini- plasmid DNA preparations. 
Restriction digests were then carried out on 10pl of the RF DNA to screen 
for the desired clones.
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2.8.3 P repara tion  of Single-Stranded T em plate
Individual plaques (that were well separated) were picked into 3ml 
of L-broth using a sterile toothpick and the cultures incubated in an orbital 
shaker at 37°C, 250-300 rpm for 6 hours. 1.5ml aliquots of each culture 
were centrifuged at 10K for 5 minutes in a Heraeus microfuge and 1ml of 
the supernatant removed to a fresh microfuge tube; (the remaining 
supernatant was stored ar 4°C as it served as stock inoculum for any 
future preparations of ss or RF DNA). 2.5ml of 20% PEG (polyethylene 
glycol) 6000/2.5M NaCl was added to the supernatant and the mixture 
incubated at room temperature for 15 mins. The samples were spun at 10K 
rpm for 5 mins in a Heraeus microfuge to pellet the phage particles, the 
liquid removed and the last traces of supernatant wiped from the tube. 
After resuspending the pellets in 100pl of TNE (20mM Tris-HCl pH 7.6, 
lOmM NaCl, ImM EDTA), 50pl of phenol was added, the tubes vortexed 
and left to stand at room temperature for 5 mins, before being centrifuged 
at 10K rpm for 5 mins, in an Anderman microfuge to separate the two 
phases. 80pl of the uppper aqueous layer was removed and extracted 3x 
with diethylether. DNA was precipitated as decribed in section 2.5.2, dried 
and resuspended in 30pl of sterile water or TNE and stored at -20°C.
2.8.4 Kinasing the Mutagenic Oligonucleotide
Freeze-dried oligonucleotides, synthesized on a Applied Biosystems 
380B DNA Synthesizer, were resuspended in 300pl of sterile water and 
their concentrations determined by A26O measurements; here an optical 
density value of lunit was taken to be equivalent to 20pg/ml single- 
stranded DNA.
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lOOpmols. of oligonucleotide was kinased in a single reaction, 
carried out as follows : 10pl oligonucleotide (10 pmol/(il) was mixed with 
2(0.1 of lOx kinase buffer (lOx buffer = 500mM Tris-HCl pH 8.0, lOOmM 
MgCb), 2)0.1 lOmM ATP, 10 units of T4 polynucleotide kinase and water to 
a final volume of 20pl. The reaction mix was incubated at 37°C for 30 mins 
and the enzyme inactivated by heat treatment at 70°C for 5 minutes. 
Kinased oligonucleotide was stored at -20°C.
2.8.5 Oligonucleotide Directed Mutagenesis
Mutagenesis was performed using the method of Vandeyar et al. 
(1988), in which high efficiency mutagenesis is made possible by the 
incorporation of 5 methyl dCTP in the mutant strand which then allows 
the parental strand to be digested away by restriction enzymes and 
exonuclease 111 (Chapter 10, Figure 10.2.2).
10(0.1 of ss DNA (~1.5pg ) were mixed with 3(0.1 of kinased 
oligonucleotide (10-30pmol) and 2pl of lOx annealing buffer (200mM 
NaCl, 20mM Tris-HCl pH8.0) in a total volume of 20(il, adjusted with 
sterile water. The annealing mix was incubated at 65°C for 5 mins and 
then room temperature for 10 mins to allow the oligonucleotide to anneal 
to the template.
An extension/ligation reaction was then set up by addition of the 
reagents shown in Table 2.2 to the annealing mix.
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Table 2.2 Composition of the Oligonucleotide Directed Mutagenesis 
Extension/Ligation Reaction Mixes
Reagent Volume Final Concentration
10x Annealing Buffer 3pl
5mM dNTP's * 5pJ 0.5 mM
lOmM A TP 5H1 ImM
lOOmMDTT 2.5|xl 5mM
T4 DNA Polymerase 5 units
T4 DNA Ligase 3 units
h2o to 50pl
* = 5mM dATP, 5mM dGTP, 5mM dTTP and 5mM 5-methyl dCTP.
This mix was incubated at 37°C for 90 mins followed by 70°C for 
10 mins, to destroy the polymerase and ligase activities.
Following inactivation, 10 units (lp.1) each of Hha 1 and MspW were 
added to the extension/ligation mixture and returned to 37°C for 45 
minutes. 100 units of exonucleasel 11 (1.5pl) were finally added to the 
reaction mix and digestion allowed to proceed for a further 45 mins at 
37°C before being stopped by heat inactivation at 70°C for 10 minutes. 
Reaction volume changes were negligible upon addition of the above 
mentioned enzymes.
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2.8.6 T ransform ation  of the M utagenesis Reaction
Half of the mutagenesis reaction mix (25|il) was transformed into 
competent E. coli RD24 cells [(Mcr A‘B') New England Biolabs] 
essentially as described in section 2.8.2 with E. coli JM103 used as the 
lawn bacteria.
2.8.7 Screening the Plaques
This method of mutagenesis yields a high number of mutants, 
enabling screening to be carried out by the direct sequencing of a small 
number of plaques. Typically, single-stranded DNA from 10 plaques was 
prepared as in section 2.8.3 and analysed by sequencing as described in 
section 2.8.8 below.
2.8.8 Sequencing Reactions
Sequencing reactions were performed according to the United 
States Biochemicals (USB) handbook (1989), based upon the dideoxy 
method of sequencing described by Sanger et al. (1977).
2.8.8.1 Single Stranded DNA
An annealing reaction was set up that contained 7|xl (~ 1 fig) ss M13 
DNA template, lpl(lpmol) of -20 M13 universal primer and 2p1 of 5x 
reaction buffer (200mM Tris-HCl pH 7.5, lOOmM MgCl2, 250mM NaCI). 
The sample was heated at 65°C for 2 mins and allowed to cool slowly to 
room temperature over a period of 30 minutes. The following were added 
to the annealed primer/template :
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2|j.l of 5-15x diluted labelling mix ( 7.5|xM dGTP, 7.5|xM dTTP, 
7.5pM dCTP ), Im.1 lOOmM DTT, 0.5(il 35s dATP and 2[i\ Sequenase 
version 2.0 enzyme, diluted 1:8 in enzyme dilution buffer (lOmM Tris-HCl 
pH 7.5, 5mM DTT, 0.5mg/ml BSA ). After thorough mixing, the sample was 
incubated on ice (for short extensions of the primer) or at room 
temperature (for longer extensions) for 2-5 mins. Aliquots of 3.5pl were 
then added to the four termination mix tubes, each of which contained one 
of the relevant ddNTP solutions (i.e. ddGTP, ddATP, ddTTP or ddCTP ), 
pre-warmed to 37°C. The tubes were centrifuged to mix the solutions and 
incubated at 37°C for 5 mins. Reactions were stopped by the addition of 
4|il of formamide stop buffer (95% de-ionised formamide, 20mM EDTA, 
0.05% bromophenol blue, 0.05% xylene cyanol ).
4pl aliquots were analysed immediately on denaturing 8% 
polyacrylamide gels as described in section 2.8.9. The remainder of the 
rection mix could be stored at -20°C for up to 7 days for further analysis 
with no adverse effect on sequence integrity (USB handbook, 1989).
2.8.8.2 Double Stranded Plasmid DNA
Plasmid DNA purified by caesium chloride gradient 
centrifugation was used in plasmid sequencing reactions. 4pg of DNA was 
used in each sequencing reaction. The DNA template was made up to a 
volume of 18pl with TE and denatured by the addition of 2pl of freshly 
prepared 2M NaOH followed by incubation at room temperature for 10 
minutes. 4pl of 5M ammonium acetate pH 5.4 was added, the sample 
vortexed and lOOp.1 of 100% ethanol (-20°C) immediately added and 
vortexed . The sample was placed in a dry ice/industrial methylated spirits 
(IMS) bath for 10 mins, before being centrifuged for 10 mins at 10K in an 
Anderman microfuge to precipitate the DNA, which was subsequently
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washed in 70% and then 100% ethanol before being air dried at room 
temperature.
The dried pellet of DNA was resuspended in 7(il of sterile water 
and sequenced in the same manner as for ss DNA (section 2.8.8a). 
Denatured DNA was not stored, but used immediately in sequencing 
reactions.
2.8.9 Sequencing Gels
Sequencing reactions were analysed on denaturing polyacrylamide 
gels. 40cm gels were cast and run using commercial (Biorad) apparatus. A 
50ml gel solution consisting of 8% acrylamide (from a 38% acrylamide : 
2% bisacrylamide stock) and 7M urea in IX TBE buffer (10 x = 108g Tris 
base, 55g boric acid, 40ml 0.5M EDTA pH 8.0 per litre of distilled water) 
was made and polymerised by the addition of 0.6% (v/v) ammonium 
persulphate and N,N,N',N'-tetramethylethylenediamine (TEMED), each to a 
final concentration of 0.06%.
Gels were pre-electrophoresed in lx TBE for lhour at 1700 volts. 
Immediately prior to loading, 4pl of sample was denatured by heating to 
80°C for 3 mins and then electrophoresed for 1.5-6 hours depending upon 
the amount of sequence to be determined.
After electrophoresis, gels were fixed in 10% acetic acid/10% 
methanol for at least 15 minutes before being dried on Whatman 3MM 
filter paper under vacuum at 80°C. The dried gel was exposed to Fuji RX 
X-Ray film at room temperature for at least 12 hours.
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2.9 AGAROSE GEL ELECTRO PH O RESIS
Large and small (mini) horizontal agarose gels were used for 
analysis of DNA after restriction digests and during subcloning 
procedures. Typically, the concentration of agarose used was 1% (w/v) but 
concentrations between 0.8 - 1.5% were also employed depending upon 
the size of the fragments to be resolved.
The following method describes the preparation of a mini-gel; 
however all gels were prepared in the same manner, taking into account 
any necessary differences in volumes and weights of the appropriate 
substances. 50 ml. gels were used for rapid analysis of DNA fragments. The 
appropriate amount of agarose was dissolved in 50ml. lx TBE buffer to 
which 2pl of a lOmg/ml stock of ethidium bromide (EtBr) was added. The 
gel was poured in a commercial gel former containing a well-forming comb 
and allowed to set. Once set, the gel was submerged in lx TBE buffer in 
which it was electrophoresed. Commercial apparatus used was Biorad and 
Uniscience for mini-gels and Scie-Plas or Koch-Light Ltd (New Brunswick 
Scientific Co.) for large gels.
DNA samples were prepared for electrophoresis by adding 1/5 the 
volume of 5x TBE gel loading buffer (50% glycerol, 5x TBE, 0.02% 
bromophenol blue and 0.02% xylene cyanol) before being loaded into the 
wells of the gel. Electrophoresis was carried out for 1 hour at 80 mA. DNA 
bands were then visualized on an ultraviolet (uv) illuminator and the gel 
photographed using a Polaroid camera and type 665 or 667 Polaroid film.
2.9.1 Isolation of DNA Fragments
Fragments of DNA to be isolated were first electrophoresed as 
described above and subsequently isolated from the agarose gel in the
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following manner. After electrophoresis was complete, the gel was 
inspected on a long wavelength uv illuminator (to minimise damage to the 
DNA) and a slit cut in the gel in front of the desired fragment(s). A piece of 
dialysis tubing was then backed with Whatman 3MM paper and inserted 
into the slit with the paper facing the DNA fragment. The gel was replaced 
in the gel tank from which the buffer had been removed and the buffer 
replaced until a meniscus was formed with the end of the gel. 
Electrophoresis then continued at 150 mA for 1 - 2 minutes and the gel and 
paper inspected on the illuminator to ensure that the DNA had run into the 
paper. (This was repeated if necessary until all of the desired band had 
been eluted from the gel).
The DNA was recovered from the paper by elution with TNE 
(200mM NaCl, 20mM Tris-HCl pH 7.5, ImM EDTA ); the Whatman paper 
was placed in a 0.5ml microfuge tube which had previously had a hole 
punctured in the bottom. This was then placed in a 1.5ml microfuge tube, 
centrifuged at 10K for 2 minutes and the eluant removed to a fresh tube. 
150(xl of TNE was added to the paper and re-centrifuged. One or two 
further elutions were carried out and the washes pooled before being 
phenol/chloroform extracted and the DNA ethanol precipitated. The dried 
pellet was typically resuspended in lOp.1 of sterile water and a 1-2 p.1 
aliquot analysed on an agarose gel.
2.9.2 Agarose Gel Electrophoresis of RNA
RNA produced from in vitro transcriptions was size fractionated on 
1.2% agarose gels containing 50% formamide. Gels were prepared as 
described in section 2.7 with the exceptions that the gel mix included 50% 
de-ionised formamide (DIF) and O.lx TPE buffer (lx = 36mM Tris, 30mM 
NaH2PO4[2H20J), 2mM EDTA pH 8.0). Electrophoresis was carried out in
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O.lx TPE buffer which was only allowed to form a meniscus with the gel 
instead of submerging it. RNA samples (and DNA markers) were prepared 
in 60% DIF and denatured by heating at 65 °C for 5 minutes before 
loading into the wells of the gel. Electrophoresis was carried out for 3 
hours at 40 mA. The gel was stained in 0.1 pg mg/ml EtBr for several hours 
or O/N, destained in H2O and visualised on a uv illuminator.
2.10 IN  VITRO  TRANSCRIPTIONS
Capped, positive sense RNA was produced from DNA copies of 
various genes cloned into transcription vectors.
2.10.1 Linearisation of the DNA Template
30pg of plasmid DNA was linearised in a single reaction using either 
Smal or //¿ndlll. Reaction volumes were typically 50pl, and following 
digestion a lpl aliquot was analysed on an agarose gel to check for 
complete linearisation.
Linearised samples were then phenol/chloroform extracted, ethanol 
precipitated and resuspended in 30pl sterile water.
2.10.2 The Transcription Reaction
In order to quantitate the RNA produced from the in vitro 
transcription a trace amount of radioactive uridine triphosphate (5, 6, 3H 
uridine 5' triphosphate), was included in the reaction mix.
lOpCi (lOpI ), of tritiated uridine triphosphate was dried under 
vacuum in a sterile, 1.5ml eppendorf tube and resuspended in 25pl of 
sterile water. The reaction was then set up at room temperature as shown 
in Table 2.3 (overleaf), in a final volume of 50pl.
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Table 2.3 Com position of In  V itro  T ranscrip tion  Reactions
Reagent Final Concentration
3H-UTP 25pl ( in H20)
50mM ATP, UTP, CTP 3H1 ImM
5mM GTP 1 Ml 0.1 mM
DNA template (lmg/ml) 3pJ 0.06mg/ml
5x Transcription buffer 
(200mM Tris-HCl pH 
7.5, 30mM MgCl2, 
lOmM spermidine, 
50mM NaCl)
lOpl lx
lOOmMDTT 2.5|xl 5mM
lOmM m^GpppG111 Cap 2.5p.l 0.5mM
RNASIN (lu/p.1) lpl
T3 or T7 Polymerase 
(30u/|xl)
lpl
The above reaction mix was incubated at 37°C for 30 minutes after 
which lp.1 of 50mM GTP was added and incubation continued for a further 
60 minutes. A lp.1 aliquot was removed and the insoluble radioactivity 
measured after trichloroacetic acid (TCA) precipitation (see below).
RNA produced in this reaction was ethanol precipitated in the 
following manner. The reaction mix was adjusted to a volume of 200p.l 
with sterile water and 5M ammonium acetate to a final concentration of 
0.7M. 2.5 volumes of 100% ethanol were added and the sample 
transferred to a dry ice/lMS bath for 15 minutes. Following this, the sample
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was centrifuged at 10K for 10 minutes to pellet the RNA which was 
subsequently washed in 80% ethanol, dried under vacuum and 
resuspended in sterile water to give a final concentration of lmg/ml.
2.10.3 TCA Precipitation
The amount of RNA produced in the in vitro transcription reactions 
was quantitated by measuring the amount of radioactivity incorporated 
into TCA insoluble material.
lp.1 of the reaction mix was removed upon completion of the 
transcription reaction and placed in 400|il of 10% TCA. This was 
incubated on ice for 10 minutes and then spotted onto a 3MM Whatman 
filter disc under vacuum. The disc was washed twice in 5% TCA, twice in 
ethanol, dried and placed in 5ml. of Optiphase Safe scintillation fluid. The 
amount of TCA precipitable radioactivity was then measured in an LKB 
Wallac 1219 Rackbeta liquid scintillation counter and the resulting figure 
utilized to calculate the amount of RNA that had been synthesized. This is 
shown overleaf.
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Calculation to Determine the Amount of RNA Synthesized in  vitro:
10|iCi of 3H-UTP was included in the reaction 
lOpCi = 50nmoles UTP
l|iCi = 2.22 x 106 dpm
No. counts x sample volume = total counts
Total counts/2.22xl07 = no. moles UTP incorporated (inc.) into RNA
Assume equal amounts of the 4 rNTPs are incorporated into RNA
No. moles UTP inc. x average molecular weight for a rNTP x 4 = yield of
RNA
Yield of RNA x %age efficiency of counting = actual yield of RNA
The efficiency of counting of the scintillation counter was determined by 
spotting a lpt1 aliquot of a 1:100 dilution of the 3HUTP onto a Whatman 
3MM disc placing it in scintilllation fluid and counting in the scintillation 
counter.
No. counts x 100 (dilution factor) x 100 = % counting efficiency 
2.22 x 106
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2.11 IN  VITRO  TRANSLATIONS
2.11.1 The Rabbit Reticulocyte Lysate System
In vitro transcribed RNA was translated into protein using the 
rabbit reticulocyte lysate system. Commercially available lysate (Promega) 
and lysate prepared in the laboratories of T. Hunt (Cambridge University) 
and J. Pain (University of Sussex) were used. All, except the Promega 
lysate,were optimised for the potassium and magnesium ion concentrations 
(section 2.11.3).
A typical 25fxl reaction is shown overleaf in Table 2.4. The reaction 
mix was incubated at 30°C for 1 hour and then utilized immediately or 
stored at -70°C. 2ul aliquots were sampled at various times during the 
reaction and TCA precipitated (see section 2.11.2).
The Promega lysate was used according to the manufacturer's 
instructions.
2.11.2 TCA Precipitation
2pl samples of the translation mix were taken after 0, 30 and 60 
minutes and spotted onto Whatman 3MM 25mm filter discs. These were 
placed immediately into 5% TCA and when all samples had been taken, 
they were transferred to 5% TCA/3% cas-amino acids, boiled for 5 minutes, 
washed twice in 5% TCA, twice in 100% ethanol and dried by washing 
twice in diethyl ether. The discs were then placed in Optiphase Safe 
scintillation fluid and radioactivity counted in an LKB Wallac 1219 
Rackbeta scintillation counter.
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Table 2.4 Com position of In V itro  T ranslation Reactions
Reagent Volume added Final concentration
K/M 2|ii ~80mM K+/
~0.8mM Mg2+
Creatine Phosphate (CP)/ 1.25pl 5mg/ml CP ml /
Creatine Kinase (CK) mix 0.2mg/ml CK
tRNA (1.125mg/ml ) iMl 45pg/ml
35S methionine 1.25(0.1 (~ 20pCi)
mRNA (lmg/ml) m 40|ig/ml
Lysate 17.5pJ
K/M = Potassium acetate/Magnesium acetate
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2.11.3 O ptim isation of the Translation Reactions
Each fresh source of lysate was optimised with respect to the 
magnesium and potassium ion concentration and also to the amount of in 
vitro transcribed RNA necessary to achieve maximum stimulation of the 
system.
Reactions were set up as shown in Table 2.4 with final potasssium 
acetate concentrations ranging from 20mM - 120mM whilst the 
magnesium ion concentration was kept constant at 0.6mM. The 
magnesium ion final concentration was titrated between 0 - ImM with a 
constant potassium ion concentration of 50mM. Finally, the amount of 
exogenous RNA needed to achieve maximum stimulation was also 
determined over a twofold dilution series, at constant potassium and 
magnesium ion concentrations of 0.6 and 50mM respectively.
Promega lysate was not optimised in this manner as it was supplied 
with the exogenous magnesium and potassium already added to the lysate.
2.11.4 Analysis of Translation Products on SDS-Polyacrylamide
Gels
Aliquots of in vitro translation mixes were analysed by SDS-PAGE 
(sodium dodecyl sulphate polyacrylamide gel electrophoresis) to ascertain 
the size of the resulting protein products.
10% polyacrylamide gels (made with a 5% stacking gel) were run 
according the method of Laemmli (1970). Stacking gel and separating gel 
mixes are given in Table 2.5; stock 30% acrylamide solution used in their 
preparation contained acrylamide and bisacrylamide in the ratio 29:1. One 
fifth of the final volume of 5x sample buffer (2% SDS, 25% (3- 
mercaptoethanol, 250mM Tris-HCl pH 6.8, 50% glycerol and 0.02%
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bromophenol blue) was added to 5-6|il of in vitro translation mix, the 
remainder of the volume made up with water and the sample boiled for 5 
minutes. Samples were then pipetted into the wells of the gel and 
electrophoresed at 40mA for 2.5 hours in lx running buffer (52mM Tris- 
base, 53mM glycine, 0.1%SDS, pH adjusted to 8.3). Following 
electrophoresis, gels were fixed in 10% acetic acid/25% methanol for lhour 
before being fluorographed and dried (section 2.11.5).
2.11.5 Fluorography of Polyacrylamide Gels
After fixing, gels were incubated in Amplify (Amersham) for 15 
minutes and dried for 1-2 hours at 60°C. They were then exposed to Fuji 
RX X-Ray film overnight at room temperature or at -70°C after pre­
flashing the film, when the bands on the gel were to be quantified by 
scanning laser densitometry ( see section 2.11.6 ).
99
Separating Gel Mix
8.3ml 30% acrylamide (29:1 
acrylamide : bisacrylamide)
6.25ml 4x separating gel buffer
(4x = 1.5M Tris-HCl pH 8.8, 0.4% SDS)
2.5ml glycerol
15pl TEMED
200pl 10% ammonium persulphate (APS) 
7.8ml water
T able  2.5 Com position of SD S-Polyacrylamide Gel Mixes
Stacking Gel Mix
2ml 30% acrylamide
3ml 4x stacking gel buffer (0.5M Tris-HCl pH 6.8, 
0.4% SDS)
3ml APS (70mg/25ml H20)
4ml water
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2.11.6 Scanning Laser Densitometry
2.11.6.1 Calibration of the X-Ray Film
X-ray film was pre-flashed with a Hanimex flashgun to enable a 
linear response of the film to the radioactivity and hence quantification of 
bands by densitometry. The exposure of the film to the pre-flash was 
calibrated according to the Amersham Autoradiography Handbook (1987). 
Briefly, strips of film were exposed to the light source at various distances 
from the flashgun and their A595 values compared to that of non pre­
flashed film. An A595 of 0.1-0.2 indicated the correct distance at which to 
pre-flash the film. After pre-flash treatment, the film was exposed to the 
dried, processed gel overnight at -70°C.
2.11.6.2 Quantifying the Bands
Gels were scanned and bands quantified on a Molecular Dynamics 
scanning laser densitometer according to the manufacturers intructions.
2.12 L-CELL BINDING ASSAYS
Two binding assay protocols were used; one in which the amount 
of radioactive protein (produced in the in vitro translation reaction) bound 
to the cells was assayed by a direct counting method and a second in 
which bound protein was visualised by SDS-PAGE and fluorography. 
These are described overleaf.
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2.12.1 Direct Counting M ethod
Monolayers of L-cells in 24 well dishes were washed once with 
cold PBS and placed on ice. 4-5pl of reticulocyte translation mixture were 
diluted into lOOpl of ice-cold PBS and overlayed on the monolayers of 
cells. Binding was allowed to occur for one hour with intermittent rocking, 
after which the binding mix was removed and the monolayers washed 
three times with cold PBS and once with cold sterile distilled water. They 
were then allowed to dry before being solubilized in lOOpl 1M NaOH. This 
was neutralized with lOOpl of 1M HC1 before being added to 10ml of 
Optiphase Safe scintillant and counted in an LKB Wallac scintillation 
counter.
2.12.2 Visualisation of Bound Protein
Monolayers of L-cells in 12-well dishes (5 x 105 cells) were washed 
once with cold PBS and placed on ice. Reticulocyte translation mix was 
diluted 6-8 times in ice-cold PBS and 100pl applied to the monolayers for 
one hour with intermittent rocking. After this time the binding mix was 
removed, the cells washed 3x in cold PBS, scraped into 0.5ml of cold PBS 
and pelleted by a brief spin in a microfuge. The PBS was decanted and the 
cells resuspended in solubilization mix (0.5% NP40 in PBS) and then left 
on ice for 15 minutes. Following this, nuclei were pelleted by 
centrifugation for 1 minute in a microfuge and 50pl of the supernatant 
analyzed by SDS-PAGE and fluorography, as in sections 2.11.4 and 2.11.5 
with the exception that the incubation step in sample buffer was carried 
out at either 37°C for 30 minutes or 100°C for 5 minutes prior to gel 
loading.
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CHAPTER 3
Cloning Reovirus SI Type 1 and Type 3 cDNA Sequences into a 
Transcription Vector
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3.1 INTRODUCTION
The production of reovirus mRNA in vitro from purified virions was 
first possible over twenty years ago (Skehel and Joklik, 1969; Levin et al., 
1970 and Banerjee and Shatkin, 1970). Relatively large amounts of mRNA 
could be obtained owing to the stability of the core associated RNA 
dependent RNA polymerase and this obviated the need for purifying viral 
mRNA from infected cells. A disadvantage of this method is that a 
heterogeneous mix of all 10 viral transcripts is obtained. A route for 
studying individual species of message sense RNA was devised by 
McCrae and Joklik (1978) who demonstrated that the ds RNA genome 
was a source of mRNA. The resolution of the ds RNA segments of reovirus 
on polyacrylamide gels is far superior to that of the ss RNA species 
(Schuerch et al., 1975) and hence individual segments could generally be 
isolated in a reasonaby pure state. Denaturation of these isolated segments 
followed by in vitro translation produced polypeptides that were similar in 
mobility to that of native reovirus proteins. The major disadvantages of this 
approach are however, that it is time consuming and carries the inherent 
risk of the presence of contaminating species in any single gel purified 
population. Also, it was designed to specifically solve the problem of the 
coding potential of the reovirus genome and is of limited use when a more 
detailed, molecular analysis of a single gene and its products is required.
The commercial availability of transcription vectors (e.g., Promega: 
pGEM-Z vectors and Stratagene: Bluescribe and pBluescript vectors) has 
greatly facilitated the study of individual gene products in vitro. Problems 
associated with isolating rare species of mRNA or of producing sufficient 
quantities as a relatively pure product are largely overcome if the gene of 
interest, or its cDNA counterpart, can be cloned into a transcription vector, 
allowing microgramme quantities of RNA to be produced in vitro.
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A large selection of such transcription vectors is now available; 
many combine several of the following features to make them particularly 
useful as cloning vehicles:
1) A polylinker containing a wide number of retriction enzyme sites, 
enabling flexibility in cloning strategies.
2) A selectable marker, often the (J-lactamase gene, conferring 
antibiotic resistance.
3) Location of the polylinker within a portion of the lac Z gene 
allowing blue/white colour selection of bacterial colonies.
4) Different bacteriophage promoters situated at either end of the 
polylinker. This facilitates the production of plus and minus sense RNA. 
Transcription also begins at a defined, known point and terminates either 
under the direction of the inserted fragment or at a chosen site in the 
vector via a template run off process.
5) An M13 type origin of replication which enables ss DNA to be 
rescued from the vector via helper phage. This facilitates sequencing 
and/or site-directed mutagenesis of the cloned gene.
Creating mutants of a wild type gene provides one means of 
studying the expression or function of that gene. However, techniques to 
manipulate either ss or ds RNA with the same precision as DNA do not 
exist at present. Thus, by generating a cDNA clone of the appropriate 
reovirus gene, an opportunity is provided to create genetically altered 
variants. These can be subsequently expressed in vitro to determine their 
effect on the function of the wild type polypeptide.
Expression of a cloned gene in a eukaryotic system is an alternative 
to the in vitro approach. Vectors based on eukaryotic viruses, such as 
vaccinia virus, can confer the advantage of high yields of protein from a 
cloned gene, but a rigorous and stringent isolation procedure is required 
for its purification. A further disadvantage is that manipulations and
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preparations involving these vectors are generally more time consuming 
than those utilizing bacterial vectors.
3.2 STRATEGY
It was decided to clone cDNA copies of the reovirus Sl-1 and Sl-3 
genes into a transcription vector which incorporates all of the above listed 
features. The resulting clones could then be used to direct the synthesis of 
what should be a homogeneous population of message sense RNAs via a 
simple in vitro reaction.
The mRNA thus synthesized would be used to produce protein via 
in vitro translation reactions. Again, this ensures that an individual protein 
species derived from a specific mRNA is investigated.
The transcription vectors used in this study were Bluescribe 
(Stratagene) and pGEM-3Z (Promega). Bluescribe contains the T7 and T3 
bacteriophage promoters and pGEM-3Z the SP6 and T7 phage promoters. 
Maps of each vector illustrating their salient features are given in appendix 
A and B respectively. The use of pGEM-3Z was more indirect as it is the 
basis of clone pG3T3, a gift from Dr. P. Lee (University of Calgary Health 
Sciences Centre, Canada). Plasmid pG3T3 is a transcription plasmid 
containing the Sl-3 coding sequence (see later chapters).
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3.3 RESULTS
3.3.1 Cloning the Reovirus SI-1 Gene into Bluescribe
A cDNA copy of the reovirus Sl-1 gene (SI gene from reovirus 
typel) had been cloned by M. A. McCrae (University of Warwick) and 
placed into the bacterial vector pAT153 by the method of GC tailing to 
create pATSITl. During the cloning process, oligonucleotides containing 
various restriction sites had been added to the 5' and 3' ends of the cDNA 
sequence to facilitate further cloning manipulations. These will be referred 
to as the 5' and 3' gene oligonucleotides and their sequences and 
restriction sites are shown in Figure 3.3.1.
The strategy adopted for placing the Sl-1 gene into Bluescribe to 
create clone pBSSl-1 is shown in Figure 3.3.2. Plasmid pATSITl was 
digested with Bglll and BamHl and the ends filled as described in sections
2.6.1 and 2.6.2 respectively. The approximately 1.5 Kb Sl-1 band was 
separated on an agarose gel, purified and ligated into H indi digested 
Bluescribe. Recombinant clones producing white colonies on indicator 
plates were screened by digestion with a range of restriction enzymes. If 
oriented such that the 5' end of the gene is adjacent to the T3 promoter, a 
Hindlll fragment of approximately 450 base pairs (bp) and a Sphl fragment 
of about 1Kb are predicted. The restriction digests of Figure 3.3.3 confirm 
these and other similar predictions. A full-length clone was identified in 
this way and designated pBSSl-1.
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Figure 3J.1 Sequences of the Reovirus Sl-1 Gene Oligonucleotides
The sequence of the 5' and 3' gene oligonucleotides used in the cloning 
of the reovirus Sl-1 gene are shown in this diagram. For clarity, the 
sequence of the 3' end of the plus strand of the gene is written above the 
3' gene oligonucleotide sequence. Restriction enzyme sites are underlined 
and the bases marked in bold type represent sequence derived from the 
respective ends of the Sl-1 gene.
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Figure 3.3.3 Restriction Enzyme Digest Analysis o f pBSSl-1
Shown opposite is a 1.5% agarose gel of the restriction enzyme digests 
used to characterise pBSSl-1. lpg of plasmid DNA was digested with the 
appropriate enzymes (see key below), before electrophoresis as described 
in section 2.9. A ladder of DNA fragments (BRL) was used as size markers. 
A map of pBSSl-1 based on interpreting the restriction enzyme digests 
performed is shown below the photograph of the agarose gel. The Sl-1 
cDNA restriction enzyme sites are based on sequence data reported by 
Munemitsu et al. (1986) and Duncan et al. (1990).
Key
Lane M = Ladder
Lane A = Hindlll
Lane B = Sstl
Lane C = Pst I
Lane D = EcoRl
Lane E = Sphl
Sstl
= Polylinker
= Gene oligonucleotide sequences
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3.3.2 Cloning a cDNA Sequence of the Sl-3 Gene into
Bluescribe
A cDNA sequence of the Sl-3 gene was cloned into Bluescribe by 
M. A. McCrae essentially as described above for the Sl-1 gene, to generate 
clone pBReo3Sl. As for the type 1 gene, a unique set of 5' and 3' gene 
oligonucleotides were also placed at the respective ends of the gene as an 
aid to further cloning procedures (Figure 3.3.4). The Sphl site of 
Bluescribe had been tailed with cytidine residues to recreate the site and 
complement the guanosine tailed Sl-3 cDNA clones; restriction enzyme 
analysis revealed that the Sl-3 gene was full length and oriented with its 5' 
end adjacent to the T7 promoter. The G/C tails flanking the cDNA insert 
were undesirable for future in vitro syntheses of sl-3 transcripts and so 
another Bluescribe/Sl-3 recombinant was made.
The subcloning strategy used to place the Sl-3 gene (minus the G/C 
tails) in Bluescribe is shown in Figure 3.3.5. Plasmid pBReo3Sl was 
digested with Nru\ and Sma\ and the approximately 1.5 Kb fragment 
containing the Sl-3 gene separated on and purified from an agarose gel. 
This fragment was ligated into the HincU site of Bluescribe to create clone 
pBSSl-3B in which the 5' end of the gene is adjacent to the T3 promoter. 
In this orientation a fiamHI fragment of approximately 1.4 Kb is predicted. 
This fragment should be cut by fig/II to generate two fragments of 
approximately 1.1 Kb and 0.3 Kb. The restriction enzyme digest analysis 
shown in Figure 3.3.6 confirmed this, and allowed the full-length nature 
and unambiguous orientation of the gene to be determined. This analysis 
also revealed that contrary to expectation, the EcoRI recognition 
sequence was not present in the 5’ gene oligonucleotide sequence (see 
lanes G and H in Figure 3.3.6).
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5’ Gene oligonucleotide sequence 
PvuI EcoRI
__l_  I__
5' CGATCGCGAATTCTAGAGCGCTATTGGTCGGA 3'
T  t
Nru I Eco 47111
3' Gene oligonucleotide sequence
Pvu II Sma 1
I i
Gene 5' GGGGCAUUUCAUC 3' *  *
3' CCCC GTAAAGTAGACGTCGACGGGCCCTTCGAA 5'
T
Pst 1
T
Hind III
Figure 3.3.4 Sequences of the Reovirus Sl-3 Gene Oligonucleotides
The sequence of the 5’ and 3’ gene oligonucleotides used in the cloning 
of the reovirus Sl-3 gene are shown in this diagram. For clarity, the 
sequence of the 3’ end of the plus strand of the gene is written above the 
3’ gene oligonucleotide sequence. Restriction enzyme sites are underlined 
and the bases marked in bold type represent sequence derived from the 
respective ends of the Sl-3 gene.
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Figure 3.3.5 Strategy Adopted to Create Plasmid pBSSl-3B
The cDNA sequence for the SI-3 gene was released from plasmid 
pBReo3Sl by digestion with restriction enzymes Nrul and Smal which 
cut in the 5' and 3' gene oligonucleotide sequences respectivley. The ~
1.5 Kb SI-3 "gene fragment" was purified from a 1% agarose gel 
(section 2.9.1) and ligated into Hindi digested and phosphatased 
Bluescribe. The ligation and phosphatase treatment were carried out as 
described in sections 2.6.5 and 2.6.4 respectively.
Key : This is the same as given in Figure legend 3.3.2 I I
Smal Nrul
Hindi
Digest, isolate 
gene fragment
▼
-► ligate
I
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Figure 3.3.6 Restriction Enzyme Digest Analysis of pBSSl-3B
Shown opposite is a 1.5% agarose gel of the restriction enzyme digests 
used to characterise pBSSl-3B. lpg of plasmid DNA was digested with the 
enzymes indicated in the key below before electrophoresis on the gel 
(section 2.9).
A map of pBSSl-3B based on the interpretation of restriction enzyme 
digests performed is given below the photograph of the agarose gel. The 
positions of the restriction enzyme recognition sites within the SI-3 cDNA 
are derived from analysis of the sequence data of Cashdollar et al. (1985).
Key
Lane M = Ladder
Lane A = Pst I
Lane B = Sst 1
Lane C = BamHl
Lane D = HindlU/Sst I
Lane E = BamHl/Bglll
Lane F = Xhol
Lane G = EcoRl
Lane H = EcoRl/Nco\
3 3 2
4 0 7
= Polylinker
= Gene oligonucleotide sequences
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3.4 SUMMARY
Both the Sl-1 and SI-3 cDNAs were therefore oriented within their 
respective vectors such that plus sense RNA could be produced from them 
by using T3 RNA polymerase.
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4.1 INTRODUCTION
The cDNA sequences for the reovirus Sl-1 and SI-3 genes had been 
cloned into Bluescribe such that T3 RNA polymerase could be used to 
produce message sense RNA in vitro. A cap analogue was included in the 
transcription reaction for two main reasons:
1) To give the RNA a 5' terminal structure analogous to that found 
in vivo.
2) The presence of a 5' terminal cap can increase the translational 
activity of in vitro transcribed mRNA in cell-free translation systems 
(Paterson and Rosenberg, 1979 and Krieg and Melton 1984).
The transcription clones used in this study were linearised at a 
restriction enzyme site immediately downstream of the 3' end of the gene 
in the vector polylinker. This site determines the 3’ end of the transcript 
and so each round of RNA synthesis is terminated via a "run-off step 
where the polymerase literally falls off the end of the DNA template.
Throughout the study, restriction enzymes producing blunt or 5' 
overhanging ends were used to linearise templates in order to prevent the 
possibility of "snapback" (Vector Cloning Systems manual 1985) which 
can result from DNA with a 3' overhanging end. Snapback creates the 
potential for the production of spurious transcripts as the 3' overhanging 
end of the DNA can fold back on itself and allow the RNA polymerase to 
non-specifically initiate RNA synthesis.
In this chapter the quantitation and integrity of RNA synthesized 
from clones pBSSl-1 and pBSSl-3B are described.
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4.2 RESULTS
4.2.1 Quantitation of the RNA Transcribed In Vitro
A trace amount of 3H-UTP was included in the in vitro 
transcriptions to enable the yield of RNA to be determined from the 
number of TCA precipitable counts present upon completion of the 
reaction (section 2.10 and Figure 4.2.1). The chemical amount of 3H-UTP in 
the reaction is negligible in comparison to the cold UTP and so is not 
considered in the calculation.
Typically, approximately 8,000cpm/pJ were obtained from the 
transcription reactions, which is equal to approximately 20pg of RNA or 
an incorporation of approximately 28% of the 3H-UTP. This level of 
incorporation is not optimal but was not improved by increasing the 
amount of linearised DNA template. Addition of a further aliquot of RNA 
polymerase after the first 60 minutes of reaction time followed by 
incubation at 37°C for a further hour also had no effect. Hence, neither 
template or enzyme concentration appeared to be limiting factors. 
Impurities associated with the DNA can decrease the yield of RNA 
(Sambrook et al., 1989), but template was always phenol extracted after 
being linearised for use in subsequent transcription reactions. PEG 
precipitation of the DNA template can act as a further purification step 
(Sambrook et al., 1989) but its effect was not assessed in this study. 
Several commercial transcription buffers plus the buffer recommended in 
Sambrook et al. (1989) were employed during this investigation. These 
buffers varied slightly with respect to the concentration of some of their 
components (such as magnesium chloride and sodium chloride); however, 
none of the buffers were found to markedly affect the polymerase enzyme 
activity.
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Figure 4.2.1 Quantitation of RNA Transcribed from the SI cDNA 
Transcription Plasmids
Worked example of a calculation to determine the yield of RNA from a 
transcription reaction. The number of TCA precipitable counts in lpl of 
the completed reaction mix was determined as in section 2.10.3 and a 
typical value (8,384) is used in this example. The calculation is based on 
that given in section 2.10.3.
No. counts/pl reaction = 8,384 cpm 
Reaction volume = 50pl 
Total no. counts = 4.19 x 105
lOpCi of 3H-UTP are included in the reaction. lOpCi = 2.22 x 107dpm 
Specific activity of 3H-UTP = 52Ci/mmol. 
lOpCi = 0.19nmoles 3H-UTP
No. moles cold (non-radioactive) UTP in the reaction = lpl of 50mM UTP
= 50 nmoles
Thus, the chemical amount of 3H-UTP (0.19 nmoles) is negligible in 
comparison to the amount of cold UTP (50 nmoles)
Therefore, effectively lOpCi of 3H-UTP = 50 nmoles cold UTP 
OR 2.22 x 107 dpm = 50 nmoles UTP 
No. mols UTP incorporated into RNA = 50 x (4.19 x 105)
2.22 x 107
Average M.wt. of a ribonucleotide = 360
Amount RNA = 50 x (4.19 x IQS) x 360 x 4 ng = 1.36pg
2.22 x 107
Efficiency of counting = 7.3% (determined by counting lpl of a 1:100 
dilution of 3H-UTP as described in section 2.10.3)
Actual yield of RNA = 18.6pg
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4.2.2 Integrity of the RNA
The integrity of the in vitro transcribed RNA was analysed to 
ensure it was both full length and not degraded. Such an analysis was 
important as the proteins encoded by the si transcripts were to be used in 
functional assays. Figure 4.2.2 shows the migration of the si transcripts 
when electrophoresed through a 50% formamide/agarose gel. This method 
allows direct visualisation of the RNA bands by uv illumination.
The 1.5 Kb size of the s i-1 and s i -3 transcripts is as expected from 
their cDNA sequences (lanes A and B respectively). No degradation of the 
si RNAs was evident (see Figure 4.2.2).
Digestion of the DNA template with DNAse and subsequent phenol 
extraction are often recommended as part of the in vitro transcription 
procedure in protocols in the literature (for example, Promega 
"Transcription in vitro" Technical Manual 1989). These steps were omitted 
in the protocol used in this study in order to speed the process and so 
reduce the points at which the RNA can be degraded. Neither of these 
factors were found to have any effect on the in vitro translation of the si 
transcripts.
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Figure 4.2.2 Agarose Gel Electrophoresis of In V itro  Transcribed 
sl-1 and sl-3 mRNA
Transcription reactions were performed as described in Materials and 
Methods, section 2.10.2. Approximately lpg of the RNA was then 
denatured in 60% de-ionised formamide, electrophoresed in a 1.2% 
agarose gel containing 50% formamide and stained as in section 2.9.2.
Lane M = DNA Ladder
Lane A = sl-1 RNA
Lane B = sl-3 RNA
M A B
2 . 0 -
1 . 6 -
—
1 . 0 - —
0 . 5 - —
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4.3 SUMMARY
A homogeneous population of intact, full-length sl-1 and s i -3 RNA 
was consistently synthesized from their respective transcription clones 
using the phage T3 RNA polymerase.
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5.1 INTRODUCTION
Pelham and Jackson (1976) produced a highly efficient rabbit 
reticulocyte lysate in vitro translation system that for the first time was 
dependent upon the addition of exogenous mRNA to provide the major 
stimulus for protein synthesis. It is now a widely used laboratory technique 
having the advantage of a very low level of endogenous activity plus the 
ability to efficiently translate mRNAs into full-length products of up to 
200 kDa. Additionally, some cotranslational processing events can be 
studied by including microsomal membranes in the reaction mix (Walter 
and Blobel, 1983).
A second system used for the in vitro production of protein is the 
wheat germ lysate, originally devised by Roberts and Paterson (1973). A 
disadvantage of this system however, was that incomplete products often 
resulted from the reaction, especially where high molecular weight proteins 
were involved (Pelham and Jackson, 1976). This problem has since been 
overcome by the incorporation of spermidine in the reaction mix to 
stimulate efficient chain elongation (Anderson et al., 1983).
It is therefore largely a matter of choice as to which method is 
employed. The rabbit reticulocyte lysate was chosen for this study as a 
source was readily available in the laboratory. Messenger RNA derived 
from the cloned Sl-1 and SI-3 genes was translated and analysed by SDS- 
PAGE and the lysate optimised with respect to salt and RNA 
concentration in order to maximize the translational capability of the 
system.
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5.2 RESULTS
5.2.1 Optimisation of the Reticulocyte Lysate System
To achieve maximum stimulation of translation with exogenous 
mRNAs over the background level of synthesis seen in the absence of 
added mRNA, the lysate system must be optimised with respect to 
potassium and magnesium ion concentration and the concentration of the 
exogenous RNA. The optimum values for each of these variables is 
dependent upon the particular RNA employed in the translation reaction. 
The lysate was optimised using in vitro transcribed s 1 -1 mRNA. Reactions 
were set up as described in section 2.11.1 (with the exception that 20|il 
volumes were used) and the level of protein synthesis measured by TCA 
precipitation of the radioactive protein products as in section 2.11.2.
The results of these assays are shown graphically in Figure 5.2.1. 
The optimum values for potassium (K+), magnesium (Mg2+) and mRNA 
concentrations were 80mM, 0.8mM and 50pg/ml respectively. These 
optimum concentrations were used in subsequent experiments and did not 
vary significantly between the different non-commercial sources of lysate 
(those from Cambridge University and Sussex University) utilised in this 
study. The lysate obtained from Promega was already supplemented with 
potassium and magnesium (to final concentrations of 113mM and ImM 
respectively).
Typical lysate stimulation values obtained with the two types of si 
RNA and two control RNA species (tobacco mosaic virus [TMV| RNA and 
in vitro transcribed s4-l mRNA, the latter supplied by P. Martin, University 
of Warwick - see also next section) are given in Table 5.2.1. As expected, 
TMV RNA produced the largest stimulation when added to the lysate, the 
high value confirming the quality of the lysate. On first inspection, the s4-l
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Figure 5.2.1 Optimisation of the Reticulocyte Lysate 
Translation System
The lysate system was optimised for maximum translation efficiency 
with respect to potassium and magnesium ion concentration and in 
vitro transcribed RNA concentration; the graphs depicting the 
results of such titrations are shown opposite. All reactions were 
performed at 30°C for 1 hour in a final volume of 20pl. 2pl aliquots 
were TCA precipitated at 0, 30 and 60 minutes and the associated 
radioactivity counted as described in 2.11.2. The graphs opposite 
were constructed using the 60 min. data, the time when the highest 
count (cpm) values were obtained.
A) For the optimum potassium ion determination, reactions were 
set up as shown in Table 2.4, with the exception that potassium 
acetate and magnesium acetate were added individually . In all the 
reactions, the Mg2+ and sl-1 RNA concentrations were constant at 
0.6mM and 30pg/ml respectively, whilst that of K+ was varied 
between 0-120mM (final concentration) in 20mM increments. B) 
The Mg2+ concentration was titrated between 0-1 mM, as described 
above with a constant K+ concentration of 50mM and sl-1 RNA of 
30|xg/ml. C) The optimum concentration of sl-1 RNA was 
determined using a twofold dilution series whilst K+ and Mg2+ 
concentrations were maintained at 50mM and 0.6mM respectively.
[Mg2+] mM
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TRANSCRIPT CPM STIMULATION
Endogenous 13,840
s1 -1 57,926 4.19
s1-3 38,859 2.8
s4-1 139,027 10.04
TMV 637,897 46.1
Table 5.2.1 Typical Values Obtained when Cloned Reovirus 
Genes were Translated in a Reticulocyte Lysate
Various in vitro transcribed RNAs were translated in the Cambridge 
lysate and the reactions followed by TCA precipitation as described 
in sections 2.1 1.1 and 2.11.2. The values in the table represent the 
number of counts determined after 60 minutes of reaction time.
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control mRNA appeared to be translated more efficiently than both si -1 
and s i-3 mRNA. However, the in vitro translations carried out in this study 
utilized radiolabelled methionine. When the differences in methionine 
content of these proteins are taken into account, the relative translation 
efficiencies are almost equivalent, although two major protein products do 
contribute (approximately equally) to the TCA precipitable count value in 
the case of o l- l .  When this is accounted for, polypeptide o3-l (derived 
from s4-l mRNA) was synthesized approximately 2.5 times more efficiently 
than either of the al-1 doublet proteins.
5.2.2 SDS-PAGE Analysis of the Sl-1 and Sl-3 Translation
Products
As the proteins derived from the in vitro expression of the two 
reovirus SI cDNA clones were to be functionally assayed, it was necessary 
to determine that full-length proteins could be produced. Accordingly, the 
two reovirus SI transcription plamids, pBSSl-1 and pBSSl-3B, were 
transcribed and translated in vitro and the translation products analysed 
by SDS-PAGE. A further transcription plasmid containing the cDNA 
sequence of the reovirus S4-1 gene (pBS4-l) was used as a positive 
control for the translation reaction. This was utilized because in vitro 
transcribed s4-l RNA derived from this clone was known to translate well 
in reticulocyte lysate (P. Martin, personal communication). The protein 
product (a3-l) could also be used as a size marker as it has a known 
molecular weight of approximately 34 kDa. A map of pBS4-l is given in 
appendix C. Tobacco mosaic virus RNA or brome mosaic virus (BMV) 
RNA were also used as control substrates to check the translational 
activity of the lysate. These RNAs are known to stimulate reticulocyte
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lysate 50-100 times over the endogenous level (Pelham and Jackson, 1976 
and Promega "Translation in vitro" Manual, 1989).
Figure 5.2.2 shows a photograph of these translation reactions 
after SDS-PAGE and fluorography. (Neither the TMV or BMV profiles are 
shown). Translation of the sl-1 mRNA produced a doublet of bands, at the 
size expected for protein a l  type 1 (al-1) of approximately 51 kDa. The 
molecular weight of al-1 is that predicted from the sequence data of 
Duncan et al. (1990) and Nibert et al. (1990). It is not always possible to 
visualise a band representing al-1 in the reovirus infected cell profile (lane 
R) as it only represents 1-2% of the total viral protein and is synthesized in 
small quantities in vivo (Smith et al., 1969; Skehel and Joklik, 1969; Joklik. 
1981 and Gaillard and Joklik, 1985 ). In addition to the doublet at the size 
expected for a l ,  several lower molecular weight bands are also evident on 
the gel and probably represent premature termination or internal initiation 
events. Similar putative incomplete a l  products have also been reported 
by others carrying out in vitro transcription/ translation analyses of the 
reovirus Sl-3 gene (Roner et al., 1989 and Banerjea and Joklik, 1990).
No band of the correct size is present for the a  1-type 3 protein (al- 
3); this is discussed in section 5.2.4. Translation of in vitro transcribed s4-l 
mRNA gave the expected a3-type 1 protein (o3-l) of approximately 34 
kDa which co-migrated with the authentic a3 in the reovirus marker track 
(lane R).
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Figure 5.2.2 
a l  Proteins
SDS-PAGE Analysis of In Vitro Translated
Reovirus mRNAs were transcribed in vitro and then translated in a 
rabbit reticulocyte lysate as in section 2.11.1. The plus sense s4-l 
RNA was derived from plasmid pBS4-l, a gift from P. Martin 
(University of Warwick). Protein products were fractionated on a 
polyacrylamide gel (section 2.11.4) which was processed as 
described in 2.11.5. A photograph of the resulting autoradiograph is 
shown opposite. Radiolabelled reovirus T3 infected cells were 
prepared by the method described in section 2.4.5 and the labelled 
reovirus polypeptides served as markers; an uninfected cell 
preparation was electrophoresed for comparison. In this and 
subsequent appropriate Figures, the positions of the reovirus X, p 
and a  proteins are indicated alongside the "reovirus infected cell"
track.
Lane R Reovirus infected cells
Lane U Uninfected cells
Lane A Endogenous lysate reaction
Lane B In vitro translated sl-1 RNA from pBSSl-1
Lane C In vitro translated s i-3 RNA from pBSSl-3B
Lane D In vitro translated s4-1 RNA from pBS4-1
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5.2.3 Analysis of the Appearance of al-1  as a Doublet of Bands
Several possible explanations can be put forward to account for the 
appearance of a doublet of protein products as opposed to the expected 
single band; these include :
a) Translational readthrough of the normal stop codon. A
doublet of bands could be produced if termination at two sites was 
occurring. That is, a proportion of the translating ribosomes pass through 
the first termination codon and terminate on reaching a second 
downstream stop codon. However, there is a gap of just one triplet of 
bases between the first and second termination codons in the published 
al-1 sequence (Duncan et al., 1990 and Nibert et al., 1990), which would 
not be sufficient to account for the sizes of the proteins constituting the 
doublet. Readthrough of two such closely juxtaposed stop codons to 
terminate at a third site seems unlikely.
b) Initiation at a second initiation codon. Readthrough of the 
normal a l  start codon by some of the translating ribosomes and 
subsequent initiation of protein synthesis at a downstream AUG site could 
also result in a doublet of bands. Inspection of the published sequence for 
the Sl-1 gene revealed that there are no in frame AUG codons downstream 
of the authentic a l  start codon in close enough proximity to produce the 
observed doublet of bands. However, there is an upstream AUG codon in 
frame with the authentic al-1 initiation codon as a result of the cloning 
strategy adopted for pBSSl-1. The sequence containing the putative 
initiation codon is shown in Figure 5.2.3. This codon is derived from the 
recognition sequence for the restriction enzyme Sph I, which constitutes 
part of the Bluescribe polylinker. Initiation at this upstream site would 
yield a protein with an N-terminal 14 amino acid extension.
131
Figure 5.2.3 5' Untranslated Leader Sequence of Clone 
pBSSl-1
The Bluescribe sequence is shown in plain type and the +1 
nucleotide of the T3 promoter is indicated. cDNA derived 
SI-1 gene sequence is shown in bold type. The authentic o l-l 
ATG codon is boxed and the potential upstream initiation 
codon is underlined. The nucleotides in positions -3 and +4 
with respect to both of these initiation codons are 
appropriately marked.
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The putative extra 14 amino acids would be sufficient to account 
for the larger of the two proteins. This number of amino acids would result 
in a polypeptide approximately 1.5 kDa larger than the expected al-1  
protein (~ 51 kDa). Proteins of these sizes (51 kDa and 52.5 kDa) can be 
resolved in 10% polyacrylamide gels (Sambrook et al., 1989) and would 
therefore be apparent as distinct entities under the SDS-PAGE conditions 
used in this study.
The rules proposed by Kozak (1981; 1983; 1984 and 1986) provide 
a mechanism by which ribosomes can read through upstream initiation 
codons. In accordance with this model, the putative upstream codon (in 
the Sl-1 cDNA) lies in a poor context for initiation, with pyrimidines in the 
-3 and +4 positions (U and C respectively). Translational readthrough of 
this weak initiation sequence, would allow initiation at the authentic al-1 
codon in addition to the upstream AUG. The two bands in the doublet are 
of roughly equal intensity, which could be explained by the fact that the 
authentic al-1  codon is also in a poor context for initiation, having a C 
and G present in positions -3 and +4 respectively.
That the upstream codon was responsible for the second band of 
the doublet was resolved as a result of work shown in Chapter 7 (section 
7.2.2).
c) Initiation at an alternative codon, e.g. GUG. Initiation at a 
codon other than AUG is possible and has been shown to occur in the 
Sendai virus P/C gene at an ACG site in an excellent context for initiation 
(Curran and Kolakofsky, 1988 and Gupta and Patwardhan, 1988). 
However, this phenomenon has mainly been observed in bacteria at GUG 
sites and occasionally CUG (Ghosh el al., 1967 and reviewed in Kozak. 
1983) and was therefore deemed unlikely to have occurred here.
d) Proteolytic cleavage. Proteolysis of the full-length a l  protein 
was another possible cause for the production of two bands. To
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investigate this possibility, translation was carried out in the presence of 
the protease inhibitors aprotinin and soybean trypsin inhibitor. However, 
no difference was observed in the banding patterns obtained after SDS- 
PAGE and fluorography (results not shown).
e) A lysate specific effect. The doublet may have been due to a 
lysate specific effect in that a factor or factors could cause premature 
termination of translation or degradation of RNA. To test this possibility, 
the sl-1 mRNA was translated in a wheat germ lysate. However, no 
difference was seen in the resulting translation products compared to those 
produced in the reticulocyte lysate system (results not shown).
5.2.4 Analysis of the Unsuccessful Translation of al-3
Translation of the s i-3 transcript did not give a full-length protein 
product of the expected 49 kDa size, a phenomenon which could not be 
attributed to the integrity of the RNA as it was undegraded and of the 
correct size. This RNA also stimulated the lysate less than the sl-1 mRNA 
(Table 5.2.1).
Several experiments were performed in an effort to successfully 
translate a l-3  in vitro. Translation in wheat germ lysate was carried out to 
ascertain if the failure in the reticulocyte system was a lysate specific 
effect. For this experiment, in vitro transcribed preproricin mRNA (a gift 
from M.Westby, University of Warwick) was translated as a positive 
control to give a correctly sized protein product. However, priming the 
wheat germ system with in vitro transcribed s i-3 mRNA failed to give a 
full-length a l-3  molecule (results not shown).
The inclusion of protease inhibitors in the reticulocyte lysate 
reaction had no effect on the banding pattern of the products on
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polyacrylamide gels. Hence, degradation of any putative intact ol-3 
polypeptides was unlikely.
The above two experiments suggested that the apparent inability to 
synthesize a full-length a l-3  protein in vitro was not due to an inherent 
property of the reticulocyte lysate. The alternative was that the s i-3 
mRNA itself was somehow defective. As the in vitro transcribed s i-3 
mRNA was intact, another feature of the molecule may have rendered it 
non-functional for translation purposes. One such possibility is that a stop 
codon may have been introduced into the S I-3 cDNA during the cloning 
procedure. This is discussed further in section 5.3.
5.3 DISCUSSION
The optimum conditions for the in vitro translation of RNA derived 
from the reovirus SI transcription clones were determined. The RNA 
concentration required to maximally stimulate the system is relatively high, 
being greater than the concentration of endogenous globin RNA 
necessary for saturation of the system (Pelham and Jackson, 1976 and 
Jackson and Hunt, 1983). This may be due in part to the fact that the si 
message is an inherently poorly translated species as shown by in vivo 
studies (Skehel and Joklik, 1969; Levin and Samuel, 1980; Gaillard and 
Joklik, 1985 and Atwater et al., 1987). Therefore, large amounts of RNA 
may be required for in vitro translations. However, optimum 
concentrations as high as 50|ig/ml have also been reported for 
encephalomyocarditis (EMC) virus RNA stimulation of lysates 
(Jackson, 1986). It has been reported that high concentrations of mRNA 
can have a detrimental effect on the fidelity of translation, reducing the 
ratio of full-length to incomplete products (whilst simultaneously enabling 
the greatest level of stimulation) (Dasso and Jackson, 1989). Although the
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si -1 transcript was ineffeciently translated, a poor ratio of complete to 
truncated products was not evident (Figures 5.2.1 and 6.3.2 for example).
SDS-PAGE analysis of the in vitro translation products obtained 
from the sl-1 and s i-3 mRNAs did not give the expected bands. A doublet 
of bands of the expected molecular weight was present for al-1 but no 
correct sized band was present for a l-3 . In both cases this did not appear 
to be due to either proteolysis or a reticulocyte lysate specific effect. The 
respective transcripts were also intact and undegraded.
Initiation at a codon upstream of and in addition to the authentic 
AUG codon for al-1 was thought to be a likely explanation for the 
doublet of bands observed following translation of sl-1 mRNA. In the in 
vitro transcribed mRNA, there is a candidate upstream initiation codon that 
is in-frame with the authentic start site and which lies in a poor context of 
initiation. Thus, potentially, the ribosomes could sometimes scan through 
this site and initiate downstream at the correct a l  codon. Subsequent 
experiments (Chapter 7) confirmed this explanation as the likely cause of 
the doublet.
The reason for the absence of a a l-3  sized band was less obvious. 
One possibly relates to an inherent defect in the s i-3 transcript itself. Thus, 
incorrect copying by reverse transcriptase during cloning may have 
resulted in the insertion or deletion of one or two bases in the coding 
sequence. This would result in translation being thrown out of frame 
leading to premature termination of translation and the absence of a 
correct sized protein product. A second but less likely possibility was a 
mutation in the initiation codon to render it non-functional. As the primers 
used to clone the SI-3 gene (described in Chapter 3) were already 
available it was decided to re-clone the gene. It was hoped that the re­
cloned cDNA would be capable of expressing a full-length protein in 
vitro. This work is described in the next chapter.
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5.4 SUMMARY
The reticulocyte lysate system was optimised with respect to 
magnesium, potassium and si RNA concentration to maximise the 
efficiency of translation. Translation of s 1 -1 RNA in this system produced a 
doublet of bands apparently representing protein o l- l ,  whilst translation 
of sl-3 RNA did not produce a full-length a l-3  polypeptide.
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6.1 INTRODUCTION
The preceding chapter described the in vitro translation of si 
mRNA derived from the SI-1 and SI-3 transcription clones. Whilst the 
former produced a full-length protein, the latter did not, which was 
thought to be due to an error being introduced into the cDNA during the 
original cloning procedure.
A second cDNA clone of the SI-3 gene was therefore isolated using 
PCR and the same 5' and 3' oligonucleotide primers as before (Chapter 3). 
The reovirus RNA employed as template in the reaction was from a 
different virus stock to that used in the original cloning. The PCR, 
subsequent ligation into pAT153 and transformation into E. coli was 
performed by M. A. McCrae.
6.2 RESULTS
6.2.1 Construction of the Re-cloned Sl-3 Gene-Bluescribe
Recombinant
Putative clones containing the re-cloned Sl-3 gene in vector 
pAT153 were screened by restriction enzyme digests in order to select a 
recombinant plasmid containing a full-length copy of the gene. The Sl-3 
gene was isolated from an appropriate clone and ligated into Bluescribe to 
form recombinant pR2A as shown in Figure 6.2.1. The strategy chosen to 
create pR2A ensured that there were as few nucleotides as possible 
between the T3 bacteriophage polymerase promoter (which would direct 
the synthesis of plus sense sl-3 RNA) and the beginning of the Sl-3 gene, 
to minimise the possibility of spurious initiation events in the ensuing in 
vitro expression, as was observed with the Sl-1 construct. Consequently,
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Figure 6.2.1 Construction of Plasmid pR2A
The reovirus SI-3 gene was cloned for a second time into the vector 
pAT153 at the Pst I site (by M. A. McCrae) to generate pATR2A.
Synthetic oligonucleotides containing several restriction enzyme 
recognition sites were incorporated at the 5' and 3' ends of the cDNA. The 
5' end of the cloned S I-3 gene was digested with £co47III to generate an 
exact 5' end of the gene. The 3' end was then digested with Smal to 
release the SI-3 gene fragment which was purified from a 1% agarose gel 
as described in section 2.9.1. Bluescribe vector DNA was digested with 
//¿«dill, treated with mung bean nuclease (section 2.6.3) to create flush 
ends and phosphatased by the action of CIP (section 2.6.4). The SI-3 gene 
fragment was then ligated into Bluescribe.
Key : This is the same as for Figure 3.3.2
Shown below is the sequence of the 5' gene oligonucleotide utilized in the 
cloning described above. Restriction enzyme sites are marked and the 
bases shown in bold type denote sequence derived from the 5' end of the 
SI-3 gene. From this, it can be seen that digestion with £co47III would 
generate an exact 5' end.
S1-3 - 5' Gene oligonucleotide sequence 
PvuI EcoRI
__ l_  I ___
5' CGATCGCGAATTCTAGAGCGCTATTGGTCGGA 3’
t t
Nrul Eco 47III
EC047III
5'
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there were no restriction enzyme sites between the T3 promoter and the 5' 
end of the SI-3 gene.
The integrity of the re-cloned gene was subsequently checked by 
restriction enzyme digest analysis (Figure 6.2.2). A fragment of 
approximately 1.4 Kb would be expected after BamYW digestion of pR2A 
if the gene is full-length and adjacent to the T3 promoter; an Ss il fragment 
of about 0.9 Kb is similarly predicted. Digestion with the enzyme //¿ndlll 
should leave the DNA uncut as there is no //tndlll recognition site in the 
SI-3 gene whilst that in the polylinker sequence should have been 
removed during the cloning procedure. This is confirmed in the data 
shown in Figure 6.2.2.
6.2.2 Transcription and Translation of pR2A
Plus sense s i -3 RNA was transcribed in vitro from plasmid pR2A 
and analysed on a formamide-agarose gel as shown in Figure 6.2.3. As can 
be seen, full-length, undegraded transcripts were synthesized. However, 
upon in vitro translation of the mRNA and SDS-PAGE analysis of the 
protein products, no band of the size expected for a l-3  (~ 49 kDa) was 
evident. This is shown in Figure 6.2.4 (lane B).
Interestingly, measurement of the radioactivity associated with the 
TCA precipitable products from the in vitro translation reactions (section 
2.11.2) revealed that the s i-3 mRNA had stimulated the lysate 
approximately eightfold more than that observed for the background level 
from translation of the endogenous globin RNA (see Table 6.2.1 in section 
6.2.4). This was equivalent to that routinely observed for the s4-l message 
and greater than for sl-1 mRNA, yet no obvious protein band representing 
this level of translation efficiency was seen on the polyacrylamide gel. A 
possible explanation is that translation was occurring from the short ORF
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pR2A
Shown opposite is a 1.5% agarose gel of the restriction enzyme sites used 
to characterise pR2A. lpg of plasmid DNA was digested with the 
appropriate enzymes (see key below) and electrophoresed as described in 
section 2.9. Undigested pR2A DNA (lane F) was electrophoresed in the 
lane next to that containing the HinAYll incubated DNA for comparative 
purposes as this enzyme was not expected to cut. A ladder of DNA 
fragments (BRL) was used as size markers.
A map of pR2A based on the interpretation of these restriction enzyme 
digests is shown below the photograph of the agarose gel. The SI-3 cDNA 
restriction enzyme sites are based on sequence data reported by 
Cashdollar et al (1985).
Figure 6.2.2 Restriction Enzyme Digest Analysis of Plasmid
Key:
Lane M = Ladder
Lane A = Sst I
Lane B = Bam HI
Lane C = BamHl/Bgl II
Lane D = Pst I
Lane E = Hindlll
Lane F = Undigested
Lane G = Pvull/Pst I
Kb
4.07
3.05
M A B C D E F G
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Figure 6.2.3 Agarose Gel Electrophoresis of In Vitro
Transcribed sl-3 mRNA Derived from Plasmid pR2A
In vitro transcription reactions were performed as described in section
2.10.2 utilizing plasmids pBSSl-1 and pR2A as templates. The integrity of 
the resulting si RNA species was examined by electrophoresis through a 
1.2% agarose gel containing 50% DIF as described in section 2.9.2.
Lane M = Ladder of DNA fragments (BRL)
Lane A = pBSSl-1 derived RNA
Lane B = pR2A derived RNA
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Figure 6.2.4 SDS-PAGE Analysis of the In  Vitro Translation
Products Synthesized from sl-3 mRNA
s i -3 message sense RNA was in vitro transcribed from plasmid pR2A and 
translated in a reticulocyte lysate (section 2.11.1). The protein products 
were analysed by SDS-PAGE (section 2.11.4) and the gel processed as 
described in Materials and Methods section 2.11.5. In vitro translated al-1 
was electrophoresed as a size marker. Radiolabel led reovirus polypeptides 
(prepared as detailed in section 2.2.5) were also used as size markers.
Lane R = 
Lane U = 
Lane A = 
Lane B =
Reovirus infected cell polypeptides 
Uninfected cell polypeptides 
In vitro translated sl-1 RNA from pBSSl-1 
In vitro translated sl-3 RNA from pR2A
within the S I-3 gene, which is downstream of the start codon for a l  and 
would lead to the synthesis of a ls  (see section 1.1.3). As a ls  is only about 
14 kDa in size, it would not be visualized under the conditions of analysis, 
migrating with the dye front to the bottom or even off the gel. The a ls  
AUG start codon lies in a relatively good context for initiation having an A 
and a G in the -3 and +4 positions repectively. If the translating ribosomes 
were to read through the initiation codon for a l  synthesis, then the next 
AUG they would encounter would be that for initiating a ls . Roner et al. 
(1989) did find an inverse relationship between a l  and a ls  in that if the 
former was given a strong initiation sequence then its synthesis increased 
whilst that of the latter decreased; weakening the initiation sequence 
surrounding the AUG of a l  had the opposite effect.
The reason(s) for the apparent readthrough of the a l  initiation 
codon observed in this study are unclear. Further discussion concerning 
the inability of pR2A to yield a a  1-3 protein product is given in sections
6.2.4 and 6.3.
6.2.3 Clone pG3T3
As a l-3  could not be expressed in vitro from either of the two separate 
cloned copies of the SI-3 gene, it was decided to obtain an SI-3 cDNA 
clone from another source. Clone pG3T3 was a gift from P. Lee (University 
of Calgary Health Sciences Centre, Canada) and contains a cDNA of the 
S I-3 coding sequence downstream of the T7 phage promoter of plasmid 
pGEM-3Z (Promega). The essential features of this clone are shown in 
Figure 6.2.5. Advantage had been taken of the fact that there is a flumHI 
restriction enzyme site immediately after the initiating ATG codon for o l in 
the S I-3 cDNA. A DNA copy of the gene was therefore digested at the 5' 
end with the enzyme BamW\ and ligated into pGEM-3Z by means
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Figure 6.2.5 C onstruction of plasmid pG3T3
Plasmid pG3T3 was a gift from P. Lee (University of Calgary Health 
Sciences Centre) and had been constructed as shown opposite. A cDNA 
clone of the reovirus SI-3 gene was digested at the 5' end with BamW\ and 
ligated to an EcoK\ - Bam\\\ initiation linker. The 3' end of the gene was 
joined to a synthetic oligonucleotide containing the recognition sequence 
for Kpnl. This construct was then ligated into EcoR\ - Kpnl digested 
pGEM-3Z.
The circular plasmid map opposite shows the orientation of the S I-3 gene 
within pG3T3.
The scheme outlined below the map represents the cloning strategy and 
shows the relevant restriction enzyme sites and initiation codons of the Sl- 
3 gene and initiation linker.
Key
SP6 = Promoter sequence for SP6 RNA polymerase
T7 = Promoter sequence for T7 RNA polymerase
EcoR1-BamH1 Initiation Linker
T7 promoter EcoR!
PGEM-3Z 5’ T AAT ACGACT CACT AT AGGGCG AATTC
+ 1 A
Kpnl
GGTACC
1 r BamHI
Initiation 5. GAATTCGGAGGAAAAAATTATGGATCC 3 ' 
Linker EcoR| # TCATCGGTACC 3' Synthetic 
Oligonucleotide
/
S1-3 gene 5' GCTATTGGTCGGATGGATCCTCG........TCATC 3'
Î t Î
BamHI 1416
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of a BamH\ initiation linker. This regenerated the c l -3 initiation codon and 
placed it in a strong consensus sequence. A synthetic oligonucleotide was 
employed in the ligation of the 3' end of the gene to the vector (P. Lee, 
personal communication). The main difference between this clone and the 
two S I-3 clones previously described - namely pBSSl-3B and pR2A - is 
that the latter two contain the 5' untranslated region of SI-3 whereas 
pG3T3 does not.
6.2.3.1 Expression of pG3T3
Plus sense s i-3 RNA produced by the in vitro transcription of 
pG3T3 was translated in vitro and the proteins thus synthesized size- 
fractionated by SDS-PAGE. The resulting autoradiograph of the gel is 
shown in Figure 6.2.6. A full-length ol-3 product of the expected size of 
approximately 49 kDa was evident (lane B) that migrated just below the 
doublet of bands representing the in vitro translated cl-1 protein. An 
approximate fivefold stimulation over the endogenous level of the lysate 
was achieved with sl-3 mRNA derived from plasmid pG3T3, which is 
slightly greater than was routinely observed with the type 1 si mRNA (see 
Table 6.2.1, which is shown below Figure 6.2.6).
6.2.4 Expression of a pG3T3/pR2A Hybrid
Protein c l -3 could be successfully expressed in vitro from plasmid 
pG3T3 but not pR2A. The most significant difference between the cDNA 
copies of the Sl-3 genes within these two plasmids was that the 5' 
untranslated leader sequence in pG3T3 had been replaced with an 
initiation linker. It was therefore decided to substitute the Sl-3 coding 
sequence of pG3T3 with that from pR2A. To this end. each of the plasmids
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Figure 6.2.6 In V itro  T ranslation of a l - 3
RNA was transcribed in vitro from the plasmids indicated in the key below 
and translated in a reticulocyte lysate (as in section 2.11.1). The resulting 
proteins were subjected to SDS-PAGE (section 2.11.4) and the 
polyacrylamide gel processed as described in section 2.11.5. A photograph 
of the resulting autoradiograph is shown opposite.
Lane M = 
Lane A = 
Lane B = 
Lane C = 
Lane D =
Radiolabelled protein markers (Amersham)
In vitro translated al-1 proteins from pBSSl-1 derived RNA 
In vitro translated al-3  from pG3T3 derived RNA 
In vitro translated products from pBSSl-3B derived RNA 
In vitro translated products from pR2A derived RNA
The molecular weights (in kDa) of some of the radiolabelled markers are 
marked on the left hand side of the photograph.
Table 6.2.1 Stimulation of a Rabbit Reticulocyte Lysate by Reovirus 
si Transcripts
The incorporation of 35S-methionine into protein products from the in 
vitro translation reactions described above was measured by TCA 
precipitation and subsequent counting in scintillation fluid as described in 
section 2.11.2; the results are shown in the table opposite. The value for 
pBSSl-1 in the final column has been corrected to account for the 
difference in methionine content between al-1 and the a l-3  product. The 
values for pBSSl-3B and pR2A are not similarly corrected as the identity 
of the protein products derived from the in vitro expression of these 
plasmids is uncertain.
M A B C D 
69
46  “
Table 6.2.1 Stimulation of a Rabbit Reticulocyte Lysate by Reovirus 
si Transcripts
P L A S M ID T R A N S C R IP T C O U N T S RELA TIVE
S T IM U L A T IO N
Endogenous 15,961
p B S S l-1 s 1 -1 7 0 ,9 0 0 3 .23
pG 3T3 s1-3 7 4 ,9 7 2 4 70
p B S S 1 -3 B s1-3 2 1 ,4 7 6 1 35
pR2A s1-3 1 97 ,60 9 12 38
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was digested with the restriction enzyme Bam\\\ (which cuts the SI-3 
gene immediately after the a l  initiation codon) to release both SI-3 gene 
fragments. The gene fragment from pR2A (minus the untranslated leader 
sequence) was subsequently ligated into the vector fragment of pG3T3, 
thereby generating clone pG3Sl-3. This strategy is shown schematically in 
Figure 6.2.7.
Restriction enzyme sequences contained within the 3’ gene 
oligonucleotide sequence of the pR2A derived SI-3 sequence enabled the 
hybrid clone to be distinguished from pG3T3 when screening bacterial 
colonies for the putative hybrid. Analysis of twenty potential pG3Sl-3 
clones by digestion with the restriction enzyme PvmII is shown in Figure 
6.2.8. Putative positives (i.e. pG3Sl-3 clones) were expected to produce 
bands of approximately 1.5 Kb and 0.3 Kb in comparison to a 1.8 Kb band 
from pG3T3 DNA. The former can be seen in lanes 6, 7 and 9 and the latter 
in lane 1 respectively. Further digests were performed to confirm the 
integrity of the chosen pG3Sl-3 clone (results not shown).
The autoradiograph obtained after SDS-PAGE of the in vitro 
translation products directed by s i-3 mRNA derived from this clone is 
shown in Figure 6.2.9. A band of the correct size for a  1-3 can be seen as 
shown by its co-migration with al-3  protein similarly derived from clone 
pG3T3 (lanes C and D respectively). This indicated that the coding 
sequence for the SI-3 gene cloned in our laboratory was functional and 
that the sequence upstream of the initiation codon appeared to be 
abrogating the expression of a full-length protein in vitro.
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Figure 6.2.7 Construction of pG 3Sl-3
The SI-3 gene from plasmid pR2A was used to replace that of pG3T3. The 
SI-3 gene within pR2A was released by Bam\U digestion and purified 
from an agarose gel (section 2.9.1). Plasmid pG3T3 was similarly digested 
(i.e. with BamM\ to remove its copy of the SI-3 gene) and the resulting 
vector fragment purified on an agarose gel. The pR2A SI-3 gene was then 
ligated into the pG3T3 vector fragment to generate clone pG3Sl-3. The 
PvuW recognition site in the 3' gene oligonucleotide of the pR2A SI-3 
gene is shown, as it enabled selection of the appropriate recombinant 
clones in the screening process.
Key
SP6 = SP6 phage promoter sequence
T7 phage promoter sequence 
pGEM-3Z polylinker sequence 
3' gene oligonucleotide sequence
5' pR2A 3’
Bam HI Digest
Ligate ◄---------------------------  Isolate Vector Fragment
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Figure 6.2.8 Selection of pG 3S l-3  Recombinant Clones
Twenty putative pG3Sl-3 clones were screened by PvuII digestion of 
plasmid DNA prepared from white bacterial colonies as described in 
section 2.7.3. Digests were electrophoresed on a 1.2% agarose gel as 
described in section 2.9 and DNA bands visualised by uv illumination. 
pG3T3 DNA digested with PvmII was also electrophoresed to illustrate the 
different banding pattern of pG3T3 and pG3Sl-3.
A photograph of the gel is shown opposite, below which is a map of 
pG3Sl-3 with the positions of the PvmII sites marked. The asterisked PvmII 
site is not present in pG3T3.
Lanes 6, 7 and 9 of the photograph show the correct sized fragments of ~
1.5 Kb and 0.3 Kb expected for the substituted SI-3 cDNA in the correct 
orientation.
Lane M = Ladder
Lane A = pG3T3 DNA digested with PvuII
Lanes 1-20 = Mini-plasmid preparations of putative pG3Sl-3 
clones.
Figure 6.2.9 In V itro Translation of RNA Derived from Plasmid
p G 3 S l-3
Plasmid pG3Sl-3 was employed in an in vitro transcription reaction to 
produce s i-3 mRNA. This RNA was used as template in the reticulocyte 
lysate translation system. Protein products were analysed by SDS-PAGE 
and the gel processed by fluorography. The result is shown opposite. Lane 
R shows many host cell polypeptides as well as the reovirus proteins that 
act as size markers. This was probably due to an insufficiently high moi 
being used in the preparation of the cells (section 2.2.5) resulting in an 
incomplete inhibition of host cell protein synthesis.
Lane R = Reovirus infected cell lysate
Lane A = Endogenous lysate mix
Lane B = pBSSl-1 RNA translation mix
Lane C = pG3T3 RNA translation mix
Lane D = pG3Sl-3 RNA translation mix
R A B C D
X  —  
p  l
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6.3 DISCUSSION
The SI-3 gene was cloned for a second time as the original cDNA 
sequence had not produced a full-length protein when expressed in in 
vitro transcription/translation reactions. However, when the second clone, 
pR2A, was similarly expressed no al-3  protein was produced despite 
attaining an eightfold stimulation over that observed with the residual, 
endogenous RNA of the lysate. This was proposed to be due to translation 
occurring from the short ORF of the s i-3 mRNA, the initiating AUG of 
which lies in a fairly strong initiation context sequence approximately 70 
nucleotides downstream of the initiation codon for o l. The protein 
encoded by this short ORF, a  Is, was not visualised on the SDS 
polyacrylamide gels utilized in the analysis of the in vitro translation 
products as it is only approximately 14 kDa and would have co-migrated 
with the dye front to the bottom or off the gel. Roner et al. (1989) found it 
necessary to immunoprecipitate this protein from reticulocyte lysate 
reactions in order to visualise it as a sharp band after SDS-PAGE. The 
diffuse band otherwise observed was thought to be due to the presence of 
endogenous globin that is co-synthesized in the reaction mix.
The ribosomes therefore appeared to be scanning through the AUG 
for a l in the sl-3 mRNA derived from pR2A. Evidence consistent with 
such "leaky" scanning of in vitro transcribed sl-3 mRNA has been 
obtained by Roner et al. (1989) who reported that in general, the strength 
of the sequence around the a l  initiation codon had a direct effect on the 
translation efficiency of the downstream initiated a ls. Thus, a weak Kozak 
consensus sequence for a l resulted in a poor yield of this protein but a 
high yield of a ls , whereas a better consensus sequence for the former had 
the opposite effect.
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Similar observations have been reported for other virus systems. A 
mutational analysis of the Sendai virus P/C gene, where the P and C 
proteins are encoded in different, overlapping reading frames gave results 
that were consistent with leaky scanning (Curran and Kolakofsky, 1988). 
More recently, Lin and Lo (1992) reported in vitro and in vivo data that 
the hepatitis B virus pol gene product resulted from partial readthrough of 
the C (core) gene AUG. Expression of the HIV-1 env gene is also 
dependent upon a weak consensus sequence for the upstream situated 
vpu AUG (Schwartz et al., 1990; 1992).
Further investigation of the putative readthrough phenomenon that 
was apparently taking place with the pR2A derived s i-3 mRNA expressed 
in vitro in this study was not pursued as the priority was to achieve 
synthesis of al-3.
Another SI-3 transcription clone, pG3T3, did yield the desired al-3  
protein product upon in vitro transcription and translation. Hence, the 
previous failures to express a l-3  from plasmids pBSSl-3B and pR2A was 
not owing to an s i-3 mRNA-specific inhibitory effect of the lysate on s i -3 
mRNA. Equally unlikely was the possibility that an adverse mutation had 
been incorporated into the coding sequence of two independent cDNA 
clones of Sl-3.
Replacing the coding sequence for Sl-3 from pG3T3 with that from 
pR2A, created plasmid pG3Sl-3 that also gave a full-length ol-3 in vitro 
expression product. The main difference between clones pG3T3 and 
pG3Sl-3 and pR2A and pBSSl-3B was that only the latter two contain 
the 5' untranslated leader sequence (i.e. the region upstream of the a l-3  
initiation codon) of the Sl-3 gene (Figure 6.3.1). The former two clones 
contain an initiation linker sequence in place of the leader sequence. This 
implied that the 5' leader region present on sl-3 mRNA transcribed from 
pR2A (and pBSSl-3B) was in some way preventing the synthesis of a l-3
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+1 pR 2A - 3
GGAAC AAA GCTATTGGTCGojvTGG ■
pG3T3/pG3S1-3
U____________ i
•• GGGCGAATTCGGAGGAAAAAATT^TGGATCC. . .
Figure 6.3.1 Comparison of the 5' Untranslated Sequences of the Four Sl-3 
Transcription Plasmids
The 5' untranslated regions derived from the Sl-3 cDNA's in plasmids pBSSl-3B. 
pR2A and pG3T3 / pG3Sl-3 are shown above as boxed residues. The first base 
transcribed is indicated by a "+I" and the bases in the "-3" and "+4" positons with 
respect to the a l-3  initiation codons in each of the plasmids are marked. Sequence 
in bold type represents Sl-3 gene sequence. In the pG3T3 / pGSl-3 sequence, the 
ATG initiation codon is not shown in bold type as it is derived from an initiation 
linker utilized in the cloning procedure.
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in the in vitro translation reactions. Clone pR2A had been created in such 
a manner that the polylinker sequence of the vector contributed as few 
nucleotides as possible to this untranslated region. Native s i-3 mRNA 
produced by the virus would not have a very different sequence upstream 
of the initiation codon for o l  compared to the mRNA transcribed in vitro 
from plasmid pR2A. Since the type 3 virus appeared to replicate as 
expected in tissue culture and was therefore presumably synthesizing o l-  
3, the effect was apparently specific to the in vitro situation.
The precise reason for the inability to express a  1-3 from the plasmid 
pR2A is unclear. The 5' untranslated region is only short, so the ribosomes 
do not have to scan very far. One other possibility is that it was an 
inherent feature of the 5' untranslated sequence that was responsible for 
the putative inhibition of translation. A particularly stable secondary 
structure could have an inhibitory effect but a previous analysis of this 
region in viral s i -3 mRNA, did not predict such a feature (Antczack et al.,
1982). Although the ol-3 AUG codon has a fairly weak initiation 
sequence - CGGAUGG - compared to the Kozak consensus sequence of 
-ACCAUGG - (Kozak, 1981; 1983 and 1986), it is not the poorest and so 
some synthesis of o l would be expected. Other individual bases or 
sequences lying upstream (or even downstream) of the AUG may have 
been effecting the apparent inhibition. Investigation of this possibility 
would have required a time consuming mutagenesis approach and was not 
within the scope of my objectives.
6.4 SUMMARY
The re-cloned Sl-3 gene did not produce a full-length ol-3 protein 
when expressed in vitro from clone pR2A. However, a l-3  was expressed 
from an alternative Sl-3 recombinant clone, pG3T3, provided by another
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laboratory. Substituting the coding frame of the re-cloned SI-3 gene for 
that within pG3T3, revealed that the former was functional. The precise 
reason(s) for the non-expression of a l-3  from pR2A is unclear, but may 
have involved translation-inhibitory effects mediated by the 5’ 
untranslated region of the SI-3 cDNA.
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7.1 INTRODUCTION
The primary aim of translating a l  in the reticulocyte lysate system 
was to enable an investigation of the cell binding properties of the protein. 
Small quantities of protein are produced by this method, a yield of l-10ng 
being typically obtained from a 30pl reaction volume (Ausubel et al..
1990). The si type 1 and type 3 in vitro synthesized mRNAs only 
stimulated the lysate poorly (see sections 5.2 and 6.2.3.1) and 
consequently yields were probably less than the average value quoted 
above. It was therefore considered desirable to increase the amount of 
protein synthesized in this system. The lysate reaction conditions had 
already been optimised (Chapter 5) and so two further methods for 
increasing the amount of a l  produced in the translation system were 
decided upon, one "genetic” and the other biochemical.
The genetic approach involved oligonucleotide directed 
mutagenesis of plasmid pBSSl-1 to effect both a point mutation and a 
deletion. The point mutation was aimed at improving the poor context of 
initiation of the a l  ATG in the cloned S1 -1 gene by altering the -3 
nucleotide from a "weak" C to a "strong" A. The deletion would remove all 
the intervening nucleotides between the T3 phage promoter of pBSSl-1 
and the first base of the S I-1 gene (Figure 7.1.1). This would enable the 
production of transcripts with 5’ untranslated (leader) sequences identical 
(apart from the -3 nucleotide) to that of si mRNA synthesized in vivo. 
Such a deletion would also address the question of whether the putative 
upstream initiation codon present in the leader region was in fact 
functional and initiating the synthesis of one of the bands of the a l  
doublet (see section 5.2.1).
The biochemical method employed to improve translation efficiency 
was to include 2-aminopurine (2AP), an inhibitor of ds RNA activated
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Figure 7.1.1 Schematic Representation oF the Mutagenesis of Plasmid 
pBSSl-1
The diagram opposite shows the point mutation of the nucleotide in 
position -3 with respect to the a l  initiation codon and the region of DNA 
between the T3 promoter and first base of the cloned Sl-1 gene to be 
deleted. The a l  initiation codon is underlined and the -3 nucleotide 
marked with an asterisk. +1 and -1 refer to the first base transcribed from 
the T3 promoter and the nucleotide immediately preceding it respectively. 
The bent arrow at the top of the diagram represents the direction of 
transcription from the T3 promoter.
T3 = T3 phage promoter sequence 
T7 = T7 phage promoter sequence
= Polylinker + gene oligonucleotide sequence
5 ’
p B S S I-1
3’T 3 T 7
S1-1 V /.
-TCACTAAAGGGAACAA
+1
I
Transcription
▼
S1-1 G E N E *
-------- GCTATTCGCGCCTATGG —
-3
I
Translation
▼
M U T A G E N E S IS
I
D E L E T IO N
+
P O IN T  M U T A T IO N
▼
T3 PBSS1-1AL T 7
ÎÎ-TCACTAAA GCTATTCGCG ACTATGG
-1 +1 -3 -------
I I
Transcription Translation
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protein kinase PI, in the translation reaction mix. A brief summary of PI 
function will be given to more clearly define the reason for the inclusion of 
this inhibitor.
One of the factors involved in the initiation of translation is 
eukaryotic initiation factor-2 (eIF-2), a multi-subunit protein that binds 
methionyl-tRNAi and GTP to form a ternary complex, this then binds 40S 
ribosomal subunits (Safer, 1983 and Ochoa, 1983). The activity of eIF-2 is 
down-regulated by phosphorylation of its a  subunit, a reaction catalysed 
by an RNA dependent kinase known as the Pl/eIF-2a kinase (Samuel, 
1979; Berry et al., 1985 and Pestka et al., 1987). This kinase is induced 
physiologically by interferon (Samuel, 1979 and Pestka et al., 1987) and 
has two distinct activities: first it activates protein PI by 
autophosphorylation (Berry et al., 1985 and Galabru and Hovanessian,
1987) and second, it phosphorylates eIF-2a. Protein kinase Pl/elF-2a can 
be activated in vivo by virus infection, for example with reovirus, or by ds 
RNA treatment of cell cultures (Gupta, 1979; Samuel et al., 1984 and Rice 
et al., 1985). Activation in vitro is achieved with either synthetic or 
natural ds RNA (Baglioni, 1979; Samuel, 1979; Lasky et al., 1982 and 
Samuel et al., 1984). However, reovirus ss RNA, as a mixture of all ten 
transcripts synthesized by the core associated polymerase can similarly 
activate the kinase (Samuel, 1979). These interactions are shown in Figure 
7.1.2.
The adenosine analogue 2-aminopurine is a known inhibitor of 
Pl/eIF-2a kinase activity (Legon et al., 1974 and De Benedetti and 
Baglioni, 1983). It was therefore decided to include 2AP in the in vitro 
translations to alleviate possible inhibitory effects induced by si mRNA 
activation of the kinase.
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Interferon
Some Viral Infections 
ds RNA
Some ss RNA's
Figure 7.1.2 Interactions of Protein Kinase Pl/eIF-2a
The above figure summarises the effects of various agents upon protein kinase 
PI/eIF-2a. An encircled + indicates a stimulatory effect and an encircled - 
indicates an inhibitory effect. See text for details.
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7.2 RESULTS
7.2.1 Mutagenesis of pBSSl-1
The strategy adopted for the oligonucleotide directed mutagenesis 
of pBSSl-1 to both place the S I-1 gene exactly adjacent to the T3 
promoter and change the c l -3 initiation nucleotide from a C to an A is 
shown in Figure 7.2.1. Thus, a fragment encompassing the T3 promoter 
and the Sl-1 gene was subcloned from pBSSl-1 into M13mpl9 to create 
clone m pl9Sl-l. The sequence of the oligonucleotide used in the pBSSl-1 
mutagenesis is also shown in Figure7.2.1. One oligonucleotide was used to 
effect both mutational changes.
The method of Vandeyar et al. (1988) was used to create the 
mutation as it results in a high proportion of mutant clones (~ 90%) unlike 
the original method for oligonucleotide directed mutagenesis of Zoller and 
Smith (1983). An efficiency of 80% was achieved in this particular 
instance (data not shown). This method of mutagenesis was also used at a 
later stage in this study and is described in more detail in Chapter 10.
Putative mutant clones were cultured and replicative form (RF) 
DNA prepared as described in section 2.8.2. Mutant clones were initially 
identified by digestion of RF DNA with the appropriate restriction enzyme 
(//mdlll) as shown schematically in Figure 7.2.2. Mutated and non- 
mutated DNA produced different banding patterns upon agarose gel 
electrophoresis of the digested DNA as a consequence of the deletion in 
the former. A mutant was selected and a fragment of DNA encompassing 
the mutated region was subcloned back into pBSSl-1 (from which the 
equivalent piece of DNA had been excised), to create pBSSl-lAL. 
Sequencing was then performed to confirm that both the deletion and the 
point mutation had been generated and that no other mutations were
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Figure 7.2.1a Strategy for the Mutagenesis of pBSSl-1
Plasmid pBSSl-1 was digested with the restriction enzymes PvuU and 
BamW\ and the ~ 1.8 Kb fragment encompassing the S I-1 gene and T3 
promoter sequence was purified from a 1% agarose gel (section 2.9.1). This 
fragment was ligated into M13mpl9 vector DNA that had been previously 
digested with HincU and Bam\U, to generate clone m pl9Sl-l.
Mutagenesis was carried out as described in section 2.8.5 using 
oligonucleotide Sldel, whose sequence is shown overleaf (Figure 7.2.1b). 
DNA from half of the resulting reaction mix was then transformed into £. 
coli Mcr A'B* cells (section 2.8.6). RF DNA was prepared (as described in 
section 2.8.2) from an appropriate mutant and digested with HindlW. The 
ends of the DNA were then made flush by Klenow filling (section 2.6.2) 
before further digestion with XhoI to release a small fragment containing 
the mutated sequence. Plasmid pBSSl-1 was partially digested with PvuU, 
exactly as described in section 2.6.1.1 followed by digestion with Xhol to 
release a small fragment (encompassing the T3 promoter and ~ 250 
nucleotides of the 5' end of the S1 -1 gene), and a large, vector fragment; 
the latter was purified from an agarose gel (section 2.9.1). The small 
mutated fragment was then ligated into the large pBSSl-1 vector fragment 
to create pBSSl-lAL.
T3 phage promoter sequence 
T7 phage promoter sequence 
Polylinker sequence of M13 and/or pBSS 1 -1
Figure 7.2.1b Sequence of Oligonucleotide S Idei
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mp19S1-1
mp19S1-1AL (mutated m pl9S l-1)
H indlll H indlll
= polylinker derived 
from pBSS1-1
= T 3  prom oter sequence
= gene oligonucleotide 
sequence
= m p19  polylinker
Figure 7.2.2 Schematic Representation of the Selection of m pl9Sl-l 
Mutants
The maps above show the number and positions of the HindlU 
recognition sites present in mp!9Sl-l before and after the mutagenesis 
described in the text. The sizes of the fragments that enabled 
differentiation of the mutated and non-mutated clones after digestion with 
Him1III are indicated by the numbers between the restriction enzyme 
recognition sites.
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present in this fragment. Figure 7.2.3 shows that in the selected clone the 
Sl-1 gene is positioned immediately adjacent to the T3 promoter such that 
the first base transcribed is the first base of the Sl-1 gene and that the -3 
initiation nucleotide has been mutated to an A.
7.2.2 Effect of the Mutation on the Synthesis of al-1
Plasmids pBSSl-lAL and pBSSl-1 were transcribed and translated 
in vitro and equal volumes of reaction mix were analysed by SDS-PAGE. 
A photograph of the fluorographed gel is shown in Figure 7.2.4; lane B 
represents the expression of pBSSl-1 and lane C that of pBSSl-lAL. Two 
features are immediately obvious: the mutated clone directs the synthesis 
of a single band of the expected size for a l ,  instead of a doublet and the 
efficiency of translation is increased as shown by a more intense band in 
comparison to either of the bands belonging to the doublet. The single a l  
protein band derived from the mutated Sl-1 clone comigrated with the 
lower of the doublet bands resulting from expression of pBSSl-1. Thus, it 
would appear that the putative upstream initiation codon present in 
pBSSl-1 (see Chapter 5) was responsible for initiating the synthesis of the 
larger of the doublet bands.
Aliquots of the two different a l  translation mixes described above 
were TCA precipitated and the associated radioactivity measured by 
scintillation counting (section 2.11.2) to enable an estimation of the 
efficiency of translation of the respective si mRNAs to be made (see Table
7.2.1 shown below Figure 7.2.4).
The figures for the TCA precipitated counts revealed that RNA 
synthesized fom pBSSl-lAL was translated approximately twice as 
efficiently as that from pBSSl-1. However, the latter RNA directs the 
translation of two a l  proteins, only one of which can be considered as an
Figure 7.2.3 Sequencing of pBSSI-1 and pBSSl-lAL
DNA from plasmid pBSSl-lAL was sequenced as described in section 
2.8.8.2. A photograph of the resulting autoradiograph is shown 
opposite.The tracks on the left hand side of the picture represent analysis 
of pBSSl-lAL and those on the right hand side pBSSl-1 for comparison. 
The asterisks denote the -3 nucleotide of the o 1 initiation sequence and 
confirms that in the mutant it has been altered to an A from a C. The arrows 
denote the first base of the S I-1 gene. In the mutant sequence this base is 
immediately preceded by an A which is the -1 nucleotide of the T3 
promoter confirming that the intended deletion had taken place. Compare 
this with the pBSSl-1 sequence where the nucleotides preceding the first 
base of the S1-1 gene are derived from the 5' gene oligonucleotide used in 
its cloning.
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Figure 7.2.4 SDS-PAGE Analysis of a l  Proteins Encoded by
Transcripts Synthesized from pBSSl-1 and pBSSl-lAL
s 1 -1 mRNA was transcribed in vitro from plasmids pBSS 1 -1 and pBSS 1 - 1 AL. 
Each mRNA was used to prime in vitro translation reactions carried out as 
described in section 2.11.1 for the non-commercial sources of lysate. Equal 
volumes of the reaction mixes were subjected to SDS-PAGE (2.11.4) and the 
polyacrylamide gel processed as described in section 2.11.5. A photograph of 
the resulting autoradiograph is shown opposite. The radiolabelled reovirus 
polypeptides (lane R) were prepared as described in section 2.2.5.
Lane R Reovirus infected cells
Lane A Endogenous lysate reaction
Lane B a l protein from pBSS 1-1 transcripts
Lane C a  I protein from pBSSl-l AL transcripts
Table 7.2.1 Comparison of al-1 Synthesized from pBSSl-1 and 
pBSSl-lAL mRNAs
2/d aliquots of the in vitro translation reactions described above were TCA 
precipitated and the radiolabel incorporated into protein products measured 
(section 2.11.2). The resulting values are shown in the Table oppposite.
The column headed "Ratio al-JA L : a l - l ” represents the amount of a l 
synthesized from pBSS I -1 AL derived RNA compared to that from pBSS 1 - 1 
RNA. In the "cpm value" for this comparison, a value equal to half the number 
of counts given for the pBSS 1-1 transcript is used to calculate the ratio since 
two a l  proteins are produced from this RNA in approximately equal 
quantities. The densitometer value was derived by laser scanning 
densitometry (as described in section 2.11.6) of the autoradiograph shown 
opposite.
R A B C
^  [
Table 7.2.1 Comparison of al-1 Synthesized from pBSSl-1 and 
pBSSl-lAL mRNAs (Legend is opposite).
TRANSCRIPT COUNTS
Ratio a l-1 ' AL" : o l - l
From cpm 
values
From
densitometer
values
Endogenous 17.853
sl-1 103.869 3.5 3.8
sl-lA L 182.098
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authentic product (the lower molecular weight polypeptide). Each of these 
proteins are synthesized in approximately equal amounts and thus 
contribute equally to the TCA counts value. Therefore the mutations 
performed in generating pBSSl-lAL result in a fourfold increase in the 
amount of al-1 expressed. A more accurate comparison would have been 
possible if only the lower band of the a l  doublet had been synthesized. 
Quantitation of the autoradiograph shown in Figure 7.2.4 by laser 
scanning densitometry also revealed a fourfold difference between the 
single a l  band in lane B derived from the mutant clone and the lower band 
of the doublet in lane C (Table 7.2.1).
One other effect of the mutation in pBSSl-lAL was to decrease the 
amount of s 1-1 mRNA produced in in vitro transcription reactions to about 
1/3 that of the non-mutated typel clone (results not shown). This effect 
was probably due to the T3 promoter nucleotides deleted in the process of 
placing the Sl-1 gene exactly adjacent to this promoter. This is discussed 
further in the final section of this chapter (7.2.4).
7.2.3 The Effect of 2AP on Translation
Plus sense si RNA derived from plasmids pBSSl-1. pBSSl-lAL and 
pG3T3 was translated in reticulocyte lysate in the presence and absence of 
2AP and the protein products subjected to SDS-PAGE. The gel was 
processed by fluorography and the result is shown in Figure 7.2.5. 
Quantitation of the representative a l  bands by scanning laser 
densitometry revealed that all three mRNAs were translated 3-4 times more 
efficiently in the presence of 2AP (Table 7.2.2).
To ascertain if this effect was specific to the si mRNA. further 
reactions were conducted to include an analysis of the effect of 2AP on 
the translation efficiency of s4-l mRNA (transcribed in vitro from plasmid
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Reovirus Messenger RNAs
Figure 7.2.5 T he Effect o f 2AP on the In  Vitro  T ransla tion  o f
Reovirus si mRNA was transcribed in vitro from plasmids pBSSl-1, 
pBSSl-lAL and pG3T3 . These transcripts were translated in a non­
commercial reticulocyte lysate as described in section 2.11.1 in the 
presence or absence of 15mM 2AP. Equal volumes of the individual 
reaction mixes were electrophoresed on an SDS-polyacrylamide gel as 
described in section 2.11.4 and the gel processed by fluorography as in 
section 2.11.5. The resultis shown opposite. Radiolabelled reovirus 
proteins were prepared from infected cells as described in section 2.2.5.
Lane A Reovirus infected cells
Lanes B and C Endogenous lysate
Lanes D and E al-1 translated from pBSSl-1 RNA
Lanes F and G al-1 translated from pBSSl-lAL RNA
Lanes H and I a l-3  translated from pG3T3 RNA
The + and - symbols represent the presence or absence of 2AP in the in 
vitro translations.
-  +  -  +  —C D E F G
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Table 7.2.2 Effect of 2AP on the Translation Efficiencies of 
Reovirus mRNAs
In vitro translations carried out in the presence and absence of 2AP 
and the subsequent SDS-PAGE were performed as described in the 
legend to Figure 7.2.6 with the exception that s4-l mRNA transcribed 
from plasmid pBS4-l was included in the analysis and both commercial 
and non-commercial sources of reticulocyte lysate were utilized. The 
appropriate bands on the resulting autoradiographs (corresponding to 
the relevant species of a  protein) were analysed by laser scanning 
densitometry (section 2.11.6) and the results are presented in the Table 
opposite. * denotes that only the lower band of the a l  doublet was 
analysed. The final column in the table is the amount of each protein 
synthesized in the absence of 2AP and normalized with respect to a l  
translated from sl-lAL RNA; differences in the methionine content of 
each protein are accounted for. The cpm values were determined 
essentially as described in the legend for Table 7.2.1. The densitometer 
values represent the average of three experiments and the cpm values 
are typical of one experiment; actual values varied between 
experiments (and the source of the lysate) but the calculated ratios 
were similar in each case.
pBS4-l). This RNA was routinely used as a control in the in vitro 
translation reactions and the encoded protein product (a 3) was intended 
for use as a control in future cell binding assays (Chapter 8). Thus, in vitro 
translations of si and s4 mRNAs were carried out in the presence and 
absence of 2AP and the amounts of respective a  proteins quantitated by 
densitometry scanning as described above. These results are presented in 
Table 7.2.2. Including 2AP in the reaction mix increased the production of 
a3 twofold and a l  approximately threefold (as initially observed). The 
amount of TCA precipitable radioactivity incorporated into the products of 
these translations was measured by scintillation counting (Table 7.2.2) and 
gave values close to those obtained by the scanning densitometry 
analysis. Therefore, the effect of 2AP did not appear to be specific to the 
translation of in vitro transcribed si mRNAs. The increase in translation 
efficiency of the si and s4 mRNA induced by 2AP also implies that these 
transcripts are activating the Pl/eIF-2a kinase in the reticulocyte lysate. 
Further discussion concerning this issue is given below.
7.3 DISCUSSION
Oligonucleotide directed mutagenesis was performed to alter the 
weak a l  initiation codon sequence in the Sl-1 cloned gene to a stronger 
context and to delete the nucleotides between the T3 phage promoter and 
the SI gene of plasmid pBSSl-1, such that in vitro transcripts would be 
devoid of vector derived nucleotides at their 5' ends. The purpose of the 
mutagenesis was to effect an increase in the in vitro translation of al-1 . 
This was observed, as transcripts from the mutated plasmid, pBSSl-lAL. 
directed the in vitro synthesis of al-1 more efficiently than their pBSSl-1 
counterparts.
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Several other groups of workers have used a similar approach in an 
attempt to explain the poor translation of c l .  Munemitsu and Samuel
(1988) mutated DNA copies of the SI type 1 gene that had been cloned 
into an SV40 based expression vector. Quantitation of expressed a l  was 
achieved after transfection of the plasmids into COS cells. These authors 
found that changing the nucleotide in position -3 relative to the a l AUG 
codon, from a C to a G in line with the strong initiation sequence proposed 
by Kozak (Kozak, 1981; 1983 and 1986), had no significant effect on a l  
synthesis compared to a wild type clone. In an in vitro study, Roner et al.
(1989) mutated the -3 to -1 positions of the a l-3  initiation sequence to the 
strongest Kozak consensus sequence (ACC respectively) which resulted 
in a tenfold increase in the amount of a l  translated. The result obtained in 
this study, namely a 4-6 fold increase in a l  synthesis effected by the 
mutant clone is more in agreement with the latter study and suggests that 
the nature of the -3 nucleotide is an important factor in controlling the 
translation frequency of si mRNA. The expression vectors of Munemitsu 
and Samuel (1988) produced s 1 -1 transcripts with a 5' untranslated 
sequence longer than authentic sl-1 mRNA as a consequence of the 
method of expression. It is possible that these sequences were exerting a 
dominant influence over the introduced mutation.
Another effect of the mutation was that a l  was resolved as a single 
band on SDS polyacrylamide gels unlike protein expressed from the 
original typel plasmid which produced a doublet of bands. A putative, 
weak initiation codon upstream of the normal a l  AUG was one of the 
possibilities suggested in explanation of the doublet and was deleted in 
pBSSl-lAL. This resulted in the in vitro translation of a a l  polypeptide 
equivalent in size to the lower of the doublet bands. Hence, the role of the 
putative initiation codon in producing the doublet was confirmed. The 
reduction in the length of the 5’ untranslated sequence of sl-1 mRNA
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transcribed from this clone to the same as that found in s 1 -1 mRNA in vivo 
may also have contributed to the increase in translation efficiency, as 
Roner et at. (1989) determined an optimum 5' untranslated length of 
approximately 14 nucleotides in effecting maximum stimulation of c l 
synthesis.
The deletion of some T3 phage promoter nucleotides in pBSSl-lAL 
affected the transcriptional activity of the clone, reducing RNA yields from 
in vitro transcriptions by 1/2 - 1/3 that of the non-mutated pBSSl-1, which 
contained an intact T3 promoter. Despite this decrease, 8-lOp.g of sl-1 
mRNA were still obtained upon transcription in vitro (results not shown). 
An SP6 based vector designed to allow the production of transcripts with 
authentic 5' ends, and therefore containing no vector derived bases, has 
been constructed and found to have no effect on RNA yields (Jobling et 
al., 1988). However, only crude estimates were performed and comparison 
with a "wild type" clone containing a complete SP6 promoter sequence 
was not made.
Inclusion of 2-aminopurine in the reticulocyte lysate translation 
reactions resulted in an increase in the synthesis of c l  (of both serotypes) 
and c3-l (Figure 7.2.5 and Table 7.2.2). The observed increase was 
marginally greater for c l  than for c3. The effect was presumably due to 
inhibition by 2AP of Pl/eIF-2a kinase activation, as has been reported by 
others (Legon et al., 1974 and De Benedetti and Baglioni, 1983). This in 
turn implies that both in vitro transcribed si and s4 messages were 
activating the kinase in the reticulocyte lysate system. Reovirus ss RNA, 
produced by transcription from viral cores and the genomic ds RNA are 
potent activators of this kinase (Samuel, 1979). Later studies revealed that 
si mRNA, but not s4, is an activator of protein kinase Pl/eIF-2a in vitro 
(Bischoff and Samuel. 1989) and that 2AP increases the synthesis of c l  
but not c3 when expressed in vivo by means of plasmid based
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transfections (Samuel and Brody, 1990). The latter, in vivo study, is clearly 
contradictory to the results presented above where a 2AP mediated 
increase of ctl and a3 was noted. The discrepancy may be a consequence 
of the two systems utilised to examine the influence of 2AP on translation. 
In the investigation of Samuel and Brody (1990) cells were transfected 
with plasmids containing the appropriate reovirus cDNA and the cell 
culture treated with 2AP. Expression of the reovirus gene product was 
examined 48 hours after transfection. Between 4-12 hours of exposure to 
2AP was necessary to increase ctI synthesis; no concomitant effect upon 
host cell protein synthesis was noted. Steady state levels of si mRNA were 
also comparable to untreated control cells. Obviously, the action of 2AP is 
more immediate in the reticulocyte lysate system. The opportunity for 2AP 
to potentially interact with factors that may be present in the in vivo 
situation but not in vitro is a possibility and could contribute to the 
increase in a3 translation observed here but not in the aforementioned in 
vivo study. A higher order structure of sl-1 mRNA comprising single and 
double stranded components not possessed by s4 mRNA (Bischoff and 
Samuel, 1989) and /or the possibility that a3 acts as an antagonist of the 
kinase by virtue of its ability to bind RNA (Imani and Jacobs, 1988) was 
proposed by Samuel and Brody (1990) to account for the differential 
effect of 2AP on a l  and ct3 synthesis. However, neither of these 
explanations appear to be applicable to the observations made in this 
study as 2AP did effect an increase in the synthesis of a3.
A fivefold increase in sl-1 mRNA translation efficiency was noted 
by Samuel and Brody (1990) in the presence of 2AP which is slightly 
greater than the threefold increase noted with the reticulocyte translations 
performed in this study. This difference may be due to the relatively high 
concentrations of RNA employed in the in vitro translations (40pg/ml). 
Bischoff and Samuel (1989) found that the optimum concentration of sl-1
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mRNA required for in vitro activation of the kinase was approximately 
lpg/ml and that activity decreased with increasing RNA concentration.
7.4 SUMMARY
An increase in a l-1  expression was effected by the use of plasmid 
pBSSl-lAL in comparison to pBSSl-1. Therefore, the former plasmid was 
used to direct the expression of al-1 in all the appropriate experiments 
described in subsequent chapters. The biochemical 2AP increased the 
efficiencies with which the a l  (and a3) proteins were synthesized in the 
reticulocyte lysate system,. Consequently, it was included in all subsequent 
in vitro translation reactions described in this study unless otherwise 
stated.
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8.1 INTRODUCTION
Weiner et a i (1978) utilized réassortant viruses to identify a l  as the 
viral haemagglutinin and thus as the protein that interacted with 
erythrocytes. A more biologically significant finding regarding the virus- 
host interaction was made by Lee et al. (1981b), who showed that it is the 
virus cell-attachment protein. Here, infected L-cell cytoplasm was used as a 
source of viral proteins from which a l  (of all three serotypes) was the only 
species to bind specifically to monolayers of L-cells. This criterion has been 
used to confirm the identity of a l  when expressed from a variety of 
sources including bacteria (Masri et al., 1986 and Nagata et a i, 1987) and 
vaccinia virus recombinants (Banerjea et a i, 1988) as well as when 
purified from whole virions (Yeung et a i, 1987). All used the method of 
assay originally employed by Lee et a i  (1981b) where a l  was applied to 
cell monolayers and the bound product analysed by SDS-PAGE and 
autoradiography.
In this study it was initially decided to assess the binding activity of 
in vitro expressed a l  to L-cells by means of a "radioactive counts" 
method. Reticulocyte translation products are labelled with 35S- 
methionine. Therefore, appropriate protein products could be bound to 
cells and the relative amounts of bound protein measured by scintillation 
counting. The cell binding assay of Lee el a i (1981b) (described above) 
was also used and became the favoured of the two methods. The 
development of the former method and reasons for switching to the latter 
are described in this chapter.
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8.2 RESULTS
8.2.1 Development of a Direct, Radioactive Counts Assay of the
a l  - L-Cell Interaction
Binding assays described in this section were carried out essentially 
as described in section 2.12.1. The number of radioactive, TCA precipitable 
counts incorporated into each of the in vitro translated proteins to be used 
in the binding assays was known. An equivalent number of counts for 
each protein, that is o l- l ,  al-3 and a3 -l, were diluted into PBS/1% BSA 
and applied to monolayers of L-cells. The BSA was added to prevent non­
specific binding. Two negative controls were used: one was protein ct3-1 
and the other a sample of endogenous lysate where no exogenous RNA 
had been added to the translation reaction mix. For the latter, a volume of 
lysate equivalent to that for the al-1 sample was applied to the monolayers 
as a control for the number of counts bound due to the translation mix 
itself. The amount of radioactive material bound to the cell monolayers was 
then measured for each sample.
In these assays, although more a l  than a3 counts had seemingly 
bound to the cells, the value for the endogenous control was equal to that 
for a l  (data not shown). This was thought to be due to the non- specific 
binding of unincorporated 35S-methionine from the translation reaction.
An assay was therefore performed in which aliquots of the appropriate 
translation mixes were bound in the presence of increasing amounts of 
"cold" (i.e. non-radiolabelled) methionine. A concentration of lOmM 
methionine was found to reduce the endogenous control value to a 
background level; a concomitant reduction in the values for a l  and a3 
was also noticed. Typical binding values in the presence of lOmM 
methionine are shown in Figure 8.2.1. As can be seen, a l-3  bound
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Figure 8.2.1 Cell-Binding Assay of the In Vitro Translated ol 
Proteins
o l- l .  o l-3  and a3-l were in vitro translated in commercial lysate at 
30°C as desribed in section 2.11.1 and the radioactivity associated with 
the TCA précipitable products measured as in section 2.11.2. Volumes 
of each of the lysates containing -  200,000 cpm of TCA précipitable 
protein product were diluted into 100/ri of ice-cold PBS containing \c7c 
BSA and lOmM methionine. These were overlayed on PBS washed 
monolayers of L-cells in 24-well dishes and allowed to bind for 1 hour 
on ice, with intermittent rocking. The binding mixes were then 
removed, the monolayers washed 3 times with cold PBS, once with 
cold sterile distilled water and solubilized in 1M NaOH. This was then 
neutralized with 1M HCI, placed in scintillant and counted in a 
scintillation counter. Duplicate samples of each protein were assayed 
and the data represents the average of two experiments.
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approximately 2.5x as well as al-1 , which in turn bound twice as well as 
the a3 control. Similar data was obtained when the translation reactions 
were subjected to gel filtration to separate protein from the 
unincorporated, labelled methionine (data not shown).
The main points evident from this assay were (i) The apparent level 
of a l  L-cell binding activity was low; (ii) Both type 1 and type 3 a l  were 
more capable of binding to cells than the control protein cr3-l; (iii) The 
o3-l negative control showed a relatively high level of apparent binding 
in comparison to al-1 (approximately 1/2 that of al-1). Since a3-l does 
not appear to be involved in the virus-cell-attachment process, this was 
thought to represent non-specific binding of this protein.
8.2.2 Competition Assays
To demonstrate the specificity of the attachment process, assays 
were carried out with increasing amounts of reovirus in the binding mix, 
the results from which are shown in Figure 8.2.2. The homologous 
serotype virus for each of the species of a l  protein was used owing to the 
uncertainty over whether all three serotypes of reovirus utilize the same 
receptor on L-cells. Conflicting evidence concerning this matter has been 
presented by Lee et al. (1981b), Epstein et al. (1984) and Weiner et al. 
(1988); see also Chapter 9 for further relevant data. Several experiments 
were carried out using both T1 and T3 virus as the competing species; 
however, at amounts of up to 300|ig of added virus, no competition was 
evident for either al-1 or a l-3  (data not shown). This was unexpected 
considering the observations of Lee et al. (1981 b), Masri et al. (1986) and 
Banerjea et al. (1988) who demonstrated that virus was able to inhibit 
binding of homologous type a l  protein.
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Proteins o l- l , c l -3 and a3-l were translated in vitro as described in the 
legend to Figure 8.2.1. Aliquots of each of the reaction mixes equivalent to 
~ 200,000 cpm of TCA precipitable protein product were diluted into 
binding buffer (PBS/l%BSA/10mM methionine) containing increasing 
amounts of homologous type reovirus (0, 5, 10, 25, 50 and lOOpg). These 
mixes were bound to monolayers of L-cells and processed as described in 
section 2.12.1. The endogenous lysate control reaction was not primed 
with exogenous RNA and a volume of this lysate equal to that for the al-1 
translation mix was assayed; type 3 reovirus was the competing species. 
The graph opposite represents the average of duplicate samples. The 
pattern of results seen in replicates of this experiment was the same as 
shown here.
F igure  8.2.2 Com petition Assay Involving In V itro  T ranslated
R eovirus Proteins and Reovirions
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8.2.3 Oligom erization of P rotein a l
Two reports, originating from the same laboratory concerning a l 
appeared relevant to the results presented above. One of the studies had 
investigated the oligomeric nature of a l  (Leone et al., 1991b) and the 
other its function as a cell-binding protein (Duncan et al., 1991). 
Importantly, both had expressed a  1-3 in a similar fashion to this study, that 
is, in reticulocyte lysate utilizing RNA transcribed from a cloned copy of 
the S I-3 gene. However, both reported an incubation temperature of 37°C 
for the a l  in vitro translation reactions, not the 30°C recommended in the 
accepted protocol (Pelham and Jackson, 1976 and Jackson and Hunt,
1983); thus far, a temperature of 30°C had been employed in this study. 
Both studies reported SDS-PAGE analysis of the a l  proteins under non­
dissociating conditions, i.e. incubation in sample buffer at 37°C prior to 
electrophoresis as originally defined by Bassel-Duby et al. (1987). These 
analyses revealed the presence of monomeric and oligomeric forms of the 
protein. Also, unpublished data referred to in these reports (later published 
in Leone et al., 1991a) stated that only oligomers were capable of binding 
to L-cells. As specific attachment to cells had not thus far been observed in 
this study, it seemed pertinent to examine the oligomeric nature of a l  
synthesized at 30°C and 37°C and to determine its significance in relation 
to the protein's cell-binding ability. This is described in the remainder of 
this chapter.
8.2.3.1 Comparison of a l Oligomerization at 30°C and 37°C
The quaternary structure of a l  was examined at the two 
temperatures of 30°C and 37°C, (essentially as described by Leone et al., 
1991b and Duncan et al., 1991) and the results are shown in Figure 8.2.3.
Figure 8.2.3 Oligom erization of a l  Proteins a t 30°C and 37°C
Plasmids pBSSl-lAL and PG3T3 were transcribed in vitro to produce si -1 
and s i-3 mRNA respectively. These RNAs were translated in vitro at 30°C 
or 37°C for 60 minutes in a commercial reticulocyte lysate as described in 
2.11.1; each reaction mix was then diluted lOx in PBS. Duplicate samples 
from each of the 30°C reactions were added to sample buffer and 
incubated at either 30°C or 37°C for 30 minutes. Aliquots of the 37°C 
reactions were mixed with sample buffer and incubated for 30 mins, at 
37°C only. All samples were then electrophoresed on a 10% SDS- 
polyacrylamide gel as described in section 2.11.4. Fluorography of the gel 
was carried out as detailed in section 2.11.5. A photograph of the 
processed gel is shown opposite. Radiolabel led reovirus polypeptides 
(prepared as described in section 2.2.5) were electrophoresed as size 
markers, lane R; lane U represents an uninfected cell lysate for comparison. 
Endogenous lysate mixes (i.e. reactions primed only with the endogenous 
lysate RNA) were treated as described above for the a l  translations and 
acted as controls.
Lanes A and B = 
Lanes D and J = 
Lanes E and K = 
Lane G =
Lane H =
Lanes C, F and I =
in vitro translated al-1  and a  1-3 repectively, boiled in
sample buffer before SDS-PAGE
al-1 synthesized at 30°C and incubated in sample
buffer at 30°C and 37°C respectively
a  1-3 synthesized at 30°C and incubated in sample
buffer at 30°C and 37°C respectively
al-1 synthesized at 37°C and incubated in sample
buffer at 37°C
al-3  synthesized at 37°C and incubated in sample 
buffer at 37°C
endogenous lysate treated as samples in lanes D, G 
and J respectively.
The major oligomeric species are arowed.
R U A B C D E F G H  I J K
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Lanes E and K represent ol-3 protein that was translated in reticulocyte 
lysate at 30°C and incubated in sample buffer at 30°C or 37°C 
respectively. Two major oligomeric species are present in both tracks, 
although the latter temperature appears to have induced the formation of a 
slightly greater number of oligomers. Lane H shows the result of carrying 
out both the translation reaction and subsequent incubation at 37°C. The 
highest degree of oligomerization is evident with this sample and two 
major species of a  1-3 oligomer are also evident. The significance of these 
different oligomeric species became apparent later when their ability to 
bind to cells was investigated (section 8.2.4). Oligomers of al-1  were not 
observed under any of the conditions used (lanes D, G and J).
8.2.3.2 Effect of Sample Buffer on Oligomerization
From the results in section 8.2.3.1, it was seen that oligomers of al-3 
were formed at 30°C although not as efficiently as when the translation 
and subsequent incubation in sample buffer were both carried out at 37°C. 
Thus, oligomerization appeared to be influenced by temperature. The 
oligomers of al-3  were the putative cell-binding species but despite their 
presence in the 30°C translation reactions, specific binding to L-cells had 
not been observed (section 8.2.2). It was considered possible that the 
sample buffer was not only stabilizing those molecules from the lysate that 
possessed quaternary structure but was also promoting their formation. 
Hence, the relative amounts of oligomers observed in the SDS-PAGE 
analysis above (Figure 8.2.3) may not have been representative of the 
amounts in the lysate. This in turn would imply that only small amounts 
were present in the 30°C reactions. Therefore, the effect of sample buffer 
on the oligomerization process was determined in the experiments 
described overleaf.
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In vitro translations of a  1-3 were performed at 30°C and 37°C. 
Aliquots of these reaction mixes were analysed by SDS-PAGE either 
directly or following incubation in sample buffer at their respective 
temperatures; the former conditions precluded a sample buffer step. The 
autoradiograph resulting from this analysis is shown in Figure 8.2.4. Very 
little oligomerization of ol-3 was evident when it was synthesized at the 
lower temperature with or without subsequent incubation in sample buffer 
(lanes C and D). However, at an in vitro translation temperature of 37°C, 
significant quantities of oligomers were formed irrespective of incubation 
in sample buffer incubation, although this did increase the relative amount 
of the higher order structure, lanes E and F. The samples in lanes E and F 
originate from another gel which accounts for the different migration 
patterns of the monomeric and oligomeric species compared to the 30°C 
samples (lanes C and D).
Hence, the sample buffer appeared to be aiding the formation of 
quaternary structures for a l-3  following its synthesis at 37°C.
The time course of oligomer formation was next followed, which 
also confirmed the effect of the sample buffer. A translation primed with 
a l-3  mRNA was incubated at 37°C and duplicate samples were taken at 
various intervals. These were either incubated in sample buffer for 30 
minutes or snap frozen in dry ice. All of the samples were then analysed by 
SDS-PAGE with the frozen samples thawed and mixed with sample buffer 
immediately prior to loading. This gel is shown in Figure 8.2.5. Only 
monomeric species were present after 5 minutes of reaction time and 
thereafter a mixture of monomers and oligomers were evident. The relative 
amounts of the oligomers were greatly increased by the incubation in 
buffer; compare lanes F and G and H and 1 for example. However, the 
maximum amount of oligomerization was achieved after 30 minutes of
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F igure  8.2.4 The Effect of Sample Buffer on the O ligom erization
Protein al-3  was translated in vitro at 30°C and 37°C and diluted in PBS 
as described in the legend to Figure 8.2.3. Duplicate aliquots from each of 
these reactions were either incubated in sample buffer for 30 minutes at 
37°C (non-dissociating conditions) or stored on ice for 30 minutes before 
the addition of sample buffer. All samples were then analysed by SDS- 
PAGE (section 2.11.4) and the gel treated as in section 2.11.5. The 
resulting autoradiograph is shown opposite.
Lane R = Reovirus infected cell lysate 
Lane A = al-1 (boiled in sample buffer)
Lane B = a l-3  (boiled in sample buffer)
Lane C = a l-3  translated at 30°C, stored on ice
Lane D = a l-3  translated at 30°C, incubated in sample buffer
Lane E = a l-3  translated at 37°C, stored on ice
Lane F = a l-3  translated at 37°C, incubated in sample buffer
NOTE : Samples represented in Lanes E and F are derived from a separate
gel to the those in the other lanes.
Figure 8.2.5 Time Course o f a l - 3  Oligomerization
An in vitro translation reaction mix was primed with s i-3 mRNA and 
incubated at 37°C for 60 minutes. At intervals during the incubation, 
duplicate aliquots of the mix were removed and either snap frozen on dry 
ice or diluted lOx in PBS and incubated under non-dissociating conditions 
(that is, in sample buffer at 37°C) for 30 minutes. After the final incubation 
period, the frozen aliquots were mixed with sample buffer and all samples 
were then analysed by SDS-PAGE (section 2.11.4). A sample of the a l-3  
reaction mix was boiled in sample buffer before electrophoresis to act as a 
size marker. The autoradiograph of the processed gel (section 2.11.5) is 
shown opposite.
Lane R = Reovirus infected cells
Lane A = Endogenous lysate
Lane B = 0 minute sample, snap frozen
Lane C = 0 minute sample, incubated in sample buffer (ISB)
Lanes D and E = 5 minute sample, snap frozen or ISB respectively
Lanes F and G = 10 minute samples, snap frozen or ISB respectively
Lanes H and I = 20 minute samples, snap frozen or ISB repectively
Lanes J and K = 30 minute samples, snap frozen or ISB respectively
Lanes L and M = 40 minute samples, snap frozen or ISB respectively
Lanes N and O = 50 minute samples, snap frozen or ISB respectively
Lanes P and Q = 60 minute samples, snap frozen or ISB respectively
Lane S = boiled al-3
R A B C D E F G H  I J K L M N O P Q S
A »rB*B*rS*
M
189
synthesis, after which a small decrease was observed. It is important to 
note that significant amounts of the multimers were formed at 37°C in the 
lysate reaction mix alone in contrast to the situation at 30°C. In addition to 
the two previously observed oligomeric species there is another that 
migrates just below the position of the reovirus X. proteins at aproximately 
150 kDa, whose presence is abrogated by incubation in sample buffer; 
compare lanes F and G for example. This was initially thought to be an 
alternative order of oligomer. Further discussion concerning this issue is 
presented in section 11.1 of the General Discussion (Chapter 11).
To be certain that the oligomers were composed of the monomeric 
species, the bands corresponding to the two major, slower migrating 
multimers were excised from the gel and analysed under dissociating 
conditions. Both oligomeric species dissociated to give bands that 
comigrated with a l-3  protein that had been in vitro translated and 
denatured in sample buffer before electrophoresis (data not shown). The 
oligomers were therefore unlikely to be artifacts of the non-dissociating 
conditions.
8.2.4 Binding of the Monomeric and Oligomeric Species to L-Cells
The result of the time course assay described in section 8.2.3.2 
suggested a means by which the cell-binding abilities of the a l-3  
monomers and oligomers could be ascertained. It was noticed that after 5 
minutes of synthesis in the reticulocyte lysate only the former species was 
present and thereafter a mixture of both; thus, monomers could be 
produced as a separate species. Accordingly, al-3 in vitro translations 
were carried out for various time intervals between 5-30 minutes and the 
reaction mixes assayed on monolayers of L-cells at 4°C. Aliquots of the 
translated protein and the bound and unbound species were subjected to
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SDS-PAGE and the result is shown in Figure 8.2.6. Unexpectedly, 
monomers were not formed after 5 minutes (lane A) and so were not 
assayed for their cell-binding ability in isolation from the oligomers. 
However, lanes E-H revealed that only oligomers were able to bind to cells, 
with the monomers present in the unbound material (lanes J and K). 
Furthermore, it appeared that it is mainly the slowest migrating oligomeric 
species that exhibits cell-binding activity, although some activity was 
apparent for the minor, approximately 150 kDa structure (compare lanes G 
and H with J and K).
Protein al-1 was similarly assayed with the exception that only a 
single time of translation was examined. The autoradiograph resulting from 
this assay is shown in Figure 8.2.7 and revealed that al-1 was unable to 
bind to L-cells.
8.2.5 Oligomerization of al-1
The results above [and of Leone et al., (1991a) and Duncan et al., 
(1991)] show that oligomerization of the a l-3  protein is necessary for it to 
bind to L-cells. The type 1 protein was only present as a monomer when 
translated in vitro and exhibited no cell-binding activity. Therefore, it 
seemed reasonable to believe that al-1 could manifest a cell binding 
function if the protein was to oligomerize.
Two approaches were taken in an effort to cause the type 1 
monomers to attain the relevant quaternary stucture; these are described in 
sections 8.2.5.1 and 8.2.5.2.
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Figure 8.2.6 SDS-PAGE Analysis of the Species of a l-3  
Exhibiting L-cell Binding Activity
Protein a l-3  was translated in a commercial reticulocyte lysate at 37°C. 
25|il aliquots of the reaction mix were removed after 5, 10, 20 and 30 
minutes of the incubation period and diluted into 200pl of PBS. lOOp.1 of 
these mixes were then assayed on monolayers of L-cells as described in 
section 2.12.2 and the remainder was stored on ice. After the assay, each of 
the binding mixes was placed on ice; this represented unbound material. 
Aliquots of the translated protein (that had been stored on ice), the cell- 
bound the unbound material were incubated in sample buffer under non­
dissociating conditions and analysed by SDS-PAGE as described in 
sections 2.11.4 and 2.11.5. The resulting autoradiograph is shown
opposite.
Lane R = Reovirus infected cells
Lane U = Uninfected cells
Lane A = 5 minute sample “ ““l
Lane B = 10 minute sample
Lane C = 20 minute sample
Lane D = 30 minute sample 1
Lane E = 5 minute sample
Lane F = 10 minute sample
Lane G = 20 minute sample
Lane H = 30 minute sample 1
Lane I = 5 minute sample ——"I
Lane J = 10 minute sample
Lane K = 20 minute sample _ J
Translation
Cell-bound
Unbound
There was not sufficient room on the gel for the analysis of the 30 minute 
unbound sample.
R U A B C D E  F G H  I J K
Figure 8.2.7 al-1 : L-cell Binding Assay
Plasmid pBSSl-lAL was in vitro transcribed to produce sl-1 mRNA. This 
was utilized to prime a reticulocyte lysate reaction that was incubated at 
37°C for 30 minutes. The al-1 protein thus produced was bound to 
monolayers of L-cells and analysed by SDS-PAGE under non-dissociating 
conditions as described in section 2.12.2; a sample of the unbound material 
(i.e. the binding mix resulting from the 1 hour's incubation with the cells) 
was similarly electrophoresed. Reovirus infected cells were prepared as in 
section 2.2.5. The autoradiograph resulting from this analysis is shown
opposite.
Lane R = Reovirus infected cells
Lane U = Uninfected cells
Lane A = Cell-bound sample
Lane B = Unbound sample
8.2.5.1 Attempts to Produce Hetero-oligomers
The first approach involved an attempt to form hetero-oligomers 
between the typel and 3 proteins by translating them separately, mixing 
together aliquots from each reaction and then incubating the mix in sample 
buffer at 37°C. The a  1-3 translation reaction was performed with cold 
methionine and the a l-1  with the radiolabelled amino acid. However, no 
oligomeric species were visible after SDS-PAGE analysis. The two 
messages were then co-translated. Under these conditions virtually no 
oligomers were formed, implying that al-1 was preventing the usual 
associaion of al-3 monomers into their oligomeric forms.
8.2.5.2 Construction of an S1-3/S1-1 Hybrid Clone
The N-terminal half of the a l  protein has been postulated to assume 
a coiled-coil configuration and hence be responsible for causing (at least in 
part) the oligomerization of a l  (Bassel-Duby et al., 1985 and Nibert et al., 
1990). That it possessed an intrinsic oligomerizing property was later 
demonstrated experimentally for the type 3 protein (Banerjea and Joklik, 
1990 and Leone et al., 1991b;c). It was therefore decided to generate a 
hybrid protein where the N-terminal 1/3 of a l-3  would be fused to the C- 
terminal 2/3 of al-1 by manipulation of the respective genes. The cell­
binding properties of a l  apparently reside within the C-terminal half of the 
protein (Nagata et al., 1987 and Yeung et al., 1989). Thus, it was hoped 
that the protein resulting from the expression of this hybrid gene would 
oligomerize but retain the cell-binding properties of the type 1 protein.
All three reovirus SI genes are highly diverged (Gaillard and Joklik, 
1983; Cashdollar et al., 1985; Duncan et al., 1990 and Nibert et al., 1990) 
which prevented an exact replacement of the two N-terminal regions.
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However, it was possible to create an in frame hybrid with just 23 extra 
amino acids and Figure 8.2.8 represents schematically the strategy adopted 
to produce this clone. A fragment corresponding to approximately the 5'
1/3 of the SI-3 gene was removed from plasmid pG3T3 with the 
appropriate restriction enzyme digests and DNA modification reactions. 
The remaining vector/gene fragment was then purified. A fragment of 
plasmid pBSSl-lAL corresponding to the 3' 2/3 of the S1 -1 gene isolated 
and ligated to the pG3T3 vector/gene fragment to create the hybrid clone 
pGT3Sl-l. Plasmid DNA was prepared from the putative recombinant 
clones and screened by the appropriate restriction enzyme digest analysis 
to identify this hybrid.
8.2.5.2.1 Oligomerization and Cell Binding Ability of pGT3Sl-l
In vitro transcribed mRNA from clone pGT3Sl-l was translated in 
reticulocyte lysate and analysed by SDS-PAGE under dissociating (boiled 
in sample buffer) and non-dissociating (incubated at 37°C in sample 
buffer) conditions to ascertain that a full-length ctI hybrid polypeptide 
could be produced and that it was capable of oligomerizing. The resulting 
autoradiograph is shown in Figure 8.2.9 and demonstrates the apparent 
full length nature of the protein which, as expected, is larger than a  1-3 (see 
lanes A and C for a comparison). It also formed two major oligomeric 
species (lane D) which were slightly larger than their a l-3  counterparts. 
The N-terminal region of a l-3  therefore appeared to have conferred upon 
the hybrid molecule the capacity to oligomerize.
The ability of this protein to attach to L-cells was next examined 
and it was found to be unable to bind (Figure 8.2.10). Thus, the ability of 
the hybrid molecule to oligomerize appeared to be insufficient for the 
proposed cell binding region of al-1 to manifest cell binding activity.
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Figure 8.2.8 Construction of pGT3SI-l
Plasmid pG3T3 was digested with restriction enzyme Ncol and the ends of 
the DNA were filled by Klenow polymerase 1 before digestion with Xbal 
(which cuts in the 3' polylinker). The large, vector fragment containing the 
5' SI-3-terminus was then purified fom an agarose gel as described in 
section 2.9.1. Plasmid pBSSl-lAL was digested with the enzyme EcoRI 
and the ends made flush as with pG3T3 before Xbal digestion to release the 
3' - 2/3 of the S I-1 gene. This fragment was isolated from an agarose gel and 
ligated to the pG3T3 vector fragment to give the recombinant pGT3Sl-l. 
Shown below the map of the hybrid gene is a cartoon depicting the 
proposed morphological domains contributed by each portion of the hybrid 
gene based on the assignments for authentic a l  by Nibert et al. (1990); see 
also Figure 1.4.1. The extensions to the stalk are the main features to note 
and are marked with an asterisk (details given in the text).
Key to a l  cartoon
= C-terminal globular head
= Cross-P sheet
= a-helix
fragment
SP6 3* pGT3S1-1
S1-1 S 1 - 3
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Figure 8.2.9 SDS-PAGE Analysis of the Hyrid a l Protein
In vitro transcriptions were carried out utilizing plasmids pG3T3 and 
pGT3Sl-l as templates to produce the appropriate si mRNA. The 
corresponding a l  proteins were synthesized in a commercial reticulocyte 
lysate as described in section 2.11.1 with the exception that the reaction 
was performed at 37°C for 30 minutes. Duplicate samples of each protein 
were either heated to 100°C in sample buffer or incubated at 37°C for 30 
minutes in sample buffer before SDS-PAGE (as described in section 2.11.4). 
The resulting gel was processed by fluorography (section 2.11.5). A 
photograph of the processed gel is shown opposite. (Reovirus infected 
cells were prepared as in section 2.2.5)
Lane R = Reovirus (T3) infected cells
Lane U = Uninfected cells
Lane A = a  1-3 incubated at 100°C
Lane B = a l-3  incubated at 37°C
Lane C = Hybrid a l  incubated at 100°C
Lane D = Hybrid a l  incubated at 37°C
Lane R' = Reovirus (Tl) infected cells
Figure 8.2.10 
Protein
Assay of the Cell-Binding Ability of the Hybrid a l
The hybrid-type a l protein was synthesized in vitro as described in the 
legend to Figure 8.2.9. This was subsequently assayed for L-cell-binding 
activity as described in section 2.12.2; the resulting "cell-bound" sample 
was incubated under non-dissociating conditions before SDS-PAGE. A 
photograph of the processed gel is shown opposite.
Lane R = Reovirus infected cells
Lane U = Uninfected cells
Lane A = Cell bound sample
8.3 DISCUSSION
The expression of full length a l  proteins from cloned copies of the 
Sl-1 and S I-3 genes had been achieved (Chapters 5-7). However, no firm 
evidence of the cell-binding functions of these proteins was at first 
obtained, typified in assays where homologous virus did not prevent the 
apparent attachment of either serotype of a l  protein to L-cells. Thus, the 
apparent binding was probably non-specific. Two reports by Lee and co­
workers, Leone et al. (1991b) and Duncan et al. (1991), demonstrated the 
formation of al-1 oligomers when synthesized in reticulocyte lysate at 
37°C; both authors also alluded to experiments in which a l  was only able 
to bind to cells as an oligomer. This suggested that possibly, oligomers 
were not formed at 30°C which would subsequently account for the 
apparent non-specific binding of the a l  proteins initially observed in this 
study.
The formation of a l oligomers in reticulocyte lysate reaction mixes 
incubated at 30°C and 37°C was therefore investigated. SDS-PAGE 
analyses under non-dissociating conditions revealed that very little 
oligomerization occurred at 30°C without incubation in sample buffer at 
37°C, whilst in reactions carried out at 37°C this process was obvious but 
greatly enhanced by the subsequent action of sample buffer (at the same 
temperature). This should be qualified by stating that only the type 3 
protein oligomerized; type 1 remained as monomers under all the 
conditions employed. Two major oligomeric species that migrated close to 
the top of the gel were always observed in these assays, although a faster 
migrating approximately 150 kDa complex was sometimes visualised. 
Subsequent binding assays utilizing protein translated at 37°C revealed 
that only the oligomeric form and more specifically, mainly the slowest 
migrating species was able to bind to L-cells. A similar observation was
made by Leone et al. (1991a). Hence, oligomerization of a l-3  appears to 
be necessary for manifestation of the protein's cell-binding ability. The 
relevance and possible relationship between the different sized oligomers 
is discussed more fully in the General Discussion, Chapter 11.
These results therefore suggest that the temperature at which the 
a l-3  protein is synthesized influences the oligomerization process, at least 
in vitro. Possibly, the folding of the monomers and any subsequent 
intersubunit interactions is a largely inefficient process at 30°C. In an in 
vivo study by Bassel-Duby et al. (1987), reovirus infected L-cells that had 
been maintained at 34°C served as a source of a l  protein. Oligomerization 
of the purified a l  under non-dissociating conditions was shown to be 
extremely efficient, with the monomeric species barely evident. Such 
complete oligomerization was never observed in this study. Hence, in 
addition to the possible temperature dependence of the process, oligomer 
formation in vivo appears to be a more efficient process compared to that 
observed in vitro. It is possible that factors (or a factor) not present or 
present in limiting concentrations in the reticulocyte lysate may result in 
only a small amount of oligomers being able to form.
Thus, the greatly reduced number of oligomers formed when 
translations are carried out at 30°C would seem to account for the putative 
non-specific binding observed in the initial binding assays.
The monomeric type 1 a l protein did not manifest a cell-binding 
ability. However, Duncan et al. (1991) have demonstrated binding of al-1 
to L-cells but evidence of its oligomeric status was not given or 
commented upon. The reasons for this discrepancy are unclear, especially 
as Duncan et al. (1991) expressed al-1 in a similar way to that utilized in 
this study.
As al-1 was only able to form monomers, an attempt was made to 
oligomerize the protein with the aim of promoting the cell-binding activity
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of the protein. An S1-3/S1-1 hybrid gene was therefore created by fusing 
the 5’ 1/3 of the SI-3 gene to the 3' 2/3 of S1 -1; these two gene fragments 
encode the oligomerizing (heptad repeat) region and cell-binding domain 
of the type 3 and type 1 proteins respectively. The a l  hybrid protein 
derived by the in vitro expression of this gene was able to form oligomers 
but was unable to bind to L-cells. Together with the data concerning a  1-3, 
this suggests that oligomerization is necessary but not sufficient for a l  to 
manifest its cell-binding ability (in agreement with a deletion mutant study 
by Duncan et al., [1991]). The studies with the hybrid molecule also show 
that the N-terminal one-third of a l-3  possesses intrinsic oligomerizing 
properties as previously demonstrated by Banerjea and Joklik (1990) and 
Leone et al. (1991b;c) and that it does not possess a cell binding function, 
which is in agreement with its role in anchoring a l  to the virion (Mah et 
al., 1990 and Leone et al., 1991c).
The inability of the hybrid molecule to manifest a cell-binding 
function may have been the result of a conformational effect. A perfect, 
non-overlapping hybrid could not easily be created, resulting in a molecule 
with an N-terminal region elongated by 23 amino acids (Figure 8.2.8) 
compared to the type 1 protein. This overlap causes an interruption in the 
coiled-coil and cross-P sheet morphological domains that constitute the N- 
terminal fibrous rod or stalk (Fraser et al., 1990 and Nibert et al., 1990). It 
is feasible that this could affect the folding of the C-terminal head region 
by preventing required folding interactions or possibly promoting 
incorrect interactions between these two regions. Alternatively, the correct 
folding of an intact a l  molecule may be dependent upon interactions with 
specific residues of the N-terminal region. In the hybrid molecule, this 
region is a type 3 structure unlike the remainder of the protein. Thus, 
although the al-3  N-terminal domain enabled the hybrid protein to 
oligomerize, other important folding processes may not have been induced.
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8.4 SUMMARY
In vitro translation of a l  in a reticulocyte lysate at 37°C was 
necessary to promote oligomerization of the protein; further incubation in 
sample buffer increased the amount of oligomerization; only the oligomeric 
form of al-3  exhibited cell-binding properties and al-1 was unable to bind 
to L-cells as either a monomeric or oligomeric species.
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9.1 INTRODUCTION
One of the first steps in the replicative cycle of a virus is attachment 
to the host cell, a process which is generally accepted as occurring via 
specific receptor sites or moieties on the cell surface. The presence of a 
given receptor molecule is often important in determining whether a cell is 
permissive for infection and hence may be a major factor in determining the 
tissue tropism and virulence properties of the virus.
Evidence for a defined, homogeneous population of receptor 
molecules is usually obtained by demonstrating specific, saturable binding 
of a virus to the host cell. This has been reported for reovirus attachment to 
a variety of cell types, including L-cells (Armstrong et al., 1984 and 
Epstein et al., 1984), rat pituitary cells (Maratos-Flier et al., 1983) and rat 
endothelial cells (Verdin etal., 1989), see also Table 1.6.1. All these studies 
utilized radiolabelled virions in the binding assays. However, in this study, 
in vitro synthesized a l was used o analyse the cell-binding process more 
closely. For this approach to be of relevance to the situation involving 
virus particles, the cell-binding properties of a l had to reflect that of native 
virions and bind in a specific, saturable manner to the chosen host cells, 
which in this case was L-cells.
In this chapter, some of the parameters of the in vitro translated 
a  1-3 - L-cell binding interaction are described.
9.2 RESULTS
9.2.1 Time Course of the Binding Process
A simple kinetic analysis of the a  1-3 - cell-attachment process was 
undertaken as the 1 hour binding period of the previously performed 
binding assays had been based on the methods of Lee et al. (1981b) and 
Duncan et al. (1991). All binding assays were carried out at 4°C (as 
before) to prevent internalization of the ligand. Accordingly, aliquots of a 
translation reaction mix containing a l-3  were overlayed on monolayers of 
L-cells for various lengths of time and the proportion of bound material 
examined by SDS-PAGE, as shown in Figure 9.2.1. After 30-45 minutes 
approximately half of the protein that was able to bind had done so and by 
90 minutes essentially all of this material had bound as further incubation 
had not significantly increased the intensity of the bound al-3 .
It was possible that the relative concentration of a  1-3 in the 
translation mix was limiting and that an increase in binding after 90 
minutes would have been noticed if more protein had been present in the 
assay mixes. Alternatively, saturation of the receptor sites could have been 
achieved (although this did seem unlikely given the relatively small 
amount of protein synthesized in the lysate). Another assay was therefore 
performed to examine these alternatives. A similar volume of translation 
mix to that described in Figure 9.2.1 was bound to L-cells for 1 hour, after 
which it was transferred to a second monolayer for 1 hour and so on for a 
further two occassions. Thus, in total, four consecutive bindings with the 
same mix were performed and the result is shown in Figure 9.2.2. As 
observed previously, most of the a l-3  had bound after 1 hour although a 
little more did bind to the second monolayer; virtually no bound material
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Figure 9.2.1 Time Course of a l  A ttachm ent to L-cells
s i-3 mRNA was transcribed in vitro from plasmid pG3T3 and the encoded 
al-3  protein translated in a commercial reticulocyte lysate at 37°C for 30 
minutes. This reaction mix was diluted eightfold into PBS and lOOpl bound 
to monolayers of L-cells for periods of time ranging between 15-240 
minutes as described in section 2.12.2. Cell bound protein was analysed by 
SDS-PAGE under non-dissociating conditions (37°C for 30 minutes in 
sample buffer) essentially as described in section 2.11.4. A photograph of 
the fluorographed gel (carried out as in section 2.11.5) is shown opposite. 
The numbers at the top of each lane represent the length of time the 
samples were bound to the cell monolayers.
Reovirus infected cells were prepared as in section 2.2.5, the viral 
polypeptides in which acted as size markers; many host cell proteins are 
also evident in this lane (R) probably due to an incomplete shut-off of host 
cell protein synthesis. Lane U represents an uninfected cell lysate for 
comparison.
Figure 9.2.2 Consecutive M onolayer Binding Assay
Protein c l -3 was in vitro translated and diluted into PBS as described in 
the legend to Figure 9.2.1. 100(0.1 of this diluted binding mix was then 
overlayed on a monolayer of L-cells for 1 hour, after which it was removed 
and applied to a second monolayer for a further hour. This was repeated 
for a further two monolayers. During the 1 hour cell incubation periods, the 
preceding monolayers were washed, solubilized, incubated in sample 
buffer under non-dissociating conditions and placed on ice until the final 
monolayer had been processed. An aliquot of the remaining unbound 
material was similarly incubated in sample buffer. All samples were 
subjected to SDS-PAGE and the gel processed as in Figure legend 9.2.1. 
The resulting autoradiograph is shown opposite.
Lane R Reovirus infected cells
Lane A First binding
Lane B Second binding
Lane C Third binding
Lane D Fourth binding
Lane E Unbound sample
was evident on the 3rd and 4th consecutive monolayers. Future binding 
assays were carried out for 1 hour on the basis of these two experiments.
The presence of a relatively intense oligomer band in the unbound 
material (Figure 9.2.2, lane E) that comigrated with the cell-bound species, 
indicates that the monolayers were not saturated but that all of the protein 
capable of binding had probably done so; the rest of this oligomeric 
species present in the translation mix was possibly in an incorrect 
conformation to bind. It was also possible that the amount of oligomer in 
the unbound sample was over-represented on the gel. It had been 
incubated in sample buffer under non-dissociating conditions prior to SDS- 
PAGE and these conditions appear to increase the relative amount of 
oligomer in a  1-3 translation reaction mixes, (Figure 8.2.5). This gel also 
demonstrates that, as observed before, (Figure 8.2.6) it is mainly the 
slowest migrating oligomeric species that binds to the cells.
9.2.2 Saturation of Receptor Sites
The saturation of the binding sites for protein ctI -3 was next 
investigated. Increasing amounts of in vitro translated a  1-3 were bound to 
cells for 1 hour in an attempt to saturate the appropriate binding sites. 
Bound material was analysed both by SDS-PAGE (result not shown) and 
by directly counting aliquots of the resulting solubilized monolayer in a 
scintillation counter, the results of which are presented graphically in 
Figure 9.2.3. As can be seen, perhaps surprisingly in view of the amount of 
protein normally made in vitro, saturation was possible.
To calculate the number of "counts bound" that represents 
saturation of the receptor sites, the data was converted to a Scatchard 
format, shown as an inset figure in the larger graph. The intercept on the x 
axis is equivalent to the counts bound at saturation and a value of
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Figure 9.2.3 S atu ra tion  of L-cell Binding Sites for a l-3
a) Protein a l-3  was translated in vitro as described in Figure legend 9.2.1 
but was not diluted immediately into PBS. Increasing volumes of the 
reaction mix were diluted into lOOpl of PBS up to a maximum of lOOpl of 
lysate (which was not diluted at all). The samples were then bound to 
monolayers of cells and the cell-membranes solubilized in 100|il of 0.5% 
NP40 as described in section 2.12.2. lOpl of each sample was placed in 
scintillant and counted. These results are shown in the graph below. The 
linear region was converted to a Scatchard format and this data is shown 
in the inset graph
The Scatchard data was utilized to calculate the number of L-cell binding 
sites for al-3 . This calculation is shown opposite.
Intercept on x axis of Scatchard plot = no. counts bound at saturation
= 176, OOOcpm
Specific activity of 35S methionine = 1000 Ci/mmole (or 1 pCi/pmole) 
Concentration of 35S methionine: 66pl = 1 mmole or 15pmole/p.l 
Concentration of cold methionine in the lysate = 5p.M or 5pmoles/pl 
Ratio of cold : hot methionine in reaction mix = 17:1
= (17x5): (1x15)
= 5.6: 1
lpCi = 2.2 x 106 dpm 
8 methionines per molecule of al-3  
1/10th of sample counted
Therefore, no. pmoles a l-3  = 176.000 x 10 x 5.6
(2.22 x 106) x 8 
= 0.55 pmoles a l-3
No. molecules al-3  = 0.55 x 6.023 xlO23 (Avogadro's No.)
" " = 3.0 x 1011
There are ~ 5 x 105 cells/monolayer 
Efficiency of counting of 35S met = 70%
No. receptor sites/cell = 3.0 xlO11 x 100
5 x10s 70 
= -  8.57 x 10s
If a l-3  is a trimer, no. receptor sites = 2.86 x 10s 
If a l-3  is a tetramer, no. receptor sites = 2.14 x 10s
The efficiency of counting of 35S met was determined in essentially the 
same manner as for 3H-UTP in section 2.10.3.
b) Calculation of the N um ber of a l - 3  Receptor Sites
2 0 9
176,000 cpm was obtained. This value was used to calculate the number of 
a l-3  receptor sites/cell and figures of approximately 2.8 x 105 or 2.1 x 105 
receptor sites/cell were derived if al-3  binds as a trimer (as proposed by 
Leone et al., 1991a) or a tetramer (as proposed by Bassel-Duby et al.,
1987; Fraser et al., 1990 and Nibert et al., 1990) respectively. The 
calculation used to obtain these numbers is given in legend b to Figure 
9.2.3. The structural order of the oligomer, i.e. a trimer or tetramer is 
discussed further in section 11.1.1.
9.2.3 Specificity of the Binding Process
The specificity of the cell attachment of a l  was assessed by 
competition assays in which the in vitro translated protein was bound to 
cells in the presence of virus; if protein and virus utilize the same receptor 
then an excess of virus should inhibit binding of a l .
Binding assays were performed in which aliquots of translation mix 
contained increasing amounts of type 3 reovirus. Bound material was 
analysed by SDS-PAGE and as can be seen in Figure 9.2.4, increasing the 
amount of virus in the binding mix resulted in an increasing inhibition of 
binding until virtually complete inhibition was achieved at the two highest 
concentrations of virus employed. The small amount of a l-3  bound with 
these two amounts of virus probably represented non-specific binding.
A similar assay was performed with type 1 virus as the competing 
species, the result of which is shown in Figure 9.2.5. Here, very little 
competition is evident and only with the highest concentration of virus 
employed. This could be due to a non-specific blocking effect of the high 
concentration of virus impairing the interaction of protein with its receptor. 
Together, these experiments suggest that the T1 and T3 virus bind to 
different receptors on the same cell type.
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cl-3  was translated in vitro as described in Figure legend 9.2.1 and diluted 
sixfold into PBS. A twofold dilution series of reovirus T3 was made (in 
PBS). 20p.l of each virus dilution was added to 50pl aliquots of the c l -3 in 
vitro translation reaction and the volume made up to 100p.l with PBS. 
These mixes were then bound to monolayers of L-cells for 1 hour and 
analysed by SDS-PAGE under non-dissociating conditions as described in 
section 2.12.2. A photograph of the resulting autoradiograph is shown
Figure 9.2.4 c l-3  : Reovirus Type 3 Com petition Assay
opposite.
Lane R Reovirus infected cells
Lane A c l -3 vs Opg T3 virus
Lane B c l -3 vs lOpg T3 virus
Lane C c l -3 vs 20pg T3 virus
Lane D c l -3 vs 40|i.g T3 virus
Lane E c l -3 vs 80pg T3 virus
Lane F c l -3 vs 160pg T3 virus
r A B O D E  F
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Figure 9.2.5 a l-3  : Reovirus Type 1 Com petition Assay
Protein al-3  was competed against reovirus T1 exactly as described for the 
T3 virus in Figure legend 9.2.4. The positions of reovirus proteins co- 
electrophoresed as size markers are indicated.
Lane A a l-3  vs Opg T1 virus
Lane B a l-3  vs lOpg T1 virus
Lane C a l-3  vs 20pg T1 virus
Lane D a l-3  vs 40|ig T1 virus
Lane E a l-3  vs 80|ig T1 virus
Lane F a l-3  vs 160p.g T1 virus
A B  C D E  F
A small amount of the approximately 150 kDa species of oligomer is 
noticeable in Figures 9.2.4 and 9.2.5. This species was observed in some of 
the SDS-PAGE analyses described in Chapter 8 (e.g. Figures 8.2.5 and 
8.2.6) and is discussed further in Chapter 11.
9.2.4 SUMMARY
The interaction of a l-3  with L-cells was investigated in order to 
determine whether binding was specific and saturable. This was important 
for two reasons: to ascertain whether binding reflected the situation 
observed with native virions and as a prerequisite for the interpretation of 
intended binding assays with mutant a l-3  proteins (Chapter 10).
Maximum binding of a l-3  was seen after approximately 90 minutes 
at 4°C, which compares well with the observations of Armstrong et al. 
(1984) and Epstein et al. (1984) who both reported a similar time for the 
maximum binding of type 3 virus to L-cells. Not all of the slowest 
migrating oligomeric species present in the a l-3  translation mix - 
(demonstrated in the last chapter to be the major oligomeric a l-3  binding 
species)- was in fact able to bind to cells even after a 4 hour incubation 
period, as shown by analysis of the unbound proteins (Figure 9.2.2). The 
construction of a saturation curve also demonstrated that the amount of 
translation mix utilized in the time course assays was not a saturating 
quantity. The species unable to bind were possibly composed of 
incorrectly folded molecules and/or were structures whose subunits had 
associated improperly; this may reflect a relative inefficiency in these 
processes in the in vitro system. However, it was also possible that the 
incubation step in sample buffer, prior to analysis by SDS-PAGE increased 
the relative amount of oligomeric species by causing oligomerization of 
monomers.
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The number of receptor sites/cell reported in the literature for 
reovirus T3 on L-cells ranges from 1.6 x 104 (Sawutz et al., 1987) to 0.86-
1.1 x 105 (Gentsch and Hatfield, 1984) to a maximum of 3-5 x 105 
(Armstrong et al., 1984 and Ambler and Mackay, 1991). A figure of ~ 2.8 x 
105 was determined in this study which is in fairly good agreement with 
those given above considering the range of these values. The tenfold 
range of values itself may be due to the different methods of assay, such as 
binding of virus to cells in suspension or monolayer and differences in the 
specific activities of radiolabelled virions obtained by the various groups. 
Epstein et al. (1984) suggested that the high specific activity of their virus 
particles allowed for better resolution of their binding curves. Regardless 
of the experimental method, any such figure is probably best regarded as 
an approximation, although it was encouraging that the figure obtained in 
this study using the cell-binding protein did not differ significantly from 
those determined with virus particles.
Binding of a l-3  to L-cells was found to be specific as competition 
with homologous type virus (type 3) abolished attachment. However, type 
1 virus did not effect specific inhibition of o 1-3 binding, which would 
suggest that these two serotypes utilize different receptors to bind to L- 
cells. A small decrease in binding was noted at the highest concentration 
of T1 virus employed in the assay and may represent a non-specific 
blocking at this concentration or alternatively there could be some overlap 
in receptor determinants between the two viral serotypes. This is discussed 
more fully in Chapter 11.
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10.1 INTRODUCTION
Evidence has accumulated during the last decade to suggest that 
the cell-binding function of a l  is harboured in its carboxy-terminal region. 
This was initially proposed by Bassel-Duby et al. (1985) who predicted a 
structural model for a l  in which the C-terminal portion of the protein 
formed a globular structure, positioned atop an a-helical rod formed by the 
N-terminal region. It was suggested that the former structure contained 
receptor recognition domains whilst the latter anchored the molecule to 
the virion. The structural details were later refined by Nibert et al. (1990) 
who nevertheless suggested no major differences in the essential predicted 
morphology of the molecule (section 1.4.1 of the Introduction). 
Furthermore, Furlong et al. (1988) visualised reovirus type 2 a l  molecules, 
both attached to and in isolation from virus particles as having this 
"lollipop" structure; Fraser et al. (1990) made similar observations from 
computer enhanced micrographs of isolated a l  type 2 protein.
The cell-binding ability of various a l  deletion mutants, expressed as 
fusion constructs with the (5-galactosidase protein in E. coli (Nagata et al., 
1987) provided more direct proof that this binding function was located in 
the C-terminal half of the protein. Also, Yeung et al. (1989), found that a 
carboxy-terminal fragment of a l  (generated by trypsin treatment of the 
intact protein), was capable of binding to L-cells.
A mutational analysis of the a l protein was therefore undertaken to 
more precisely map the location of the receptor reognition region(s), the 
aim of which was to further characterise the virus-host cell attachment 
process.
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10.2 STRATEGY
The initial approach taken in the mutational analysis of the carboxy- 
terminal region of a l-3  was to generate a set of mutants by exonuclease III 
digestion of the 3' end of the cloned Sl-3 gene in plasmid pG3T3. A series 
of clones that contained an increasing amount of 3' deleted material could 
then be assayed for their cell-binding function. However, despite the 
generation of a set of 3' deletion mutants, it was found that all contained 
deletions of approximately 500 nucleotides or more. Unfortunately, 
translation of these mutants would have resulted in c l  molecules lacking 
globular head structures (data not shown).
An alternative was to delete specific sequences of nucleotides by 
oligonucleotide directed mutagenesis. The sequences of the SI genes of 
the three viral serotypes and of the predicted c l  protein sequences are 
highly diverged between the three reovirus serotypes (Cashdollar et al., 
1985; Duncan et al., 1990 and Nibert et al., 1990). However, Duncan et al. 
(1990) delineated five areas of relatively high sequence homology shared 
by all three of the proteins and proposed that they could be involved in 
certain conserved functions of c l (for example oligomerization and cell- 
attachment). These five regions are distributed throughout the molecule 
and it was further suggested that one or more of the domains located in the 
C-terminal region could be involved in the recognition of a putative 
common L-cell receptor for all three virus serotypes (Duncan et al., 1990). 
Lee et al. (1981b) had originally proposed that the reovirus serotypes 
utilized a common receptor on L-cells. This issue has already been 
introduced in section 1.6.1.
It was decided to delete two of the regions proposed by Duncan et 
al. (1990) to be involved in receptor recognition and to ascertain their role 
in cell-binding. The two areas chosen for deletion both reside within the C-
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terminal half of the protein and are labelled D (aa 360-485) and E (aa 418- 
451) as in the report of Duncan et al. (1990). Figure 10.2.1 is a diagram of 
a  1-3 showing the relative positions of regions D and E.
The mutagenesis strategy was as follows : subcloning of the cDNA 
of the S I-3 gene into M13mpl9, independent deletion of regions D and E 
by oligonucleotide directed mutagenesis and replacement of the wild type 
SI-3 cDNA fragments with those containing the deletions. The method of 
Vandeyar et al. (1988) was utilized to carry out the oligonucleotide 
directed mutagenesis (previously mentioned in Chapter 7). This protocol is 
briefly described below and is shown schematically in Figure 10.2.2.
The mutagenic oligonucleotide is annealed to ss DNA prepared from 
the recombinant M l3 clone in which the sequence to be mutated resides. 
Synthesis of the second (mutant) strand is achieved with a dNTP mix that 
includes 5-methyl dCTP, instead of dCTP; this ultimately enables selection 
of the mutant strand. The resulting heteroduplex DNA molecules are 
digested with the restriction enzymes Msp\ and Hha\. The nonmethylated 
strand of C5mCGG/CCGG duplexes can be cleaved by Msp\\ thus the 
parental strand of the duplex is selectively digested by the action of this 
enzyme. Single-stranded DNA is cleaved at about half the rate of ds DNA 
by the enzyme Hha\ but it is unable to cleave hemi-methylated DNA. This 
enzyme therefore preferentially digests uncopied and partially copied ss 
molecules which contribute to the low mutation frequency obtained with 
the original method of Zoller and Smith (1983). The parental strand of 
nicked duplex molecules, resulting from the action of Msp\, is then 
degraded by the action of exonuclease III. This protocol therefore selects 
for the mutant strand and results in a mutation frequency of approximately 
90% (Vandeyar et al., 1988).
The reaction mixes must be transformed into an Mcr A*B‘ E. coli 
host as the Mcr system is responsible for methylation dependent restriction
1 455
3 6 0  385
\  /
V D  ▼ E \t
NH2 o1-3 COOH
418  451
Figure 10.2.1 Schematic Diagram of a l-3  Showing the 
Conserved Regions D and E
The diagram of a  1-3 shown above has the conserved regions D and E 
marked upon it. These regions were proposed to be relatively 
conserved betwen the three serotypes of a l protein: region D exhibits 
a 46% homology and region E 32%. whilst the overall homology of 
the three proteins is 17%. The conserved regions are marked by 
hatched boxes and their bounding amino acid residues are denoted b> 
the numbers above or below the respective boxes.
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Figure 10.2.2 Schematic Representation of the Method of 
Oligonucleotide Directed Mutagenesis. Adapted from Vandeyar el al. 
( 1988). See text for details.
Anneal mutagenic oligonucleotide to ss 
DNA template
I Synthesize mutant strand with T4 DNA polymerase and dNTP mix containing 5-methyl dCTP instead of dCTP
Digest parental (non-mutant) strand 
with Mspl and Hhal
Remove parental strand by 
exonucleaselll digestion
\
Transform competent E coli Mcr A 'B' cells
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of the methylated target sequences 5mCG and G/A5mC (Raleigh and 
Wilson, 1986) and would thus digest the mutant strand (Vandeyar et al.,
1988).
10.3 RESULTS
10.3.1 Construction of Sl-3 : M13mpl9 Recombinant Clones
The entire Sl-3 cDNA sequence was subcloned from plasmid 
pG3T3 into M13mpl9 to generate the recombinant clone mpl9Sl-3, as 
shown in Figure 10.3.1. Single-stranded DNA prepared from this clone 
could then be utilized as template in the generation of both of the 
deletions, which obviated the need to generate two mpl9 recombinant 
clones for the deletion of regions D and E.
10.3.2 Generation and Detection of mpl9Sl-3 Mutants
Single-stranded DNA from the mpl9Sl-3 recombinant was prepared 
and mutagenised using oligonucleotides S1-3AD and S1-3AE in 
independent reactions (as described in sections 2.8.3-2.8.6) to generate 
the mutant clones mpl9Sl-3AD and mpl9Sl-3AE . The sequences of the 
mutagenic oligonucleotides are shown in Figure 10.3.2.
A high frequency of mutation is expected with this method of 
mutagenesis. Accordingly, frequencies of 70% and 80% were observed in 
the generation of the mpl9Sl-3AD and AE mutants respectively. The 
corresponding data is shown for the latter mutants only (Figure 10.3.3).
The high frequency of mutation enabled the mutant clones to be 
directly identified by sequence analysis. Sequence comparison of the 
appropriate regions of the mutant mpl9Sl-3AD and AE clones with the
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Figure 10.3.1 C onstruction of the Recom binant Clone m p l9 S l-3
Plasmid pG3T3 was digested with the restriction enzymes Bam\\\ and 
Kpnl which cut in the 5’ end of the SI-3 cDNA sequence and in the 3' 
polylinker respectively. The resulting "gene" fragment was purified from a 
1% agarose gel as described in section 2.9.1. M13mpl9 RF DNA was 
digested with these two enzymes which both cleave at sites in the 
poly linker region; this DNA was similarly purified from an agarose gel. The 
Sl-3 gene fragment was then ligated to the mpl9 RF DNA to generate 
clone mpl9Sl-3.
Key
SP6 = SP6 phage promoter sequence
T7 phage promoter sequence 
pGEM-3Z polylinker sequence 
M13mpl9 polylinker sequence 
Region D or E
B am H I
t
BamHI/Kpnl digest 
Isolate gene fragment. 
Ligate into BamHI/Kpnl 
digested M13mp19
▼
i
mp19S1-3 singie-stranded DNA functions as 
template for the independent deletion of 
regions D and E.
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Figure 10.3.2 Sequences of the Oligonucleotides Utilized in the 
Deletion of Regions D and E in the Cloned Sl-3 Gene
Panel A shows the bounding nucleotides of region D within the Sl-3 
cDNA. Oligonucleotide S1-3AD is shown in bold type and is 
complementary to two 10 nucleotide sequences located immediately 5' and 
3' to these bounding nucleotides. Annealing of the oligonucleotide to the 
ss DNA template would thus cause the sequence belonging to region D to 
loop out and ultimately be deleted.
Panel B Similarly, this diagram shows the bounding nucleotides of region 
E and the sequence of oligonucleotide S1-3AE utilized to effect its 
deletion from the DNA copy of the Sl-3 gene.
A
B
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Figure 10.3.3 Restriction Enzyme Digest Analysis of Putative 
mpl9Sl-3 Deletion Mutants to Demonstrate the High Level of Mutation 
Frequency
Ten plaques resulting from the mutageneis of mpl9Sl-3 ss DNA with 
oligonucleotide S1-3AE were cultured as described in section 2.8.3. 
Replicative form DNA was isolated (section 2.7.3), digested with the 
restriction enzyme Sst I and electrophoresed on a 1% agarose gel. A 
photograph of this gel is shown opposite.
The mutant mpl9Sl-3AE DNA has approximately 100 nucleotides deleted 
and thus produces an ~ 800 bp band after digestion with Ssl I; similar 
digestion of the non-mutated mpl9Sl-3 RF DNA results in an ~ 900 bp 
band, shown schematically in the plasmid maps below the photograph. 
Thus, it can be seen from the photograph that 80% of the putative mutants 
contained this deletion.
Lane M Ladder of DNA fragments (BRL)
Lane 1 mpl9Sl-3 RF DNA (non-mutated)
Lanes 2-11 RF DNA from putative mpl9Sl-3AE mutants
Region E
Kb M 1 A B C D E F G H  I J
P L  m p19S1-3A E PL
corresponding wild type S I-3 cDNA is shown in Figures 10.3.4 and 10.3.5 
respectively. Nucleotides 1090-1167 of the Sl-3 DNA, corresponding to 
amino acids 360-385, were removed in mutant mpl9Sl-3AD, which would 
result in a ct1-3 protein truncated by 26 amino acids. The mpl9Sl-3AE 
mutant has nucleotides 1264-1365, amino acids 418-451 deleted, resulting 
in a 34 amino acid truncated a l  molecule.
The sequence of the entire region to be utilized in the replacement 
of the equivalent wild type fragment (demarcated by the enzyme sites 
shown in Figures 10.3.6 and 10.3.7) was determined to ensure no 
adventitious mutations had been incorporated during mutagenesis. Figure
10.3.4 does show an apparent insertion of a G residue in the sequence 
determination of clone mpl9Sl-3; however several other similar sequence 
analyses proved this to be a spurious band (data not shown).
10.3.3 Construction of the pG3T3 Mutants
Replicative form DNA from each of the mutant clones was isolated 
and digested with the restriction enzymes required to release fragments 
containing the respective deletions. Aliquots of pG3T3 plasmid DNA were 
digested with the necessary restriction enzymes and recombined with the 
appropriate mutant fragments to create plasmids pG3T3AD pG3T3AE as 
shown in Figures 10.3.6 and 10.3.7 respectively. The respective mutant 
pG3T3 clones were easily identified as restriction enzyme digest analysis 
of DNA from the putative recombinant clones released a fragment that was 
truncated in comparison to pG3T3 DNA (results not shown).
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Figure 10.3.4 Sequence Analysis of m pl9Sl-3A D
Several mpl9Sl-3AD clones were sequenced, as described in section
2.8.8.1 and the resulting reaction mixes electrophoresed on an 8% 
polyacrylamide gel as in section 2.8.9. The sequence of one mutant and 
the non-mutated mpl9Sl-3 clone (for comparison) is shown opposite.
The non-coding strand of S I-3 in both the mutated and non-mutated mpl9 
clones was analysed. Hence, the sequence obtained was oriented in the 3'- 
5' direction. Nucleotides 1090-1167 (region D) were deleted in mpl9Sl- 
3AD resulting in the juxtaposition of nucleotides 1089 and 1168; these 
latter two nucleotides are marked with arrows. The arrow adjacent to the 
wild type sequence denotes sequence common to the mutated and non- 
mutated clones. An interpretation of some of the determined sequence is 
written below the photograph. Here, SI-3 "wild type" refers to the non- 
mutated mpl9Sl-3 DNA.
S l - 3  WILD TYPE
5 ' •  •  3
• . . GAA TGT CCT CTG TGA CTC GGG CGA AAA GTA TTA CTG CAC CAG • •
1167 1168
S1-3AD
5 ' •  •  3
. . .GGT CGA AAA CTG CCA AAG AGA CGA AAA GTA TTA CTG CAC CAG •
1089 1168
Figure 10.3.5 Sequence Analysis of m pl9S l-3A E
Several mpl9Sl-3AE clones were sequenced, as described in section
2.8.8.1 and the resulting reaction mixes electrophoresed on an 8% 
polyacrylamide gel as in section 2.8.9. The sequence of one mutant and 
the non-mutated mpl9Sl-3 clone (for comparison) is shown opposite.
The non-coding strand of S I-3 in both the mutated and non-mutated mpl9 
clones was analysed. Hence, the sequence obtained was oriented in the 3'- 
5' direction. Nucleotides 1264-1365 (region E) were deleted in mpl9Sl- 
3AD resulting in the juxtaposition of nucleotides 1263 and 1366; these 
latter two nucleotides are marked with arrows. The arrow adjacent to the 
wild type SI-3 sequence denotes sequence common to the mutated and 
non-nutated clones. An interpretation of some of the determined sequence 
is written below the photograph. Here. S I-3 "wild type" refers to the non- 
mutated mpl9Sl-3 DNA.
S l - 3  WILD TYPE
5' •  •  3
• • • GAC ATA TAC TCA TTC TTA GAC ACC CAC CTC GTC ACC GTC CTA . •
1263 1264
S1-3AE
5 ’ •  •  3
• • •  GAC ATA TAC TCA TTC TTA GAC ACC GCA TCA AAG TGC ACT TAG •
J K
1263 1366
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Figure 10.3.6 Construction of Plasmid pG3T3AD
The mutant clone mpl9Sl-3AD was cultured as described in section 2.8.3,
from which RF DNA was prepared (section 2.7.3). This DNA was digested
with the restriction enzymes Nco\ and Seal which cut at positions 566 and
1284 in the Sl-3 DNA respectivley. A fragment of DNA from which region D
had been deleted was thus released and subsequently purified from an
agarose gel (section 2.9.1). Plasmid pG3T3 was partially digested with the
enzyme Seal as described in section 2.6.1.1 and then cleaved with Nco\. The
resulting vector/gene fragment was purified as above and ligated to produce
the deletion mutant pG3T3AD. This scheme is shown opposite.
The key for the diagram is as for Figure 10.3.1 plus the symbol explained
below.
/  /  /
\  \
liU  = A fragment, of the Sl-3 gene from which region D has
been deleted.
mp19S1-3AD
PL S1-3 3‘ PL
t t
Nicol Seal
228
Figure 10.3.7 C onstruction of Plasm id pG3T3AE
Replicative form mpl9Sl-3AE DNA was prepared as described for the 
mpl9Sl-3AD mutant in Figure legend 10.3.6. This DNA was digested in 
the 3' polylinker sequence with the restriction enzyme £coRI and the ends 
of the DNA were filled by the action of Klenow polymerase (section 2.6.2). 
Subsequent cleavage with the enzyme Bgl II (which cuts the SI-3 DNA 
gene sequence at position 1104) released a fragment of S I-3 DNA from 
which region E had been deleted; this was purified from an agarose gel 
(section 2.9.1). Plasmid pG3T3 was digested with the restriction enzymes 
Sma\ and Bgl II which cut in the 3' polylinker sequence and in the S I-3 
gene respectively. The resulting vector/gene fragment was also purified 
from an agarose gel and ligated to the mutated SI-3 fragment to produce 
plasmid pG3T3AE.
The key is the same as for Figure 10.3.1 plus the symbol explained below.
A fragment of the SI-3 gene from which region E has 
been deleted.
S 1 - 3
mp19Sl-3AE
3' PL
EHm
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10.3.4 Oligomerization of the Mutant Proteins
It was seen in Chapter 8 that oligomerization of the type 3 a l  
protein was required for it to manifest a cell-binding function. It was 
therefore necessary to determine not only that the mutant proteins were 
synthesized as truncated products of the expected size but that they could 
also oligomerize.
Message sense sl-3 RNA produced by in vitro transcription of the 
mutant plasmids pG3T3AD and pG3T3AE was translated in the 
reticulocyte lysate system and analysed by SDS-PAGE under denaturing 
and non-dissociating conditions. These results are shown in Figures 10.3.8 
and 10.3.9 respectively and demonstrate that truncated al-3 proteins, a l-  
3AD and al-3  AE respectively, were synthesized, with the latter slightly 
smaller than the former as expected. It can also be seen that these proteins 
do form oligomers which appear to have lower molecular weights than the 
non-mutated oligomer.
10.3.5 Cell-Binding Ability of the a l  Type 3 Mutant Proteins
The ability of the mutants to attach to L-cells was examined in 
comparison to that of the full-length protein. An aliquot of each of the 
translation mixes utilized in the binding assay was co-electrophoresed with 
the resulting solubilized monolayers to ensure that the absence of a band 
representing bound protein was not due to a failure of the protein to be 
synthesized. As can be seen in Figure 10.3.10, only the full-length protein 
and neither of the mutants was able to bind to the L-cell monolayers (and 
each had been successfuly translated).
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Figure 10.3.8 In  V itro  Expression of the M utant a l - 3  Proteins
Plasmids pGT3, pG3T3AD and pG3T3AE were transcribed in vitro to 
produce full-length and mutant s i-3 mRNAs repectively. These were 
translated in a commercial reticulocyte lysate as described in section 2.11.1. 
Aliquots of each translation mix were boiled in sample buffer and analysed 
by SDS-PAGE (section 2.11.4). The gel was then processed as described in 
section 2.11.5 and a photograph of the resulting autoradiograph is shown 
opposite. Reovirus infected cells were prepared as in section 2.2.5.
Lane R Reovirus infected cells
Lane U Uninfected cells
Lane A In vitro translated s i-3 mRNA derived from pG3T3 
Lane B In vitro translated sl-3AD mRNA derived from pG3T3AD
Lane C In vitro translated sl-3AE mRNA derived from pG3T3AE
R U A B C
X -
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Plasmids pGT3, pG3T3AD and pG3T3AE were transcribed in vitro to produce 
full-length and mutant s i -3 mRNAs repectively. These were translated in a 
commercial reticulocyte lysate at 37°C for 30 minutes and the resulting 
proteins analysed by SDS-PAGE under non-dissociating conditions 
(incubation in sample buffer at 37°C for 30 minutes prior to loading on the 
gel). A photograph of the gel (which had been processed as in section 2.11.5) 
is shown opposite.
Figure 10.3.9 Oligomerization of the M utant a l - 3  Proteins
Lane R Reovirus infected cells
Lane U Uninfected cells
Lane A In vitro translated, full-length al-3
Lane B In vitro translated al-3AD
Lane C In vitro translated al-3AE
R U A B C
m.
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Figure 10.3.10 Assessment of the Cell-Binding Ability of the Mutant 
al-3 Proteins
Proteins al-3 , al-3AD and al-3AE were synthesized as described in the 
legend to Figure 10.3.9. These were assayed for their L-cell binding ability as 
described in seection 2.12.2; the solubilized, cell-bound material was analysed 
under non-dissociating conditions of SDS-PAGE. Aliquots of the three in 
vitro translation reaction mixes were analysed on the same gel, but were 
heated to 100°C (in sample buffer) prior to loading on the gel. A photograph 
of the resulting gel is shown opposite.
Lane R Reovirus infected cells
Lane U Uninfected cells
Lane A In vitro translated, full-length a l-3
Lane B In vitro translated al-3AD
Lane C In vitro translated al-3AE
Lane D Cell-bound al-3
Lane E Cell-bound al-3AD
Lane F Cell-bound al-3AE
R U A B C D E  F
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10.4 SUMMARY
A mutational analysis of the c l -3 protein was carried out in order to 
locate domains of the protein involved in cell-attachment. Two C-terminal 
c l -3 mutants were generated by oligonucleotide directed mutagenesis that 
were both able to oligomerize but were unable to bind to L-cells. However, 
a conformational effect caused by the deletion cannot be discounted as an 
explanation for the inability of the mutant proteins to manifest a cell­
binding ability. This matter is more fully discussed in the next chapter.
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11.1 General Strategy
In this study, the reovirus a l  protein was expressed in vitro to 
enable an investigation of its cell-binding properties; an attempt was also 
made to localise the cell-binding domain(s) within the protein. The 
approach employed was based on exploiting in vitro systems. Thus, a l 
was synthesized in rabbit reticulocyte lysate from cloned copies of the 
type 1 and type 3 SI genes and a binding assay developed utilizing L-cells 
grown and maintained in tissue culture. This method of a l expression in 
this project provided a convenient source of the protein that was virtually 
free from other, contaminating protein species. Prior to the beginning of 
this project, the cell-binding activity of a l  had been investigated by a 
number of other groups. In their work a l was synthesized in a variety of 
expression systems, both bacterial and viral (Masri et al., 1986 and 
Banerjea et al., 1988); isolated from intact virions Yeung et al. (1987) or 
analysed as a crude virus infected cell lysate Lee et al. (1981b). These 
methods are both more time consuming than the method employed in this 
study and carry the potential risk of problems caused by the presence of 
contaminating protein species. A further crucial advantage conferred by 
expressing a l  from a cDNA copy of its encoding gene is that it also allows 
the opportunity for a mutational analysis of the protein (Chapter 10 and 
discussed in section 11.1.3).
Whilst the "in vitro" approach adopted in this study has 
advantages, as with any such approach, there are limitations, principally in 
extrapolating the results to the situation observed in vivo. The ideal 
method of investigating the cell-binding properties of a l  and relating this 
to viral pathogenesis would be to mutate a cloned copy of the SI gene and 
rescue this back into virus in the form of RNA. Binding assays could then 
be carried out with this "mutant" virus in vitro and the effect of the
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mutation on the tissue tropism and virulence properties of the virus in vivo 
could also be investigated. A mouse system, described in section 1.3, is 
available for studies of the latter nature. Although one recent report has 
described conditions under which reovirus RNA is infectious (Roner et al., 
1990) the molecular mechanism(s) involved is poorly understood and the 
rescue of a single reovirus gene, from a cloned DNA copy into virus 
particles has yet to be achieved. Thus, the application of in vitro methods 
represented a means by which the characterization of a l  and its cell­
binding activities could be further pursued. During the course of this study 
it became apparent that this approach had also been adopted by the 
research group of Lee et al. (some of whose work is considered in the 
following sections).
The remainder of this discussion is mainly concerned with the 
oligomeric nature of a l ,  its interaction with the L-cell receptor and the 
current evidence for the nature of the reovirus receptor as issues pertaining
to the expression of the type 1 and 3 a l  proteins have already been
*
discussed at the end of the relevant chapters (i.e. Chapters 5, 6 and 7).
11.1.1 Oligomerization of Protein a l
The N-terminal heptad repeat region of a  1-3 has been shown to 
possess an intrinsic oligomerization function (Banerjea and Joklik, 1990 
and Leone et al., 1991b). This was also demonstrated in this study by the 
in vitro expression of a plasmid containing a chimeric SI T1/T3 gene. The 
resulting hybrid protein, in which the N-terminal region of a  1-3 was fused 
to the C-terminal portion of al-1 was able to oligomerize, a property not 
exhibited by the full-length al-1 protein.
Several oligomeric species of a l-3  were evident when analysed 
under non-dissociating conditions of SDS-PAGE (pre-incubation in sample
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buffer at 37°C). The amount of oligomer formed was greatly increased 
when the in vitro translations were carried out at 37°C as opposed to 
30°C. The temperature at which a l  is synthesized in vitro therefore 
appears to be quantitatively important in the oligomerization process. In 
fact in our work, synthesis of this protein at 37°C was required to generate 
sufficient quantities of oligomeric a l  for its cell-binding function to be 
observed when assayed on monolayers of L-cells.
Complete oligomerization was never observed in this study and 
typically occurred with an approximate 50% efficiency. This is in contrast 
to the almost complete oligomerization of a l  observed by Bassel-Duby et 
al. (1987) who utilized a l  isolated from intact virions and reovirus infected 
cell lysates. A factor or factors, may therefore be present in vivo that 
promote efficient oligomerization. Leone et al. (1991b) also noted that 
extrapolation of data concerning the oligomerization property of the 
heptad repeat region to the folding process should be treated with care as 
the process involving a l  in vivo could well be more complex. Furthermore, 
these authors have even suggested that the association of intact a l 
molecules into oligomers involves chaperones and is ATP dependent 
(unlike the spontaneous nature of the heptad repeat region event), 
although the evidence is as yet unpublished. It is feasible that chaperones 
could be one of the putative factors suggested above as being present in 
an in vivo situation but not in the reticulocyte lysate. Their participation in 
the oligomerization process could explain the differences in the efficiency 
of the process observed in this study with that of Bassel-Duby et al. 
(1987). In this respect, it is interesting that another cell-protein, BiP 
(Binding Protein) thought to be involved in protein folding, (Munro and 
Pelham, 1986) has been associated with influenza HA molecules.
Misfolded HA monomers and oligomers are complexed with BiP and 
appear to be locked into the endoplasmic reticulum whilst correctly folded
HA molecules are only transiently associated with this protein (Gething et 
al., 1986).
Several species of oligomer were observed for the in vitro 
synthesized al-3  in this study, of which it was predominantly the 
oligomeric species migrating slowest on SDS-PAGE analysis that displayed 
a cell-binding ability. The data of Leone et al. (1991a) is in agreement with 
this observation and these authors also reported that the oligomeric 
species unable to bind to cells were in fact misfolded molecules and that 
extensive changes in the conformation of the C-terminal region of a l  
occur upon oligomerization.
An approximately 150 kDa form of the oligomer was sometimes 
apparent in this study, most often after analyses of the protein species that 
had bound to cell monolayers (Figures 8.2.6 and 9.2.4). On most 
occasions, this lower molecular weight species was not evident in the 
reticulocyte translation mix that was the source of the a l  protein to be 
assayed on the cell monolayers but was present after the protein had 
bound to L-cells (e.g. Figure 8.2.6). It therefore seemed likely that it was 
an alternative form of the slower migrating oligomers, for example either a 
degraded product, or a lower order species resulting from the dissociation 
of a a l  subunit during the experimental procedure. Another possibility is 
that the conformation or oligomeric status of the a l  oligomer changes 
following binding to the receptor as a means of locking the protein onto 
the receptor. The initial binding would therefore be relatively non-specific 
which would change upon attaching to the actual receptor to a high- 
affinity interaction. A study by Strong et al. (1991) concerning the 
oligomeric status of a l-3  provided an alternative and what appears to be 
more likely interpretation to this observation. These authors proposed that 
a l  associates into a homotrimer based on gel filtraton data and its 
sedimentation value in sucrose gradients; SDS-PAGE of full-length a l  and
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a truncated mutant co-synthesized in a reticulocyte lysate revealed 
multiple hetero-oligomeric species, the composition of which also indicated 
a trimeric structure. However, a molecular weight of approximately 
200 kDa for the c l  oligomer has been assigned by Bassel-Duby et al. 
(1987) and Banerjea and Joklik (1990) for the c l  oligomer based on 
migration in SDS-polyacrylamide gels. This anomalous molecular weight 
for a c l  trimer (which should be ~ 150 kDa) was suggested by Strong et 
al. (1991) to be the result of the C-terminal subunits of the head structure 
opening out from a compact globular shape into a "hydra" like structure 
under the non-dissociating conditions of SDS-PAGE. Each "tentacle" of 
the hydra would be equivalent to an unfolded C-terminal subunit (Figure 
11.1.1). This shape could easily be responsible for retarding the migration 
of the proposed trimer through polyacrylamide gels. Strong et al. (1991) 
demonstrated that by reducing the pre-electrophoresis incubation 
temperature in sample buffer from 37°C to 22°C or lower, the putative 
trimer migrated to the expected position of approximately 150 kDa. Thus, 
the species that migrated to a similar position in this study (i.e. just below 
the reovirus X proteins in the marker tracks) could represent a more 
compactly folded form of the slower migrating oligomers. Consistent with 
this interpretation, an experiment was carried out in this study in which it 
was found that if the temperature of the c l  lysate/sample buffer mix was 
reduced to 4°C prior to analysis by SDS-PAGE, a similar downshift in gel 
migration of the oligomer resulted (data not shown).
Further characterisation of the factors involved in stabilising the a l 
oligomers under non-dissociating conditions was beyond the scope of this 
study. However, Bassel-Duby et al. (1987) and Leone et al. (1991b) have 
investigated the oligomeric status of a l  under similar conditions. The 
former suggested that the unique solvent properties of (3-Me (present in 
the sample buffer) enabled a l  to form multimers, whereas the latter
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Figure 11.1.1 Putative Oligomeric Form of Protein a l-3
The two forms of al-3  shown above are those proposed by Strong et at.
(1991). The oligomer is thought to be a homotrimer with the C-terminal 
heads of the three subunits folded into compact globular structures, 
stabilised by inter and intrasubunit interactions (diagram A). Under non­
dissociating conditions of SDS-PAGE. the trimer remains associated 
through the N-terminal rods, but the globular heads dissociate; this is 
shown in diagram B. The dissociated form would probably exhibit a 
retarded migration upon SDS-PAGE analysis, thus causing an 
overestimation of the molecular weight of the oligomer (Strong et al.
1991).
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suggested it was due to the little known property of P-Me as a weak 
chelating agent; thus divalent cations and P-Me were shown to have 
antagonistic effects on the stability of oligomeric c l  N-terminal tryptic 
fragments. The latter study also reported that EDTA was able to replace p- 
Me in sample buffer to similar effect. The heptad repeats of the N-terminal 
region of c l  are taken to be indicative of a coiled-coil structure (Bassel- 
Duby et al., 1985) where residues a and d of the heptad are 
characteristically apolar and thought to play a role in stabilising oligomeric 
structures via hydrophobic interactions between the strands of the 
oligomer (McLachlan and Stewart 1975). Leone et al. (1991b) suggested 
that the effect of the divalent ions would be to disrupt ionic interactions in 
the N-terminal region that are involved in contributing to oligomer 
stability. Parallel alignment of the strands of the oligomer revealed that the 
oppositely charged residues in the e and g positions (or sometimes the b 
and d positions) of the heptad are appropriately positioned to form acid- 
base pairs (Nibert et al., 1990 and Leone et al., 1991b); this is shown in 
Figure 11.1.2. However, these ionic interactions are thought to be 
secondary to the influence of the hydrophobic interactions.
The aforementioned suggestion that c l  exists as a trimer is in direct 
contradiction to all previous proposals, which favoured a dimeric or a 
tetrameric structure. It was originally believed that c l  formed a dimer 
based on stoichiometric data and its distribution at the vertices of the viral 
icosahedron (Smith et al., 1969 and Lee et al., 1981b); sequence analysis 
of the SI gene (Bassel-Duby et al., 1985) and chemical cross-linking 
experiments of purified c l  (Yeung et al., 1987) further supported this idea. 
Analysis of the protein under non-dissociating conditions of SDS-PAGE 
(Bassel-Duby et al., 1987; Banerjea et al., 1988 and Banerjea and Joklik, 
1990) as well as under the electron microscope (Fraser et al., 1990) have 
resulted in the updated proposal of c l  as a tetramer. The variance of the
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Figure 11.1.2 Schematic Representation of the Putative Ionic 
Interactions Involved in Stabilizing the a l  Oligomer
Shown opposite is a diagram of the amino acid residues in the a l  heptad 
repeat region assigned as forming acid base pairs on two adjacent helices 
of the a l  oligomer. These interactions are thought to occur between amino 
acids in positions e and g of the heptad repeat. The positively charged 
residues are shown in black and the negatively charged in white; amino 
acids in position e are marked on the left hand helix and those in position 
a, on the right. The diagram is reproduced from Leone et al. (1991b). Three 
helices are shown as these authors believe the oligomer to be a trimeric
structure.
F 1 5 8
L 2 8
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suggested trimeric nature of a l  (Strong et al., 1991) with the SDS-PAGE 
based tetramer proposals of the above studies can be explained by the 
hydra model of Strong et al. (1991). The reason for the discrepancy with 
the electron microscopy study of Fraser et al. (1990) is less clear. Strong et 
al. (1991) also found that the N and C-terminal fragments produced after 
trypsin cleavage of oligomeric a l  also migrated as trimeric particles in 
polyacrylamide gels.
The cell-attachment proteins of several other viruses, both 
enveloped and non-enveloped, have been reported to be trimers. Examples 
are : the influenza HA (Wilson et al., 1981), the coronavirus spike protein 
(Cavanagh, 1983 and Delmas and Laude, 1990), the vesicular stomatitis 
virus (VSV) G protein (Dorns et al., 1987 and 1988), the rabies virus G 
protein (Gaudin et al., 1992), the adenovirus fibre protein (van Oostrum et 
al., 1987 and Devaux et al., 1990) and the envelope (.env) glycoprotein of 
HIV-1 (Gelderblom et al., 1989 and Weiss et al., 1990). However, the 
oligomeric status of env is controversial and has been proposed to be a 
dimer, or multiple of a dimer, (Thomas et al., 1991) or a tetramer (Schawaller 
et al., 1989). The shape of these attachment proteins also appears to 
represent a common theme of a globular, cell-binding region atop a rod-like 
structure. Two segments in each of the rod sections of the spike proteins of 
several different coronaviruses have also been suggested to form coiled- 
coil ropes based on the identification of heptad periodicities in their 
predicted protein sequence (de Groot et al., 1987 and Rasschaert and 
Laude, 1987). Analysis of x-ray crystallographic data of the influenza HA 
demonstrated that it possesses complex coiled-coil structures (Wilson et 
al., 1981) whilst Devaux et al. (1990) have inferred that the stalk of the 
adenovirus fibre may be a-helical in nature rather than the previously 
proposed p-sheet (Green et al., 1983). These authors have suggested that 
an a-helical coiled-coil structure could confer flexibility to the particular
protein and thus aid in the "detection" of and binding to host cell 
receptors. In contrast to this strategy, many of the picomaviruses appear to 
have buried their host-cell receptor recognition structures in the virus 
architecture (Hogle et al., 1985, and Rossmann et al., 1985), possibly to 
avoid detection by the host's immune system (Rossmann, 1989).
Whilst this study and that of Leone et al. (1991a) has shown that 
oligomerization of a l  is undoubtedly crucial for manifestation of its cell­
binding function, a quaternary structure for the other virus cell-attachment 
proteins mentioned above, may not represent a similar functional 
prerequisite but may be a consequence of other processes affecting these 
proteins. Such an example is provided by the enveloped viruses where 
oligomerization appears to be important in the intracellular transport of 
their cell-binding proteins. Thus, trimerization of the influenza HA and of 
the VSV G protein has been shown to be necessary for transport from the 
endoplasmic reticulum to the golgi complex (Gething et al., 1986; 
Copeland et al., 1986; 1988; Kreis and Lodish, 1986 and Dorns et al., 1987 
and 1988).
11.1.2 The Reovirus L-Cell Receptor
The density of putative reovirus receptors (~ 2.8 x 105/cell) and the 
kinetics of the al-3-cell binding interaction observed in this study were 
similar to the data of other groups in which whole virions were used to 
investigate reovirus L-cell interactions (Epstein et al., 1984; Gentsch and 
Hatfield, 1984 and Gentsch and Pacitti, 1985). This suggested that the 
isolated a l-3  protein was effectively mimicking virus in the cell-binding 
process. Cell receptor densities have been calculated for several other 
viruses, including rhinovirus (major receptor group): 1-2,000 sites/HeLa cell 
(Colonno et al., 1988), adenovirus type 41: 4.3 x 104 sites/HEp-2 cell (Yeh
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and Luftig, 1991), adenovirus type 2: 3-6,000 sites/HeLa cell (Persson et 
al., 1983), Theiler's murine encephalomyelitis virus: 1.5 x 103 sites/BHK-21 
cell and 2.5 x 103 sites/oligodendrocyte (Rubio et al., 1990) and herpes 
simplex virus (HSV): 5 x 105 sites/human R970-5 cell (Johnson et al.,
1990). A broad range of densities is evident. This is probably a reflection of 
the fact that viruses utilize cell surface molecules that are normally 
involved in a particular cellular function; the specific densities may 
therefore be a reflection of the level of expression required for a particular 
cell type.
The nature of the receptors for T1 and T3 reovirus on L-cells is 
controversial in that there is evidence favouring a common receptor for the 
two viruses and there are results pointing clearly to each virus type using a 
distinct receptor. The results obtained in this study suggest that these two 
virus serotypes in fact bind to different receptor moieties, as the attachment 
of a l-3  to L-cells could be competed with type 3 virus but not type 1 
(section 9.2.3). A small decrease in the amount of a l-3  bound to the cells 
was caused by the highest concentration of T1 virus and may therefore 
indicate some overlap in the receptor molecules or merely a non-specific 
inhibition due to the high concentration of competing virus. Epstein et al. 
(1984) and Ambler and Mackay (1991), produced similar data in 
competition experiments involving whole virions of these two serotypes. 
Epstein el al. (1984) observed competition only with homologous type 
virus although some inhibition of the T1 binding was noted with the very 
highest amounts of competing T3 virus. In addition, a different number of 
receptor sites for reovirus T1 and T3 was determined by both Epstein et al. 
(1984) and Ambler and Mackay (1991). This would also appear to support 
the idea of two distinct sets of receptors, although an alternative is that a 
single receptor exists for which T1 and T3 have different affinities. Ambler 
and Mackay (1991) have even suggested that there is one receptor for
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reovirus T3 and another to which T1 and T3 can both bind, but for which 
T3 has the higher affinity.
A situation involving two distinct receptor moieties for type 1 and 
type 3 reovirus would be compatible with the a l  mediated serotype 
specific neurotropism and virulence patterns displayed by these viruses in 
the mouse model (Weiner et al., 1977 and 1980b). In this system, T1 virus 
infects ependymal cells (Kilham and Margolis, 1969; Margolis and Kilham, 
1969 and Weiner et al., 1977) and T3 neuronal cells (Walters et al., 1963; 
Margolis et al., 1971; Gonatas et al., 1971; Raine and Fields, 1973 and 
Weiner et al., 1977). These serotype specific differences in target host cell 
was shown to be a property of the respective a l  proteins. A similar 
binding pattern was observed in vitro utilizing cultured neurones and 
ependymal cells (Tardieu and Weiner, 1982). Thus, distinct sets of receptor 
molecules, specific to each of these cell types likely determines the 
different cell-binding properties of the T1 and T3 viruses.
The conclusion that the T1 and T3 viruses bind to different 
receptors contradicts the conclusions reached by Lee et al. (1981b) and 
Choi et al. (1990) who have proposed that the T1 and T3 viruses utilize 
the same receptor. Lee et al. (1981b) demonstrated that a l  protein from 
each serotype could be competed by homologous and heterologous virus 
(i.e. T l, T2 and T3) equally effectively in binding assays. Choi et al (1990) 
found that type 1 and type 3 reovirus bound to similar sets of L-cell 
membrane proteins in Western blot analyses although there were some 
minor differences between the sets of proteins identified by each virus. 
Specificity of binding was demonstrated in assays where the virus used to 
probe the blots was prevented from identifying the apppropriate 
membrane proteins by the presence of homologous type virus. Also, wheat 
germ agglutinin, a lectin with specificity for sialic acid, was found to inhibit 
binding of the T3 virus to L-cells and in Western blot assays, recognized
247
many of the proteins similarly identified by reovirus T3. Thus, it was 
reasoned that sialic acid is a major receptor determinant for reovirus and as 
it is a common cell surface component, accounted for the fact that multiple 
membrane proteins were identified by the virus in the Western blots. A 
pertinent point here is that protein samples to be analysed in Western blots 
are often boiled as part of the blotting procedure (as in the study of Choi 
et al. [1990]) and so the proteins are unlikely to remain in their native 
conformations. Therefore, when this approach is utilized to identify virus 
receptor proteins, it is probable that the virus may not be binding to the 
same structure it recognizes on the cell surface.
Prior to the study of Choi et al. (1990), others had accumulated 
evidence to suggest a role for sialic acid in reovirus receptor recognition. 
Gentsch and Pacitti (1985) reported that neuraminidase treatment of L- 
cells reduced the binding of reovirus by 60-70% and sialyl- 
oligosaccharides also mediated inhibition of binding. Subsequently, the a- 
anomeric form of sialic acid was defined as the minimal reovirus receptor 
determinant on the basis of experiments in which sialyloligosaccharides 
specifically inhibited the attachment of reovirus to L-cells and BSA-sialic 
acid conjugates were able to bind virus particles whereas control 
conjugates were not (Paul et al., 1989).
However, the precise role of sialic acid is unclear. Armstrong et al. 
(1984) and Epstein et al. (1984) showed that binding of reovirus types 1 
and 3 was not affected by pre-treatment of L-cells with neuraminidase, 
whilst Gentsch and Pacitti (1985) were still able to estimate a receptor 
density for and demonstrate specific binding of the virus (in competitive 
binding assays) after neuraminidase treatment of L-cells. The anti-idiotypic 
antibody -87.92.6- which has been reported to recognize the same 
receptor determinant as a l-3  (Kauffman et al., 1983a; Noseworthy et al., 
1983 and Co et al., 1985a) was unaffected in its binding to L-cells by their
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prior incubation in tunicamycin (Noseworthy et al., 1983). Also, Verdin el 
al. (1989) found that only a single membrane protein from rat endothelial 
cells was able to bind reovirus in Western blot assays and that both type 1 
and type 3 virus could detect this protein. This contrasts with the study of 
Choi et al. (1990) where multiple membrane proteins were identified by 
reovirus in similar Western blot analyses (owing to a proposed recognition 
of sialic acid). Thus, whilst the study of Verdin et al. (1989) appears to 
support the claim of Choi et al. (1990) of a common receptor for the T1 
and T3 viruses, it does not support their proposed role for sialic acid as the 
common receptor.
If sialic acid is a receptor determinant for both T1 and T3 virus, then 
other factors must be involved in manifesting the specific binding and 
infection patterns observed in vitro and in vivo, as it seems unlikely that 
either neuronal or ependymal cells (the serotype specific targets in vivo) 
do not possess sialylated cell surface structures. Possibly, sialic acid could 
mediate an initial attachment to the cell surface whereupon specific protein 
interactions could occur. Alternatively, sialic acid may form part of the 
receptor entity with greater specificity determined by proteinaceous 
components. It is, of course, also feasible that the receptor(s) present on L- 
cells are different to those with which reovirus interacts in vivo.
11.13 Mapping the Cell-Binding Domain of o l
Two regions of the C-terminal half of the a  1-3 protein were mutated 
in this study in an attempt to locate a cell-binding domain or domains 
involved in reovirus receptor recognition. Duncan et al. (1990) identified 
five regions of the o l polypeptide that showed relatively high levels of 
conservation between the three serotypes and suggested a possible role 
for those within the C-terminal portion of the protein in receptor binding.
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Two of these regions, designated D and E, were those deleted in this study 
to evaluate their putative function in binding to the reovirus receptor.
Thus, the nucleotides of the cloned SI-3 gene corresponding to these areas 
of the protein were removed by site directed mutagenesis and the proteins 
expressed from the mutant genes named a  1-3 AD and a  1-3 AE. A similar 
study was not possible al-1 as the full-length protein was unable to either 
oligomerize or bind to L-cells (Chapter 8).
Neither al-3AD or al-3AE were able to bind to L-cells suggesting 
that either regions D and E are involved in the binding process or that the 
deletion of the residues in these sites caused the mutant proteins to fold 
incorrectly. If both regions are involved in receptor recognition, it is 
possible that amino acids from each contribute to a conformational binding 
site on a l  responsible for binding to the receptor. Alternatively, if sialic 
acid forms part of the receptor moiety, then one region could bind to the 
carbohydrate and the other to a protein component by which specificity 
between serotypes could be attained. If the data reported by Duncan et al. 
(1991) is taken into account (see below), it would appear that the most 
likely explanation is that the AD and AE mutant proteins were not 
correctly folded.
Duncan et al. (1991) generated a set of C-terminal truncated al-3  
mutants by deleting various lengths from the 3’ end of a cloned copy of 
the S I-3 gene. None of these mutant proteins retained a cell-binding 
activity. Evidence derived from protease and immunoprécipitation 
analyses of these proteins suggested that the deletions had caused gross 
conformational changes in the a l  molecules which were postulated as 
leading to non-functional proteins. Thus, full-length a l  was cleaved by 
trypsin to generate a 26 kDa N-terminal fragment and a 23 kDa C-terminal 
fragment, whilst chymotrypsin treatment resulted in the production of a 46 
kDa polypeptide. In contrast, all the mutant proteins were degraded by
chymotrypsin digestion and trypsin treatment resulted in the generation of 
the 26 kDa N-terminal fragments but the complete degradation of the C- 
termini. The mutant proteins were thus proposed to be misfolded 
molecules, a consequence of which was the exposure of cryptic protease 
cleavage sites. Further evidence was provided by immunoprécipitation 
data in which only full-length a l  was recognized by a neutralizing 
monoclonal antibody. Similarly, the deletions introduced in a l-3  in this 
study, may have effected major conformational changes in the mutant 
proteins al-3AD and al-3AE leading to their loss of cell-binding activity. 
This would require further work to be confirmed.
There have been several other reports concerning attempts to 
identify the cell-binding domain(s) of a l ,  one of which also concentrated 
on analysing amino acid residues in the conserved regions of this protein 
delineated by Duncan et al. (1990).
Investigations utilizing a monoclonal anti-idiotypic antibody - 
87.92.6- (Bruck et al., 1986 and Williams et al., 1988 - explained in greater 
detail in section 1.6) resulted in the proposal that amino acids 317- 332 of 
a l-3  are involved in receptor recognition. A synthetic peptide, designated 
Vl as it corresponded to the CDRII sequence of the light chain variable 
region of 87.92.6, was found to inhibit the binding of reovirus T3 to L- 
cells (Williams et al., 1988). In a subsequent study, Williams et al. (1991) 
utilized variants of peptide VL in similar binding assays and from these 
suggested that the amino acids in positions 325, 326, 327 and 328 (serine, 
tyrosine, serine and serine respectively) of the a l-3  protein were likely to 
interact through their hydroxyl oxygens with the reovirus receptor (which 
was regarded as being sialic acid). These amino acids lie within one of the 
five conserved regions (region C) identified in the sequence analysis of 
Duncan et al. (1990) of which tyrosine 326 is conserved in all three virus 
serotypes.
In a more direct assessment of these residues. Turner et al. (1992) 
mutated the appropriate amino acids of a  1-3 and tested the resulting 
protein variants for their ability to bind to L-cells; amino acids within 
regions D and E were similarly targetted with both conserved and non- 
conserved amino acids being mutated. The mutation of conserved residues 
in regions C, D or E resulted in proteins that had lost their cell-binding 
activities and was associated with conformational changes in the C- 
terminal globular heads of these proteins. However, mutagenesis of the 
non-conserved residues, including those in positions 325 and 327 
suggested by Williams et al. (1991) to be involved in receptor recognition, 
had no effect on the ability of the resulting mutant proteins to bind to L- 
cells. The results from these two studies are summarised in Figure 11.1.3.
Turner et al. (1992) concluded that the conserved amino acids were 
probably not all involved in receptor binding but played important roles in 
maintaining the C-terminal globular head in a functionally correct 
conformation and that the receptor binding site was therefore likely to be 
conformationally defined. These authors also accepted that sialic acid is a 
receptor moiety for reovirus and that as a conformational sialic acid 
binding pocket has been defined for two well characterized sialic acid 
binding proteins, i.e. the influenza HA (Weis et al.. 1988) and wheat germ 
agglutinin (Wright et al., 1987), it would not be unexpected for the 
reovirus a l  receptor binding site to be conformational. Furthermore, since 
it was the amino acids conserved between all three serotypes that were 
proposed to be important in receptor recognition. Turner et al., (1992) 
suggested sialic acid to be a receptor determinant not only for T3 reovirus 
but for T1 and T2 as well. Thus, despite the contradictory conclusions of 
Williams et al. (1991) and Turner et al. (1992) that the same amino acid 
residues either do or do not contribute to the a  1-host cell receptor binding 
site, each regarded their studies as evidence for sialic acid as a component
Figure 11.1.3 
Recognition
al-3  Amino Acids Putatively Involved in Receptor
The above diagram shows the amino acid residues of a  1-3 investigated in 
the studies of Williams et al. (1991) and Turner et al. (1992) as being 
potentially involved in reovirus receptor recognition. The conserved 
regions C , D and E of the c l -3 protein (Duncan et al. 1990) are marked as 
hatched boxes. The residues above the enlarged representation of a l-3  are 
those mutated in the protein by Turner et al. (1992) whilst those below, are 
the amino acids in a l-3  corresponding to those mutated in the synthetic 
peptides utilized by Williams et al. (1991).
The amino acids marked in bold type are conserved residues in all three 
virus serotypes. "+" indicates that mutation of the amino acid diminished 
either the cell-binding ability of a l-3  or that the synthetic peptide with the 
equivalent residue mutated, was less able to inhibit binding of reovirus to 
L-cells. indicates that mutation of these residues had no effect on these 
functions of a l-3  or the synthetic peptides.
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recognized by reovirus in the cell-binding process. However, for reasons 
discussed previously in section 11.1.2, the evidence that this carbohydrate 
molecule does function in a capacity of a reovirus receptor moiety would 
appear to be inconclusive.
In summary, the in vitro approach taken in this study to the 
expression and characterisation of the cell-binding properties of the a l  
protein of reovirus has proved to be a useful model of the virus-cell 
interaction and mimicked many of the binding characteristics displayed by 
virus particles. The main advantages with this system are :
i) Synthesis of a l  in rabbit reticulocyte lysate is a convenient and 
reliable means of producing the "substrate" for the cell-binding assays. 
Virus preparations are altogether more inconvenient, time consuming and 
expensive, especially if radiolabelled virus is required.
ii) Expression of a l  from cloned copies of the appropriate SI genes 
enabled the relatively easy generation of a l  mutants in the attempt to 
identify amino acids critical for receptor recognition. At present, the 
generation of such specific mutants is not technically possible with virus 
particles.
However, despite the fact that the mutant proteins were unable to 
bind to L-cells, it was not possible to define a cell-binding domain owing 
to the high probability that they were misfolded molecules. Other 
researchers have taken a similar mutational approach to this problem and 
were also unable to discount a conformational effect of the mutation as the 
reason for the protein being non-functional. Possibly, the most convincing 
data concerning the identification of a l  residues involved in binding to 
the reovirus receptor would be obtained if a al/receptor or virus/receptor 
complex could be analysed by x-ray crystallography.
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A ppendix  A: M ap  of B luescribe  V ector (Stratagene)
The map below shows the relev ant features of the vector 
Bluescribe.
0/3.2
----- EcoR1 (881)
----- Sstl
----- Kpnl
___Xmal /
Smal
----- Bam HI
----- Xba I
___ Hindi/
Accl/Sal1
----- Pstl
----- Sphl
----- Hindi 11 (932)
tP
T7 = T7 RNA polymerase promoter
T3 = T3 RNA polymerase promoter
lacZ = Portion of lacZ  gene (encoding the a-peptide 
of p-galactosidase)
ampr = p-lactamase gene conferring ampicillin resistance
PL = Polylinker region
M13+ = Origin of replication of the bacteriophage M13 
The + indicates that the plasmid strand rescued by a 
helper phage will contain the coding region of the 
lacZ  gene
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Appendix B: Map of pGEM-3Z Vector (Promega)
The map below shows the relevant features of pGcm-3Z. The 
number 1 adjacent to the T7 bacteriophage promoter (black box) 
indicates the T7 RNA polymerase transcription initiation site and 
also represents the first base in the numbering scheme of the 
plasmid.
PL
-1
----- EcoR1 (5)
----- Sstl
-----Kpnl
___ Xmal/
Smal
---- Bam HI
----- Xba I
_  H indi/ 
Accl/Sal1
----- Pstl
-----Sphl
----- Hindlll (56)
t io0.cn
T7 = T7 RNA polymerase promoter
SP6 = SP6 RNA polymerase promoter
lacZ = Portion of lacZ  gene (encoding the u-peptide
of fi-galactosidase)
ampr = p-lactamase gene conferring ampicillin resistance
PL = Polylinker region
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A ppend ix  C : M ap  o f C lone pB S 4-l
Clone pBS4-l consists of acDNA sequence of the reovirus S4-1 gene 
engineered into the vector Bluescribe and was constructed by P. Martin 
(University of Warwick). The 5' end of the gene is adjacent to the T7 
bacteriophage promoter. Plus sense s4-l RNA can therefore be synthesized 
utilizing T7 RNA polymerase.
T7 = T7 RNA polymerase promoter 
T3 = T3 RNA polymerase promoter 
[\^ = Polylinker sequence
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A ppend ix  D: M a p  o f V ecto r M 1 3 m p l9
M13mpl9 (Yanisch-Perron et al., 1985) was utilized as the 
cloning vector to effect the oligonucleotide directed 
mutageneses of the cloned reovirus SI genes described in this 
study (Chapters 7 and 10). The linear map below the RF map 
shows the recognition sites of the polylinker and the positions 
of the forward and reverse primer sequencing sites.
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